-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WZoDW3t6beHGocIL7u7HiLi0YGw31pcOzn1v6K1NAhGJH+tmzj5K+AksbVN61S6J DR1VpgRThpup1Pe+N3ahgQ== 0000066479-97-000006.txt : 19970311 0000066479-97-000006.hdr.sgml : 19970311 ACCESSION NUMBER: 0000066479-97-000006 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 19961231 FILED AS OF DATE: 19970310 SROS: NYSE FILER: COMPANY DATA: COMPANY CONFORMED NAME: MILLIPORE CORP CENTRAL INDEX KEY: 0000066479 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 042170233 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-09781 FILM NUMBER: 97553145 BUSINESS ADDRESS: STREET 1: 80 ASHBY RD CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: 6172759200 MAIL ADDRESS: STREET 1: 80 ASHBY ROAD CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: MILLIPORE FILTER CORP DATE OF NAME CHANGE: 19661116 10-K 1 -1- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 (Fee required) For the fiscal year ended December 31, 1996 or Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 (No fee required) For the transition period from ___________ to ______________ Commission File Number 0-1052 MILLIPORE CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 04-2170233 (State or Other Jurisdiction of (I.R.S. Employer Identification No.) Incorporation or Organization) 80 Ashby Road, Bedford, MA 01730 (Address of principal executive offices) (Zip Code) (617) 275-9200 (Registrant's telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Name of Exchange Title of Class on Which Registered Common Stock, $1.00 Par Value New York Stock Exchange, Inc Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes X No Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of Form 10-K or any amendment to this Form 10-K. As of February 21, 1997, the aggregate market value of the registrant's voting stock held by non-affiliates of the registrant was approximately $1,907,834,434 based on the closing price on that date on the New York Stock Exchange. As of February 21, 1997, 43,432,561 shares of the registrant's Common Stock were outstanding. Item 1. Business. The Company Millipore Corporation was incorporated under the laws of Massachusetts on May 3, 1954. Millipore is a leader in the field of membrane separations technology and develops, manufactures and sells products which are used primarily for the analysis, identification and purification of fluids. Millipore's products are based on a variety of membrane and other technologies that effect separations, principally through physical and chemical methods. Millipore is an integrated multinational manufacturer of these products. During 1996 approximately 65% of Millipore's net sales were made to customers outside the United States. Geographic segment information is discussed in Note Q to the Millipore Corporation Consolidated Financial Statements (the "Financial Statements"). Unless the context otherwise requires, the terms "Millipore" or the "Company" mean Millipore Corporation and its subsidiaries (including, except where noted, the Amicon Separation Science Business of W. R. Grace & Co. ("Amicon") and excluding Tylan General, Inc. ("Tylan"), described below). On December 31, 1996, Millipore acquired Amicon for a purchase price of $129,300,000 in cash (including transaction costs). Amicon develops, manufactures and sells molecular separation and purification products for the life science research laboratory and for pharmaceutical/biotechnology manufacturing applications. The technologies employed in its products consist primarily of membrane ultrafiltration and liquid chromatography. Amicon's 1996 revenues were approximately $57,000,000. For further financial information concerning the accounting for the purchase of Amicon see Note C to the Financial Statements. For a discussion of the Tylan General, Inc. acquisition and business see page 6. Products and Technologies For analytical applications, the Company's products are used to gain knowledge about a molecule, compound or micro-organism by detecting, identifying and quantifying the relevant components of a sample. For purification applications, the Company's products are used in manufacturing and research operations to isolate and purify specific components or to remove contaminants. The principal separation technologies utilized by the Company are based on membrane filters, and certain chemistries, resins and enzyme immunoassays and liquid chromatography. Membranes are used to filter either the wanted or the unwanted particulate, bacterial, molecular or viral entities from fluids, or to concentrate and retain such entities (in the fluid) for further processing. Some of the Company's newer membrane materials also use affinity, ion-exchange or electrical charge mechanisms for separation. Both analytical and purification products incorporate membrane and other technologies. The Company's products include disc and cartridge filters and housings of various sizes and configurations, filter-based test kits and precision pumps and other ancillary equipment and supplies. The Company sells more than 3,000 products. Most of the Company's products are listed in its catalogs and are sold as standard items, systems or devices. For special applications, the Company assembles custom products, usually based upon standard modules and components. In certain instances (particularly with respect to process chromatography), the Company also designs and engineers process systems to meet specific needs of the customer. The Company's products also include, in some cases, proprietary software designed to operate and/or integrate certain of its other products or systems (particularly membrane ultrafiltration and chromatography systems). Customers and Markets The Company sells its products primarily to the following markets: to pharmaceutical/biotechnology, microelectronics, chemical and food and beverage companies for use in their manufacturing procedures; and to government, university and private research and testing analytical laboratories. Within each of these markets, the Company focuses its sales efforts upon those segments where customers have specific requirements which can be satisfied by the Company's products. Pharmaceutical/Biotechnology Industry. The Company's products are used by the pharmaceutical/biotechnology industry in sterilization, including virus reduction, and sterility testing of products such as antibiotics, vaccines, vitamins and protein solutions; concentration and fractionation of biological molecules such as vaccines and blood products; cell harvesting; isolation and purification of compounds from complex mixtures and the purification of water for laboratory use. The Company's membrane products also play an important role in the development of new drugs. In addition, Millipore has developed and is developing products for biopharmaceutical applications in order to meet the purification requirements of the biotechnology industry. Microelectronics Industry. The microelectronics industry uses the Company's products to purify (by removing particles and unwanted contaminating molecules), deliver, and monitor the liquids and gases used in the manufacturing processes of semiconductors and other microelectronics components. Sales to the microelectronics market accounted for 28.1 percent of Millipore's 1996 consolidated sales. The microelectronics manufacturing market has experienced historic volatility, and the effect of any such volatility in the future could significantly affect Millipore's sales growth. Chemical Industry. Chemical manufacturers and processors use the Company's products for purification of reagent grade chemicals, for monitoring the atmosphere and waste streams in the industrial workplace and for the purification of water for laboratory use. Food and Beverage Industry. The Company's products are used by the food and beverage industry in quality control and process applications principally to monitor for microbiological contamination; to remove bacteria and yeast from products such as wine and beer, in order to prevent spoilage. Universities and Government Agencies. Universities, governments and private and corporate research and testing laboratories, environmental science laboratories and regulatory agencies purchase a wide range of the Company's products. Typical applications include: purification of proteins; cell culture, and cell structure studies and interactions; concentration of biological molecules; fractionation of complex molecular mixtures; and collection of microorganisms. The Company's water purification products are used extensively by these organizations to prepare high purity water for sensitive assays and the preparation of tissue culture media. Sales and Marketing The Company sells its products within the United States primarily to end users through its own direct sales force and, in the case of analytical products, to a limited extent through an independent distributor. The Company sells its products in foreign markets through the sales forces of its subsidiaries and branches located in more than 30 major industrialized and developing countries as well as through independent distributors in other parts of the world. During 1996, the Company's marketing, sales and service forces (including Tylan) consisted of approximately 379 employees in the United States and 702 employees abroad. The Company's marketing efforts focus on application development for existing products and on new and differentiated products for other existing, newly-identified and proposed customer uses. The Company seeks to educate customers as to the variety of analytical and purification problems which may be addressed by its products and to adapt its products and technologies to separations problems identified by customers. The Company believes that its technical support services are important to its marketing efforts. These services include assisting in defining the customer's needs, evaluating alternative solutions, designing a specific system to perform the desired separation; training users, and assisting customers in compliance with relevant government regulations. Research and Development In its role as a pioneer of membrane separations, Millipore has traditionally placed heavy emphasis on research and development. Research and development activities include the extension and enhancement of existing separations technologies to respond to new applications, the development of new membranes, and the upgrading of membrane based systems to afford the user greater purification capabilities. Research and development efforts also identify new separations applications to which disposable separations devices would be responsive, and develop new configurations into which membrane and ion exchange separations media can be fabricated to efficiently respond to the applications identified. Instruments, hardware, and accessories are also developed to incorporate membranes, modules and devices into total separations systems. Introduction of new applications frequently requires considerable market development prior to the generation of revenues. Millipore performs substantially all of its own research and development and does not provide material amounts of research services for others. Millipore's research and development expenses (excluding Amicon and Tylan) in 1994, 1995 and 1996 with respect to continuing operations were, $34,327,000, $36,515,000 and $38,429,000, respectively. Amicon's research and development expenses in 1994, 1995 and 1996 were $4,144,000, $4,439,000, and $5,180,000, respectively. Tylan's research and development expenses in Fiscal 1994, 1995 and 1996 were $4,189,000, $7,526,000, and $11,807,000, respectively. See Management's Discussion and Analysis of Financial Condition and Results of Operations in Item 7 of this report and also footnotes to Selected Financial Data in Item 6 below for a discussion of research and development write-offs relating to the Amicon and Tylan acquisitions. The Company has traditionally licensed newly developed technology from unaffiliated third parties and/or acquired distribution rights with respect thereto, when it believes it is in its long term interests to do so. In this tradition, in November of 1995 Millipore entered into an agreement with IBC Advanced Technologies to combine their technologies to create a new class of purification products which Millipore intends to take to its customers in its markets. This technology places ligands (organic molecules) on membranes in order to selectively bind with a target molecule in solution, for example a calcium, iron or aluminum ion. Similarly, in May of 1996 Millipore entered into an R&D supply and distribution agreement with Celsis International plc. designed to enhance Millipore's entry into the rapid microbiological market, where there is a need for faster, easier and more accurate ways to detect microbiological contamination. The Celsis technology focuses on the development and supply of rapid diagnostics and monitoring systems to detect and measure microbial contamination. Millipore has been granted a number of patents and licenses and has other patent applications pending both in the United States and abroad. While these patents and licenses are viewed as valuable assets, Millipore's patent position is not of material importance to its operations. Millipore also owns a number of trademarks, the most significant being "Millipore." Competition The Company faces intense competition in all of its markets. The Company believes that its principal competitors include Pall Corporation, Barnstead Thermolyne Corporation and Sartorius GmbH. Certain of the Company's competitors are larger and have greater resources than the Company. However, the Company believes that it offers a broader line of products, making use of a wider range of separations technologies and addressing a broader range of applications than any single competitor. While price is an important factor, the Company competes primarily on the basis of technical expertise, product quality and responsiveness to customer needs, including service and technical support. Environmental Matters The Company is subject to numerous federal, state and foreign laws and regulations that impose strict requirements for the control and abatement of air, water and soil pollutants and the manufacturing, storage, handling and disposal of hazardous substances and waste. These laws and regulations include the federal Comprehensive Environmental Response, Compensation, and Liability Act, the Clean Air Act, the Clean Water Act and the Resource Conservation and Recovery Act. The Company is in substantial compliance with applicable environmental requirements. Because regulatory standards under environmental laws and regulations are becoming increasingly stringent, however, there can be no assurance that future developments will not cause the Company to incur material environmental liabilities or costs. Under the Clean Air Act Amendments of 1990 ("CAA"), the Environmental Protection Agency ("EPA") has been directed, among other things, to develop standards and permit procedures with respect to certain air pollutants. Because many of the implementing regulations have not yet been promulgated, the Company cannot make a final assessment of the impact of the CAA. Based upon its preliminary review of the CAA, however, the Company currently believes that compliance with the CAA will not have a material adverse impact on the operations or financial condition of the Company. Tylan General, Inc. Acquisition Millipore acquired all the shares of Tylan effective as of January 27, 1997. The acquisition of the shares of Tylan was at a price of $16 per share, or approximately $133,000,000. Millipore also assumed Tylan's outstanding debt, net of cash, of approximately $23,600,000. Tylan develops, manufactures, markets and sells a broad range of components used in the handling of process gases for the semiconductor industry. Tylan had 1996 sales of approximately $148,000,000. For further financial information concerning the accounting treatment of the Tylan acquisition, see Note D to the Financial Statements on Page F-15 of this report. Products and Technologies Tylan's mass flow controllers measure mass flow by separating a small portion of the main gas stream and sensing the heat transfer it creates as it flows through a small measuring capillary. This information is used by the product's servo control circuit as it adjusts the position of the product's internal control valve. The result is a highly accurate, reliable and repeatable measurement and control of the process gas flow rate. Tylan's pressure products are used to measure and control pressure in process reactors. Tylan's capacitance diaphragm gauges can be used to measure total pressure in a process chamber and, when used in conjunction with a variable conductance valve and a pressure controller, can be used to control the pressure in process reactors. Gas panels are typically comprised of mass flow controllers, filters, purifiers, shut-off valves, regulators and other associated hardware. Their purpose is to manage the on-tool handling of the gases that are supplied to the system. The process gases in a semiconductor fabrication facility are generally stored in large bulk containers and are distributed throughout the facility in highly pressurized pipes or gas lines. Once delivered to the tool, particles and contaminants must be removed, gas flow rates must be measured and controlled and the resultant mixture of process gases must be routed to the process chamber. These critical functions are performed by the gas panel. Tylan designs and manufactures ultraclean gas panels both for new process tools and for retrofit or replacement on existing tools. In response to the growing demand for ultraclean gas panels, it has recently developed the Intelligent Gas Panel, which allows real-time monitoring of mass flow controller performance. Sales and Marketing Tylan primarily sells its products through a worldwide network of direct sales personnel augmented by strategically located distributors and representatives. Tylan services products from six Company-owned service offices in the United States. Internationally, it provides service through seven Company-owned service offices: Korea, Japan, the United Kingdom, France, Germany (two locations) and Scotland. All of these offices provide calibration of ultraclean mass flow controllers in modern clean room facilities. In addition, service is also provided internationally through agreements with certain key distributors in Taiwan, Singapore, Ireland and Israel. Customers and Markets Tylan's customers are primarily manufacturers of semiconductor wafer processing equipment. It also sells retrofit or replacement parts directly to integrated circuit manufacturers. These manufacturers often specify to their equipment suppliers which vendor's process instrumentation should be supplied with a particular process tool. Research & Development Tylan's research and development efforts are focused on developing products that address the evolving needs of its customers and enhancing its existing products. The markets in which it competes are characterized by evolving industry standards and continuous improvements in products and services. To compete effectively in such markets, Tylan must continually improve its products and develop new products that compare favorably on the basis of price and performance. The markets in which Tylan's customers compete are also characterized by rapidly changing technology and emerging industry standards. Consequently, Tylan must adapt its products to meet such technological changes and support such standards. Competition The market for Tylan's products is highly competitive. Significant competitive factors include cost of ownership, historical relationships, product quality, performance, size of installed base, breadth of product line and customer service and support. Tylan competes with a number of companies in its mass flow controller markets and with other companies, including MKS Instruments, in its pressure products markets. Although Tylan has achieved significant sales of its pressure products to the Japanese market, the Japanese mass flow control market has been difficult for non-Japanese companies to penetrate. In addressing the Japanese mass flow control market, Tylan is at a competitive disadvantage compared to Japanese suppliers, many of which have long-standing collaborative relationships with Japanese integrated circuit manufacturers and their equipment suppliers. Restructuring and Divestitures In August 1994, Millipore completed the divestiture of its Instrumentation Divisions (the Waters Chromatography business and the non-membrane bioscience instrument business). The Company realized a net loss of $3.4 million in 1994 upon the disposition of those divisions, including all costs estimated to be incurred in connection with the divestitures as well as the pre-tax operating losses generated by those divisions from November 11, 1993 through the date of completion of the divestitures. Other Information Since April of 1988, the Company has had in place a shareholder rights plan (the "Rights Plan") pursuant to which it declared a dividend to its shareholders of the right to purchase (a "Right"), for each share of Millipore Common Stock owned, one additional share of Millipore Common Stock at a price of $80 for each share (giving effect to the 1995 two for one stock split). The Rights Plan is designed to protect Millipore's shareholders from attempts by others to acquire Millipore on terms or by using tactics that could deny all shareholders the opportunity to realize the full value of their investment. The Rights will be exercisable only if a person or group of affiliated or associated persons acquires beneficial ownership of 20% or more of the outstanding shares of the Company Common Stock or commences a tender or exchange offer that would result in a person or group owning 20% or more of the outstanding Common Stock. In such event, or in the event that Millipore is subsequently acquired in a merger or other business combination, each Right will entitle its holder to purchase, at the then current exercise price, shares of the common stock of the surviving company having a value equal to twice the exercise price. Millipore's products are made from a wide variety of raw materials which are generally available in quantity from alternate sources of supply; as a result, Millipore is not substantially dependent upon any single supplier. As of December 31, 1996, Millipore (excluding Amicon and Tylan) employed 3,482 persons worldwide, of whom 1,707 were employed in the United States and 1,775 overseas. Amicon employed approximately 400 employees at year end 1996, and Tylan employed approximately 800 employees at year end 1996. Executive Officers of Millipore The following is a list as of March 1, 1997 of the Executive Officers of Millipore. All of the following individuals were elected to serve until the Directors Meeting next following the 1997 Annual Stockholders Meeting. First Elected: To An Present Name Age Office Officer Office C. William Zadel 53 Chairman of the Board 1996 1996 President and Chief Executive Officer of the Corporation Geoffrey Nunes 66 Senior Vice President 1976 1980 of the Corporation Michael P. Carroll 46 Vice President of the Corporation 1992 1992 and Chief Financial Officer Douglas B. Jacoby 50 Vice President 1989 1989 of the Corporation John E. Lary 50 Vice President 1994 1994 of the Corporation Joanna Nikka 45 Vice President 1996 1996 of the Corporation Jeffrey Rudin 45 Vice President 1996 1996 of the Corporation and General Counsel Hideo Takahashi 55 Vice President of 1996 1979 the Corporation and (As President President of Nihon of Nihon Millipore Millipore) Mr. Zadel was elected President, Chief Executive Officer and Chairman on February 20, 1996. Mr. Zadel had been, since 1986, President and Chief Executive Officer of Ciba Corning Diagnostics Corp., a company that develops, manufactures and sells medical diagnostic products. Prior to that he was Senior Vice President of Corning Glass Works' (now Corning Inc.) Americas Operations (1985) and Vice President of business development (1983). Mr. Zadel currently serves on the Boards of Directors of Kulicke and Soffa Industries, Inc., Matritech, Inc. and Zoll Medical Corporation. Mr. Nunes joined Millipore in 1976 as Vice President and General Counsel and was elected a Senior Vice President in 1980. Mr. Nunes has announced that he will be retiring from Millipore at the end of April 1997. Mr. Carroll joined Millipore in 1986 as Vice President/Finance for the Membrane Products Division following a ten-year career in the general practice audit division of Coopers and Lybrand. In 1988, Mr. Carroll assumed the position of Vice President of Information Systems (worldwide) and in December of 1990, he became the Vice President of Finance for the Company's Waters Chromatography Division. Mr. Carroll was elected to Corporate Vice President, Chief Financial Officer and Treasurer in February, 1992. Mr. Carroll has been designated President Millipore Asia Ltd, a position he will assume once his successor as Chief Financial Officer has been appointed and installed. He will remain a Corporate Vice President. Mr. Jacoby joined Millipore in 1975. After serving in various sales and marketing capacities, Mr. Jacoby became Director of Marketing for the Millipore Membrane Products Division in 1983 and in 1985, he assumed the position of General Manager of the Membrane Pharmaceutical Division. In 1987, Mr. Jacoby assumed responsibility for the Company's process membrane business and in 1994 assumed responsibility for the sales, marketing and R&D for all of the Company's worldwide business. Mr. Jacoby was elected a Corporate officer in December, 1989. Mr. Lary was elected a Corporate Vice President in November 1994, and is responsible for the worldwide operations of the Company. From May of 1993 until his election as a Corporate Vice President, Mr. Lary served as Senior Vice President and General Manager of the Americas Operation. For the ten years prior to that time, he served as Senior Vice President of the Membrane Operations Division of Millipore. Ms. Nikka was elected Corporate Vice President for Human Resources in November 1996. Ms. Nikka was Vice President at Fidelity Investments from 1991 to November 1996. Prior to joining Fidelity in 1991, Ms. Nikka was Vice President of Human Resources at Symbolics, Inc. Mr. Rudin was elected Corporate Vice President and General Counsel in December 1996. Prior to joining Millipore, and since 1993 Mr. Rudin was Senior Vice President and General Counsel of Ciba Corning Diagnostics Corporation and was Vice President and General Counsel of that company from 1988 until 1993. Mr. Takahashi joined Millipore in 1979 as President and Chief Executive Officer of its Japanese subsidiary, Nihon Millipore Ltd. Mr. Takahashi was elected as a Vice President of the Company on February 8, 1996. Item 2. Properties. Millipore owns approximately 1.25 million square feet of facilities located in the United States, Europe and Japan. The following table identifies the principal properties owned by Millipore and describes the purpose, floor space and land area of each. Floor Space Land Area Location Facility Sq. Ft. Acres Bedford, Executive Offices, research, 352,000 31 MA pilot production & warehouse Danvers Manufacturing and office 65,000 16 MA Jaffrey, Manufacturing, warehouse 169,000 31 NH and office Cidra, Manufacturing, warehouse 134,000 36 Puerto Rico and office Molsheim, Manufacturing, warehouse 148,000 20 France and office St. Quentin Office and research 50,000 5 France Nancy, Office and research 20,000 6 France Cork, Manufacturing 83,000 20 Ireland Limerick, Manufacturing and warehouse 20,000 <1 Ireland Stonehouse Manufacturing and office 35,000 1 United Kingdom Yonezawa, Manufacturing and warehouse 144,000 7 Japan TOTAL 1,248,000 173 The facilities located in Cidra, Puerto Rico and Yonezawa, Japan are currently underutilized by approximately 25% and 50%, respectively, allowing for future manufacturing and distribution growth. The small facility in Limerick is approximately 70% underutilized. _____________________________________ In addition to the above properties, Millipore has entered into a long term lease for premises abutting its Bedford facility. This lease makes 75,000 square feet of building available to Millipore and contains rights of first refusal and options with respect to the purchase of the premises by Millipore and the sale of the premises to Millipore. During 1988 Millipore entered into a 10-year lease for a building of 130,000 square feet located in Burlington, Massachusetts, approximately 5 miles from its Bedford headquarters. This lease contains a single 5- year extension option. In 1991 the Company entered into a 15-year lease with renewal options for an aggregate of 20 years, as well as a purchase option covering a 134,000 square foot building which is adjacent to the leased property referred to in the first sentence of this paragraph, and which houses the Company's Process System Business, as well as the customer training laboratories for this group. In addition to its foregoing properties, Millipore currently leases various manufacturing, sales, warehouse, and administrative facilities throughout the world. Such leases expire at different times through 2006. The rented space aggregate is approximately 717,000 square feet (including leased facilities acquired in the Amicon transaction) and cost was approximately $9,034,000 in 1996. No single lease, in opinion of Millipore, is material to its operations. Tylan maintains offices and a manufacturing facility for its pressure measurement and control products in a leased 43,700 square foot facility in San Diego, California. The lease on this facility will expire in March 2006. Tylan's primary manufacturing facility for mass flow control products is located in a leased 54,200 square foot facility in Rancho Dominguez, California. The lease on this facility will expire in July 2005. Tylan also leases a 9,700 square foot manufacturing facility for gas panel products in Austin, Texas under a lease that expires in August 1997, and leases a 85,000 square foot manufacturing facility in Plano, Texas under a lease expiring in 2005. Tylan has additional leased sales and service facilities in San Jose, California, Tempe, Arizona and Salem, New Hampshire. Tylan's principal European manufacturing facility is leased by its subsidiary in Swindon, England, The 6,900 square foot facility serves as the European headquarters for manufacturing. Tylan's subsidiaries also lease a 6,100 square foot sales and service facility in Eching, Germany, a 570 square foot sales and service facility in Dresden, Germany, a 4,800 square foot sales and service facility in St. Quentin Fallavier, France and a 1,000 square foot facility in Livingston, Scotland. Tylan General K.K. leases a 9,300 square foot manufacturing, sales and service center in Yokohama, Japan. In addition, Tylan General Korea Ltd. leases a 1,700 square foot sales and service facility and Hanyang General Co., Ltd. leases a 1,700 square foot manufacturing facility, both of which are located in Kyunggi-Do, Korea. Millipore is of the opinion that all the facilities owned or leased by it are well maintained, appropriately insured, in good operating condition and suitable for their present uses. Item 3. Legal Proceedings. Millipore has been, over the last 13 years, notified that the EPA has determined that a release or a substantial threat of a release of hazardous substances (a "Release") as defined in Section 101 of the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended by the Superfund Amendments and Reauthorization Act of 1986 (SARA), or analogous state law ("CERCLA" or "Superfund") has occurred at twelve sites to which chemical wastes generated by the manufacturing operations of Millipore or one of its divisions may have been sent. These notifications typically also allege that Millipore is a potentially responsible party ("PRP") under CERCLA with respect to any remedial action needed to control or prevent any such Release. Because CERCLA provides for strict, joint and several liability, a government plaintiff could seek to recover all remediation costs at a waste disposal site from any one of the PRPs, including the Company. Generally, where there are a number of financially viable PRPs, liability has been apportioned, or the Company believes, based on its experience with such matters, that liability will be apportioned, based on the type and amount of waste disposed of by each PRP at such disposal site and the number of financially viable PRPs. No assurance can be given, however, that this method of apportionment will be used at any particular site. The Company has paid approximately $14 million to date pursuant to consent decrees with the EPA and relevant state agencies to settle its liability at seven of the Superfund sites at which the Company has been named a PRP. These consent decrees provide the Company with a release from further liability with respect to certain covered matters. However, as is typical with such consent decrees, EPA and the relevant state agencies reserve the right to maintain actions against the settling parties, including the Company, in the event certain actions occur or do not occur. In addition, third party private actions could be brought against the Company for matters not covered in the consent decrees. The Company is currently appealing a decision by a federal district court located in Massachusetts, which held that the Company's insurers were not required to indemnify the Company for costs incurred at five of the Superfund sites at which the Company is named a PRP. If the Company loses on appeal, the Company will not receive reimbursement from its carriers at any of the Superfund sites. The Company believes it has sufficient reserves, which do not assume recovery from its insurance carriers, to satisfy the Company's estimated remaining liabilities at the twelve Superfund sites. The Company believes that, based on the number and size of financially solvent PRPs participating at each Superfund site, the amount and types of wastes disposed of by the Company at these sites, and the likely availability of contribution from other PRP's in the event the Company were held jointly and severally liable at any of the sites, the aggregate of any future remaining potential liabilities should not have a material adverse effect on the Company's financial condition. The Company and Waters Corporation are engaged in an arbitration proceeding and a related litigation in the Superior Court, Middlesex, Massachusetts, both of which commenced in the second quarter of 1995 with respect to the amount of assets required to be transferred by the Company's Retirement Plan in connection with the Company's divestiture of its former Chromatography Division. In the second quarter of 1996, Waters filed a Complaint in the Federal District Court of Massachusetts alleging that the Company's operation of the Retirement Plan violates ERISA and certain sections of the Internal Revenue Code. The Company believes that it has meritorious arguments and should prevail in these litigations. The ultimate disposition is not expected to have a material adverse effect on the Company's financial condition, although any settlement of this matter may impact the Company's financial statements in a particular period. Item 4. Submission of Matters to a Vote of Security Holders. This item is not applicable. PART II Item 5. Market for Millipore's Common Stock, and Related Stockholder Matters. Millipore Stock Prices Stock price data from the New York Stock Exchange is based on high and low sales prices. There were approximately 3,355 shareholders of record as of December 31, 1996. Dividends Declared Range of Stock Prices Per Share 1996 1995 1996 1995 High Low High Low First Quarter $47.13 $36.00 $28.69 $22.88 $0.080 $0.075 Second Quarter 47.13 35.50 34.56 27.00 0.090 0.080 Third Quarter 43.13 33.88 39.13 31.75 0.090 0.080 Fourth Quarter 43.00 33.63 41.50 34.13 0.090 0.080 Item 6. Selected Financial Data. (In thousands except per share) 1996(a) 1995 1994 1993 1992 Net sales $618,735 $594,466 $497,252 $445,366 $427,188 Cost of sales 249,443 243,849 212,675 193,575 195,462 Gross profit 369,292 350,617 284,577 251,791 231,726 Selling, general and 202,140 195,026 159,591 145,647 142,701 administrative expenses Research and development 38,429 36,515 34,327 34,952 32,953 expenses Purchased research & 68,311 - - - - development expense(b) Operating income 60,412 119,076 90,659 71,192 56,072 Gain on sale of equity 5,329 - - - - securities Other income (expense), net - - (10,800) - (2,415) Interest income 2,780 1,682 4,091 4,069 6,888 Interest expense (11,498) (10,623) (7,035) (12,038) (14,692) Income from continuing operations before income taxes 57,023 110,135 76,915 63,223 45,853 Provision for income taxes 13,401 24,781 17,306 14,225 10,317 Income from continuing operations before extraordinary 43,622 85,354 59,609 48,998 35,536 item Earnings (loss) from - - - (10,851) 2,715 discontinued operations Loss on disposal of - - (3,400) - - discontinued operations(c) Income before extraordinary item and cumulative effect of change in accounting 43,622 85,354 56,209 38,147 38,251 principle Extraordinary item-loss on - - - (3,544) - early extinguishment of debt Cumulative effect of change in accounting for postretirement - - - - (5,068) benefits Net income $43,622 $85,354 $56,209 $34,603 $33,183 Net income per common share: Income from continuing $1.00 $1.90 $1.09 $0.88 $0.63 operations Net income per common 1.00 1.90 1.03 0.62 0.59 share Cash dividends declared per 0.35 0.315 0.295 0.275 0.255 share Average common shares and 43,602 44,985 54,726 55,902 56,484 equivalents Financial Data Working capital $95,512 $90,337 $100,649 $232,865 $220,378 Total assets 682,892 530,945 536,980 728,573 764,950 Long-term debt 224,359 105,272 109,327 110,067 103,332 Shareholders' equity $217,605 $226,475 $221,277 $461,154 $452,835 (a) On December 31, 1996, the Company acquired Amicon for $129.3 million in cash, including transaction costs. This acquisition was accounted for as a purchase. As this transaction was completed on the last business day of 1996, the accompanying 1996 consolidated statement of income excludes all 1996 business activity conducted by Amicon. However, the assets acquired and liabilities assumed are included in the Company's consolidated balance sheet at December 31, 1996. (b) Purchased research and development represents the write-off of in-process research and development arising from the acquisition of Amicon on December 31, 1996. (c) The loss on disposal of discontinued operations in 1994 include pre-tax operating losses generated by the discontinued businesses from November 11, 1993 through the completion of such divestitures. Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations. Forward-Looking Statements The matters discussed herein, as well as in future oral and written statements by management of the Company, that are forward- looking statements are based on current management expectations that involve substantial risks and uncertainties which could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements. When used herein or elsewhere, the words "anticipate", "believe", "estimate", "expect", "may", "will", "should" or the negative thereof and similar expressions as they relate to the Company or its management are intended to identify such forward-looking statements. Potential risks and uncertainties that could affect the Company's future operating results include, without limitation, foreign exchange rates; increased regulatory concerns on the part of the biopharmaceutical industry; further consolidation of drug manufacturers; competitive factors such as new membrane technology, and/or a new method of chip manufacture which relies less heavily on purified chemicals and gases; availability of component products on a timely basis; inventory risks due to shifts in market demand; change in product mix; conditions in the economy in general and in the microelectronics manufacturing market in particular; the difficulty in integrating acquired companies; potential environmental liabilities; the inability to utilize technology in current or planned products due to overridding rights by third parties, and the risk factors listed from time to time in the Company's filings with the SEC. See also "Business -- Environmental Matters", "Legal Proceedings" and "--Business Outlook and Uncertainties". Recent Developments On December 31, 1996, the Company acquired Amicon for a price of $129.3 million in cash, including transaction costs. This transaction was accounted for as a purchase and resulted in a pre- tax write-off for purchased research and development of $68.3 million in the fourth quarter of 1996. As this transaction was completed on the last business day of 1996, the accompanying 1996 consolidated statement of income excludes all 1996 business activity conducted by Amicon. However, the assets acquired and liabilities assumed are included in the Company's consolidated balance sheet at December 31, 1996. On January 22, 1997, the Company announced the successful completion of its tender offer for all of the outstanding common shares of Tylan for $16.00 per share. Tylan became a wholly owned subsidiary of the Company on January 27, 1997. The purchase price was $133.0 million, plus the assumption of Tylan's outstanding debt, net of cash, totaling $23.6 million. This acquisition will be accounted for as a purchase in the first quarter of 1997. Results of Operations Net Sales Consolidated net sales, measured in U.S. dollars, increased 4 percent in 1996 compared to an increase of 20 percent in 1995. The lower sales growth rate in 1996 compared to 1995 was primarily attributable to the microelectronics manufacturing market entering one of its periodic downturns as well as unfavorable foreign exchange comparisons. Sales growth rates by geography and market, measured in local currencies and U.S. dollars, are summarized in the table below: Sales growth Sales growth rates rates measured in measured in local currencies U.S. dollars 199 1995 1994 199 199 199 6 6 5 4 Americas 8% 15% 8% 7% 13% 8% Europe 6% 10% 6% 4% 20% 7% Asia/Pacific 14% 18% 16% 2% 27% 21% Consolidated 10% 15% 10% 4% 20% 12% Microelectroni 8% 43% 33% 0% 50% 39% cs Mfg BioPharmaceuti 14% 9% 4% 10% 14% 6% cal Mfg Analytical 8% 3% 4% 3% 8% 6% Laboratory Consolidated 10% 15% 10% 4% 20% 12% Full year sales in 1996 to microelectronics manufacturing customers measured in local currencies increased 8 percent compared to 1995. A downturn in the microelectronics market began to impact the Company's sales growth around the middle of 1996, as sales to customers in this market grew 24 percent in the first six months of 1996 compared to 1995 and declined 7 percent in the second half of 1996 compared to 1995. The slowdown significantly impacted growth in both the Americas and Japan while sales growth in the remaining Asia/Pacific microelectronics market remained strong. Sales into the microelectronics market comprised 28 percent of total consolidated sales in 1996, versus 29 percent of total sales in 1995. Sales to the BioPharmeceutical manufacturing market grew 14 percent in local currencies during 1996, compared to 9 percent growth in 1995. The higher growth rate in 1996 was due to increased sales of large protein processing systems to biotechnology customers in both the Americas and Europe, and higher sales to beer manufacturing customers in Japan, particularly in the first six months of the year. Sales to BioPharmeceutical customers comprised 31 percent of total sales in 1996 and 29 percent in 1995. Sales to the analytical laboratory market measured in local currencies grew at faster rates in 1996 than in 1995 and 1994. New product introductions and a new distribution strategy in the United States fueled sales growth in this market, particularly in the last six months of 1996. Sales growth was strongest in the Americas and Japan, while sales grew more modestly in Europe due to a difficult economic environment. Sales to analytical laboratory customers comprised 41 percent of total sales in 1996 and 42 percent in 1995. Foreign exchange rates, primarily the U.S. dollar strengthening against the Japanese yen, reduced reported sales growth by 6 percent in 1996, compared to increasing sales by 5 percent in 1995 and 2 percent in 1994. Approximately 29 percent of the Company's sales in 1996 and 1995 were generated in Japan. On average, the U.S. dollar was 15 percent stronger against the Japanese yen in 1996 compared to 1995. The year to year comparisons were particularly unfavorable in the second and third quarters of 1996 as the dollar was at historic post-war lows against the yen during this time frame in 1995. Though a weaker dollar will benefit, and a strong dollar will adversely affect future reported sales growth, the Company is unable to predict future currency fluctuations and to quantify their effect on net income. Price changes and inflation have not significantly affected the comparability of sales during the past three years. Gross Margins Gross Margins were 59.7 percent in 1996, 59.0 percent in 1995, and 57.2 percent in 1994. The margin improvement in 1996 was due to continued cost containment and increased volume in the Company's manufacturing plants. The significant volume of business transacted in foreign currencies as discussed above exposes the Company to risks associated with currency rate fluctuations which impact the Company's sales and net income. To partially mitigate this risk, the Company has entered into foreign currency transactions, forward and option contracts to sell yen, on a continuing basis in amounts and timing consistent with underlying currency exposure on inventory purchases so that the gains or losses on these transactions offset gains or losses on the underlying exposure. A realized gain of $2.7 million in 1996 and realized losses of $2.3 million in 1995 and $1.0 million in 1994 relating to these contracts were recognized. These gains and losses were reflected in cost of sales each year, partially offsetting the impact of foreign exchange fluctuations. At December 31, 1996, the Company has open forward exchange contracts to sell yen aggregating $13.4 million and open forward option contracts to sell yen aggregating $27.0 million pertaining to this hedging program. These open contracts have an unrealized gain of $1.7 million at December 31, 1996. All open contracts mature within 15 months. Operating Expenses Selling, General and Administrative (S, G & A) Expenses, excluding the effects of foreign exchange, grew 8 percent in 1996, 17 percent in 1995 and 8 percent in 1994. The Company continued to invest in selling and marketing resources to support both new product launches and future sales growth initiatives, particularly in the microelectronics and analytical laboratory markets. Research and Development Expenses increased by 5 percent in 1996 compared to 1995 after increasing 6 percent in 1995 compared to 1994. The increase in spending the past two years is principally due to investments in new products in the microelectronics manufacturing market. Purchased Research and Development Expense of $68.3 million in 1996 represents the write-off of in-process research and development arising from the acquisition of Amicon on December 31, 1996. Other Income/Expense Gain on Sale of Equity Securities reflects the sale of a significant portion of the Company's stock holdings in a Japanese Company. The Company sold these securities in the third and fourth quarters of 1996 to fund a new headquarters and research and development facility in Japan. The cost of moving to this new facility was $2.0 million and was recorded in S,G & A expense. Other Expense in 1994 reflects a non-recurring charge of $10.8 million to settle litigation which arose from the Company's sale of its Process Water Division in 1989. Net Interest Expense in 1996 was comparable with net interest expense in 1995, as the impact of slightly higher net borrowings during 1996 was offset by lower short term interest rates. Net interest expense in 1994 was significantly lower compared to 1995 and 1996 as 1994 benefited from the substantial net proceeds received from the divested business The Provision for Income Taxes was 23.5 percent of pre-tax income in 1996, versus an effective rate in 1995 and 1994 of 22.5 percent. While the Company continues to benefit from low tax rates in Puerto Rico and Ireland and tax incentives attributable to its U.S. export operations, the overall increase in profitability in 1996 slightly diminished the relative benefit derived from these low tax jurisdictions. The Net Loss on Disposal of Discontinued Operations reflects the after tax loss of disposing of the Company's Instrumentation Divisions, the sale of which was concluded in 1994. Earnings Per Share in the past three years include certain non- recurring charges. Earnings per share from continuing operations adjusted for these charges are summarized as follows: 1996 1995 1994 Earnings from continuing $1.00 $1.90 $1.09 operations after charges Charges 1.20 - 0.15 Earnings from continuing operations before charges $2.20 $1.90 $1.24 The charge in 1996 relates to the write-off of purchased in-process research and development arising from the acquisition of Amicon. The charge in 1994 resulted from the settlement of litigation relating to the Company's sale of the Process Water Division in 1989. Legal Proceedings The Company and Waters Corporation are engaged in an arbitration proceeding and related state and federal litigation, which commenced in 1995 and 1996, with respect to the amount of assets required to be transferred by the Company's Retirement Plan in connection with the Company's divestiture of its former Chromatography Division. The Company believes that it has meritorious arguments and should prevail . In the opinion of the Company, although final settlement of this matter may impact the Company's financial statements in a particular period, it is not expected to have a material adverse effect on the Company's financial condition. Capital Resources and Liquidity In 1996, the Company generated $102.2 million of cash from operating activities, compared to $99.1 million in 1995 and $88.6 million in 1994. Net cash provided by operating activities continued to be the Company's primary source of funding capital expenditures, dividends and open market share repurchases in 1996. The slight increase in cash generated from operating activities in 1996 compared to 1995 was primarily due strong collections of accounts receivable, which helped fund an $11.6 million increase in inventories. Capital spending in 1996 was the same as in 1995. The Company continued to invest in capacity expansions in the Company's manufacturing facilities and in information technology systems. In addition, the Company moved into a new headquarters and research and development facility in Japan. As previously discussed, the cost of this move was funded by a sale of equity securities in Japan. The Company expects capital expenditures and depreciation expense in 1997 to be higher than capital spending and depreciation expense in 1996. At December 31, 1996, the Company had no significant commitments for capital expenditures. During the past three years, the Company has used cash generated from its operations and, in 1995 and 1994, cash generated from the sale of its Waters Chromatography and BioScience divisions, to purchase shares of its outstanding common stock. The Company spent, net of stock option exercise amounts, $46.9 million, $64.0 million and $293.0 million in 1996, 1995, and 1994 respectively to repurchase shares of its outstanding common stock. At December 31, 1996, the Company had $9.0 million remaining to spend on a $50.0 million share repurchase program announced in the first quarter of 1996. Share repurchases were stopped at the end of the third quarter of 1996 to maintain financial flexibility in light of pending acquisitions. The Company does not expect to repurchase additional shares of its outstanding common stock in 1997 as cash generated from operations will be used to pay down borrowings required to finance the acquisitions of Amicon and Tylan. The net cash outflow of $7.9 million in 1996 for operations discontinued in 1994 was in line with the Company's expectations. The Company believes that the net cash it will spend in 1997 with respect to such divestitures will approximate the accrued divestiture liability of $3.6 million recorded on the consolidated balance sheet at December 31, 1996. The amount expected to be spent in 1997 will be lower than the amount spent in 1996 as contractual support services provided to the divested businesses will expire. The Company incurred one-time finance related costs in both 1995 and 1994, which did not repeat in 1996. In 1995, the Company paid $3.5 million to close out the Company's German Deutsche mark swap. In 1994, the Company paid a total of $15.4 million in financing related transactions; $5.1 million was used to pre-pay the Company's $100.0 million notes payable due in 1998, while $10.3 million was used to close out the Company's yen currency swap. The Company has $46.9 million of cash and short-term investments on hand at the end of 1996. The amount on hand at December 31, 1996 is higher than that normally held by the Company and consists primarily of balances held by the Company's international subsidiaries which will be used to fund their respective portions of the Amicon and Tylan acquisitions. In addition, the Company has a $450.0 million five-year credit facility (the "credit facility") in place which was drawn on to fund both acquisitions. Borrowings required to fund the acquisition of Amicon were drawn on in December, 1996. Borrowings drawn on in the first quarter of 1997 to fund the acquisition of Tylan would have caused the Company to violate a covenant with respect to the $100.0 million 6.78 percent notes payable due in 2004 which required that the Company prevent total debt from exceeding 60% of total debt plus equity. However, the holder of these notes waived the requirement that the Company comply with this covenant through March 21, 1997. The Company is currently negotiating to change the financial covenant included in this note agreement. If a revised agreement is not reached by March 21, 1997, the Company may redeem the notes using either proceeds from a planned public debt offering for up to $300.0 million or borrowings potentially available upon request by the Company under the Credit Facility. The use of debt to finance the acquisitions of Amicon and Tylan substantially increases the Company's debt-to-equity ratio. However, the Company's financial position remains strong and the Company has flexibility in financing future requirements, although such flexibility is more limited than it had been prior to these acquisitions. Dividends The quarterly dividend was increased in the second quarter of 1996 from $0.08 to $0.09 per share. Dividends paid in 1996 were $14.9 million. Business Outlook and Uncertainties The following statements are based on current expectations. These statements are forward looking and actual results may differ materially. Business Acquisitions - Operations related to the acquisitions of both Amicon and Tylan will be included in the Company's statements of income commencing in the first quarter of 1997. As both acquisitions are accounted for as purchases, all growth rates in the Company's statement of income for 1997 will include the impact of adding these two businesses to the Company's operations. In addition, the Company expects to record in the first quarter of 1997 a non-tax deductible charge in the range of $50.0 million to $100.0 million for purchased research and development arising from the Tylan acquisition. The successful completion of these acquisitions requires the integration of two companies that have previously operated independently. The process of integrating acquired businesses may involve unforeseen difficulties and there can be no assurance that the potential benefits of such integration will be realized to the extent or on the schedule expected by the Company. Moreover, such integration may require a disproportionate amount of the time and attention of the Company's management and the Company's financial and other resources. Any delays or unexpected costs in connection with such integration could have a material adverse effect on the Company's financial condition and results of operations. Sales - As previously noted, sales to the microelectronics market in 1996 represented 28 percent of consolidated 1996 sales. In 1995 and the first six months of 1996, the microelectronics market was the fastest growing market in which the Company participated. However, sales into this market declined 7 percent in the last six months of 1996. Market research data for the microelectronics manufacturing market is forecasting 1997 industry sales growth rate ranging from flat to slightly negative. Sales growth in this market in the past has been volatile, due to general cyclically historically exhibited by this market. The acquisition of Tylan in 1997 increases the Company's presence in the microelectronics manufacturing market. As this market has become a more significant component of the Company's consolidated sales, the effects of future industry volatility could significantly impact the Company's consolidated sales growth. Approximately 65 percent of the Company's sales are transacted outside of the Americas in currencies other than the U.S. dollar. Late in 1996 and early in 1997, the U.S. dollar began to further strengthen against the Japanese yen and French franc. If foreign exchange rates remain at February 1, 1997 levels, the effect of foreign exchange will reduce first quarter 1997 and full-year 1997 reported sales growth by 3 percent and 2 percent, respectively compared to 1996. Any change in foreign exchange rates will be reflected in the results of operations. Gross Margins - The Company expects gross margin percentages in 1997 before the effect of the Amicon and Tylan acquisitions to be comparable with those in 1996, as improved margins resulting from increased volume in the Company's manufacturing plants to support anticipated sales growth is expected to offset slightly lower margins associated with the new U.S. distribution agreement. Lower than expected sales growth will negatively impact the Company's ability to maintain or improve gross margin percentages. Other than the U.S. distribution agreement noted above, the Company anticipates no significant changes in the pricing of it's products. Historical gross margin percentages generated by Amicon approximate those experienced by the Company. However, historical gross margin percentages generated by Tylan have been approximately 18-20 percentage points lower than those experienced by the Company. If anticipated synergies are achieved, the Company expects that the acquisition of Tylan will reduce 1997 consolidated gross margins percentages by 1 to 2 percent compared to 1996. Operating Expenses - The Company expects to continue investing in operating expenses in a manner consistent with previous years. The acquisitions at both Amicon and Tylan will result in incremental operating expenses required to support these additional businesses. Interest Expense - The Company expects net interest expense in 1997 will be significantly higher than in 1996 due to increased borrowings of approximately $282.0 million required to complete the acquisitions of Amicon and Tylan. The Company anticipates that 1997 borrowings will fluctuate on a quarterly basis but anticipates no significant increase in borrowings on a full year basis other than the $282.0 million discussed above. Provision for Income Taxes - Excluding the impact of a non-deductible in process research and development write-off associated with the acquisition of Tylan, the effective tax rate in 1997 is projected to be in the 24 to 26 percent range, up from 23.5 percent in 1996 as the acquisitions of Amicon and Tylan will result in additional income being earned outside of the Company's low tax rate manufacturing sites. The tax rate estimate is based on current tax law and is subject to change. At December 31, 1996, the Company had a net deferred tax asset of $69.1 million. Although realization of the asset is not assured, the Company believes it is more likely than not that this net deferred tax asset will be realized. The amount of the deferred tax considered realizable, however, could be reduced if the near term estimates of future taxable income are reduced, which could result in the Company's 1997 effective tax rate increasing above the expected 24 to 26 percent range. Capital Spending - The Company expects to spend more for fixed asset additions in 1997 than it spent in 1996. The Company does not believe it needs to significantly expand or add manufacturing capacity in 1997 to handle its anticipated 1997 sales growth. The Company, however, expects to launch manufacturing operations in China in 1997 and will invest in leasehold improvements and machinery and equipment to support this new operation. The Company will also continue to invest in tooling within its manufacturing plants and in information technology as required. The Company also expects that 1997 depreciation expense will be higher than 1996 depreciation expense. Item 8. Financial Statements and Supplementary Data. The information called for by this item is attached to the back of this report commencing with Page F-1. Item 9. Disagreements on Accounting and Financial Disclosure. This item is not applicable. PART III Item 10. Directors and Executive Officers of Millipore. The information called for by this item with respect to registrant's directors and compliance with Section 16(a) of the Securities Exchange Act of 1934 as amended is set forth under the caption "Management and Election of Directors--Nominees for Election as Directors" in Millipore's definitive Proxy Statement for Millipore's Annual Meeting of Stockholders to be held on April 17, 1997, and to be filed with the Securities and Exchange Commission on or about March 21, 1997, which information is hereby incorporated herein by reference. Information called for by this item with respect to registrant's executive officers is set forth under "Executive Officers of Millipore" in Item 1 of this report. Item 11. Executive Compensation. The information called for by this item is set forth under the caption "Management and Election of Directors-Executive Compensation" in Millipore's definitive Proxy Statement for Millipore's Annual Meeting of Stockholders to be held on April 17, 1997, and to be filed with the Securities and Exchange Commission on or about March 21, 1997, which information is hereby incorporated herein by reference. Item 12. Security Ownership of Certain Beneficial Owners and Management. The information called for by this item is set forth under the caption "Ownership of Millipore Common Stock" in Millipore's definitive Proxy Statement for Millipore's Annual Meeting of Stockholders to be held April 17, 1997, and to be filed with the Securities and Exchange Commission on or about March 21, 1997, which information is hereby incorporated herein by reference. Item 13. Certain Relationships and Related Transactions. The information called for by this item is set forth under the caption "Management and Election of Directors - Executive Compensation" in Millipore's definitive Proxy Statement for Millipore's Annual Meeting of Stockholders to be held on April 17, 1997, and to be filed with the Securities and Exchange Commission on or about March 21, 1997, which information is hereby incorporated herein by reference. PART IV Item 14. Exhibits, Financial Statement Schedules, and Reports on Form 8-K. (a) 1. Financial Statements. The following financial statements are filed as part of this report: (See Index on page F-1) Consolidated Statements of Income for the three years ended December 31, 1996, 1995 and 1994. Consolidated Balance Sheets for the years ended December 31, 1996 and 1995 Consolidated Statements of Shareholders' Equity for the three years ended December 31, 1996, 1995 and 1994. Consolidated Statements of Cash Flows for the three years ended December 31, 1996, 1995 and 1994. Notes to Consolidated Financial Statements Report of Independent Accountants 2. Financial Statement Schedules. No financial statement schedules have been included because they are not applicable or not required under Regulation S-X. 3. List of Exhibits. A. The following exhibits are incorporated by reference: Reg. S-K Item 601(b) Referenced Document on Reference Document Incorporated file with the Commission (2) Amicon Worldwide Purchase and Sale Exhibit (2) to Form 8-K Report, Agreement, dated November 18, 1996, dated December 31, 1996, as Amended by Amendment Agreement [Commission File No. 0-1052] dated December 31, 1996, by and among Company and W. R. Grace & Co.-Conn. Agreement and Plan of Merger, dated Exhibit (c)(1) to Schedule 14D- 1, as of December 16, 1996, by and Filed December 20, 1996 among Company and its wholly owned subsidiary MCTG Acquisition Corp. and Tylan General, Inc. Reg. S-K Item 601(b) Referenced Document on Reference Document Incorporated file with the Commission (3) (ii) By Laws, as amended Form 10-K Report for year ended December 31, 1990 [Commission File No. 0-1052] (4) Indenture dated as of May 3, 1995, Registration Statement on Form S-4 relating to the issuance of (No. 33-58117); and an accompanying $100,000,000 principal amount Form T-1) of Company's 6.78% Senior Notes due 2004 (10) Shareholder Rights Agreement Form 8-K Report for April, 1988 dated as of April 15, 1988 [Commission File No. 0-1052] between Millipore and The First National Bank of Boston Long Term Restricted Stock Form 10-K Report for the year (Incentive) Plan for Senior ended December 31, 1984. Management* [Commission File No. 0-1052] 1985 Combined Stock Option Plan* Form 10-K Report for the year ended December 31, 1985 [Commission File No. 0-1052] Supplemental Savings and Form 10-K Report for the year Retirement Plan for Key ended December 31, 1984. Salaried Employees of [Commission File No. 0-1052] Millipore Corporation* Executive Termination Form 10-K Report for the year Agreement* ended December 31, 1984. [Commission File No. 0-1052] Executive "Sale of Business" Form 10-K Report for the year Incentive Termination Agreements (2)* ended December 31, 1993. [Commission File No. 0-1052] 1995 Employee Stock Purchase Plan Form 10-K Report for the year ended December 31, 1994 [Commission File No. 0-1052] 1995 Management Incentive Plan* Form 10-K Report for the year ended December 31, 1994. [Commission File No. 0-1052] * A "management contract or compensatory plan" B. The following Exhibits are filed herewith: (3) (i) Restated Articles of Organization, as amended May 6, 1996 (10) Distribution Agreement, dated as of July 1, 1996, by and among Company and Fisher Scientific Company (all schedules and Exhibits have been omitted; Company agrees to furnish the Commission with a copy of any such schedule or exhibit upon request) (10) Revolving Credit Agreement, dated as of January 22, 1997, among Millipore Corporation and The First National Bank of Boston, ABM AMRO Bank N.V. and certain other lending institutions which are or become parties thereto (11) Computation of Per Share Earnings (21) Subsidiaries of Millipore (23) Consent of Independent Accountants relating to the incorporation of their report on the Consolidated Financial Statements into Company's Securities Act Registration Nos. 2-72124, 2-85698, 2- 91432, 2-97280, 33-37319, 33-37323, 33-11-790, 33-59005 and 33- 10801 on Form S-8 and Securities Act Registration Nos. 2-84252, 33- 9706, 33-22196, 33-47213 on Form S-3, and 33-58117 on Form S-4. (24) Power of Attorney (b) Reports on Form 8-K. Current Report on Form 8-K, dated December 31, 1996, reporting under items 2 and 7 the acquisition of the Amicon Separation Science Business of W.R. Grace & Co. Current Report on Form 8-K, dated January 31, 1997, reporting under items 2 and 7 the acquisition of Tylan General, Inc. (c) Exhibits. The Company hereby files as exhibits to this Annual Report on Form 10-K those exhibits listed in Item 14(a)(3)(B) above, which are attached hereto. (d) Financial Statement Schedules. No financial statement schedules have been included because they are not applicable or not required under Regulation S-X. SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MILLIPORE CORPORATION Dated: March 7,1997 By Geoffrey Nunes, Senior Vice President Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacity and on the dates indicated. SIGNATURE TITLE DATE C. WILLIAM ZADEL* Chairman, President, March 7, 1997 C. William Zadel Chief Executive Officer, and Director Michael P. Carroll Chief Financial Officer Vice President, and Treasurer CHARLES D. BAKER* Director March 7, 1997 Charles D. Baker SAMUEL C. BUTLER* Director March 7, 1997 Samuel C. Butler ROBERT E. CALDWELL* Director March 7, 1997 Robert E. Caldwell MAUREEN A. HENDRICKS* Director March 7, 1997 Maureen A. Hendricks MARK HOFFMAN* Director March 7, 1997 Mark Hoffman STEVEN MULLER* Director March 7, 1997 Steven Muller THOMAS O. PYLE* Director March 7, 1997 Thomas O. Pyle JOHN F. RENO* Director March 7, 1997 John F. Reno *By Geoffrey Nunes, Attorney-in-Fact Millipore Corporation Index to Consolidated Financial Statements Consolidated Statements of Income for the three years ended December 31, 1996, 1995 and 1994 F-2 Consolidated Balance Sheets for the years ended December 31, 1996 and 1995 F-3 Consolidated Statements of Shareholders' Equity for the three years ended December 31, 1996, 1995 and 1994 F-4 Consolidated Statements of Cash Flows for the three years ended December 31, 1996, 1995 and 1994 F-5 Notes to Consolidated Financial Statements F-6 Report of Independent Accountants F-14 Item 8. Financial Statements and Supplementary Data. Consolidated Statements of Income Millipore Corporation Year ended December 31 (In thousands except per 1996 1995 1994 share data) Net sales $618,735 $594,466 $497,252 Cost of sales 249,443 243,849 212,675 Gross profit 369,292 350,617 284,577 Selling, general and 202,140 195,026 159,591 administrative expenses Research and development 38,429 36,515 34,327 expenses Purchased research & 68,311 - - development expense Operating income 60,412 119,076 90,659 Other expense - - (10,800) Gain on sale of equity 5,329 - - securities Interest income 2,780 1,682 4,091 Interest expense (11,498) (10,623) (7,035) Income from continuing operations before 57,023 110,135 76,915 income taxes Provision for income taxes 13,401 24,781 17,306 Income from continuing 43,622 85,354 59,609 operations Net loss on disposal of - - (3,400) discontinued operations Net Income $ 43,622 $ 85,354 $ 56,209 Income per share Income from continuing $ 1.00 $ 1.90 $ 1.09 operations Net income per common share $ 1.00 $ 1.90 $ 1.03 Weighted average common 43,602 44,985 54,726 shares outstanding The accompanying notes are an integral part of the consolidated financial statements. Consolidated Balance Sheets Millipore Corporation December 31 (In thousands) 1996 1995 Assets Current assets: Cash $4,010 $2,696 Short-term investments 42,860 21,062 Accounts receivable (less allowance for doubtful accounts of $2,490 in 1996 151,653 147,759 and $2,054 in 1995) Inventories 106,410 80,386 Other current assets 6,979 6,800 Receivables arising from sale of - 3,056 businesses Total current assets 311,912 261,759 Property, plant and equipment, net 203,017 191,250 Intangible assets (less accumulated amortization of $3,084 in 1996 and $2,506 58,866 7,219 in 1995) Deferred income taxes 69,086 53,179 Other assets 40,011 17,538 Total assets $682,892 $530,945 Liabilities and Shareholders' Equity Current liabilities: Notes payable $101,546 $ 80,768 Accounts payable 34,404 33,436 Accrued expenses 57,011 32,366 Accrued divestiture costs 3,604 6,543 Dividends payable 3,899 3,537 Accrued retirement plan contributions 4,705 4,846 Accrued income taxes payable 11,231 9,926 Total current liabilities 216,400 171,422 Long-term debt 224,359 105,272 Other liabilities 24,528 22,776 Accrued divestiture costs - 5,000 Commitments and contingent liabilities - - Shareholders' equity: Common stock, par value $1.00 per share, 120,000 shares authorized; 56,988 shares issued as of December 31, 1996 and 1995, 56,988 56,988 respectively Additional paid-in capital 8,800 - Unrealized gain on securities 9,536 - available for sale Retained earnings 548,598 523,633 Translation adjustments (8,280) 375 615,642 580,996 Less: Treasury stock at cost, 13,666 and 12,727 shares as of December 31, 1996 and (398,037) (354,521) 1995, respectively Total shareholders' equity 217,605 226,475 Total liabilities and shareholders' equity $ 682,892 $ 530,945 The accompanying notes are an integral part of the consolidated financial statements. Consolidated Statements of Shareholders' Equity Millipore Corporation Year ended Dec. 31, 1994, 1995 and 1996 (In thousands except per share data)
Unrealized Gain on Additional Securities Total Par Paid-in Retained Available Translation Treasury Shareholders Shares Value Capital Earnings for Sale Adjustments Shares Cost Equity Balance at January 1, 1994 28,344 $28,344 $16,803 $434,988 $ - $(7,624) (341) $(11,357) 461,154 Net income 56,209 56,209 Cash dividends declared, $0.295 per share (15,381) (15,361) Treasury stock acquired (400) (6,148) (334,702) (335,102) Stock options exercised 101 101 4,848 (15,479) 1,072 48,898 38,368 Employees' stock purchase 49 49 2,352 (1,712) 47 2,120 2,809 plan proceeds Incentive plan awards (54) 8 431 377 Stock awards 8 1 64 72 Translation adjustments 12,771 12,771 Balance at December 31, 28,494 $28,494 23,603 $458,579 $- $5,147 (5,361) $(294,546) 221,277 1994 Net income 85,354 85,354 Effect of two-for-one 28,494 28,494 (23,603) (4,891) (5,361) - stock split Cash dividends declared, (14,071) (14,071) $0.315 per share Treasury stock acquired (2,962) (90,113) (90,113) Stock options exercised (1,553) 895 28,366 26,813 Employees' stock purchase (4) 33 905 901 plan proceeds Savings and Participation 86 14 456 542 Plan proceeds Incentive plan awards 124 13 354 478 Stock awards 9 2 57 66 Translation adjustments (4,772) (4,772) Balance at December 31, 56,988 $56,988 523,633 $- 375 (12,727) $(354,521) $226,475 1995 Net income 43,622 43,622 Cash dividends declared, (15,261) (15,261) $0.35 per share Treasury stock acquired (1,462) (58,362) (58,362) Stock options exercised (4,218) 384 10,880 6,662 Employees' stock purchase 195 72 2,076 2,271 plan proceeds Savings and Participation 209 27 735 944 Plan proceeds Incentive plan awards 408 39 1,120 1,528 Stock awards 10 1 35 45 Unrealized gain on securities 9,536 9,536 available for sale U.S. tax benefit from 8,800 8,800 stock plan activity Translation adjustments (8,655) (8,655) Balance at December 31, 56,988 $56,988 8,800 $548,598 $9,536 $(8,280) $(13,666) $(398,037) $217,605 1996 The accompanying notes are an integral part of the consolidated financial statements.
Consolidated Statements of Cash Flows Millipore Corporation Year ended December 31 (In thousands) 1996 1995 1994 Cash Flows from Operating Activities: Net income $43,622 $85,354 $56,209 Adjustments to reconcile net income to net cash provided by operating activities Purchased research and 68,311 - - development expense Gain on sale of (5,329) - - securities Net loss on disposal of - - 3,400 discontinued operations Depreciation and 30,587 27,478 27,604 amortization Deferred income tax (8,212) 1,372 (2,227) provision Change in operating assets and liabilities: Decrease (increase) 247 (10,548) (14,672) in accounts receivable (Increase) in inventories (11,612) (7,218) (1,894) Decrease in other 1,661 409 1,427 current assets (Increase) in other (8,747) (8,209) (695) assets (Decrease) increase in accounts payable and accrued expenses (11,087) 5,931 2,876 expenses (Decrease) increase in accrued retirement plan contributions (36) 543 (269) Increase in accrued 1,723 6,475 6,123 income taxes Income tax refund received - - 14,035 Other 1,058 (2,438) (3,334) Net cash provided by 102,186 99,149 88,583 operating activities Cash Flows from Investing Activities: Net proceeds from sales of - - 257,899 businesses Additions to property, plant and (30,427) (30,010) (21,009) equipment, net Additions to intangible assets (1,760) (2,135) (2,718) Investments in businesses (4,010) - - Acquisition of Amicon, net of cash (122,576) - - acquired Net cash used by discontinued (7,939) (6,967) - businesses Proceeds from sale of securities 5,745 - - Net cash provided by (used in) (160,967) (39,112) 234,172 investing activities Cash Flows from Financing Activities: Treasury stock acquired (58,362) (90,113) (334,702) Issuance of treasury stock under 11,450 16,937 33,876 stock plans Cash paid to extinguish long-term - - (5,088) debt Common stock issued - - 7,350 Cash paid to close out foreign - (3,546) (10,287) currency swap Net change in short-term debt 20,045 25,795 (9,539) Borrowings (payments) of long-term 124,397 - (1,820) debt Dividends paid (14,899) (14,117) (15,802) Net cash used for financing 82,631 (65,044) (336,012) activities Effect of foreign exchange rates on cash and short-term investments (738) (1,471) 2,851 Net increase (decrease) in cash and 23,112 (6,478) (10,406) short-term investments Cash and short-term investments on 23,758 30,236 40,642 January 1 Cash and short-term investments on $46,870 $23,758 $30,236 December 31
Notes to Consolidated Financial Statements (In thousands except share and per share data) Note A - Summary of Significant Accounting Policies Principles of Consolidation The consolidated financial statements include the accounts of the Company and its subsidiaries, all of which are wholly owned. Intercompany balances and transactions have been eliminated. Translation of Foreign Currencies For all of the Company's foreign subsidiaries except Brazil, assets and liabilities are translated at exchange rates prevailing on the balance sheet date, revenues and expenses are translated at average exchange rates prevailing during the period, and elements of shareholders' equity are translated at historical rates. Any resulting translation gains and losses are reported separately in shareholders' equity. The aggregate transaction gains and losses included in the consolidated statements of income are not material. For the Company's subsidiary in Brazil, where inflation is very high, the translation is the same except that inventories, cost of sales, property, plant and equipment, and depreciation are translated at historical rates. Resulting translation gains and losses for this subsidiary are included in income. Short-term Investments Short-term investments consisting primarily of time deposits, are classified as available for sale and are carried at cost plus accrued interest, which approximates market value. All short-term investments have original maturities of three months or less and are considered cash equivalents for purposes of the consolidated statements of cash flows. Inventories The Company values the majority of its inventories manufactured in the United States at the lower of cost or market, principally on a last-in, first-out (LIFO) basis. Inventories manufactured outside of the United States are valued on a first-in, first-out (FIFO) basis. Property, Plant and Equipment Property, plant and equipment is recorded at cost. Expenditures for maintenance and repairs are charged to expense while the costs of significant improvements are capitalized. Depreciation on assets acquired before January 1, 1989 generally is provided using accelerated methods over the estimated useful lives of the assets. Assets acquired after January 1, 1989 primarily are depreciated using straight-line methods. Upon retirement or sale, the cost of assets disposed and the related accumulated depreciation are eliminated and related gains or losses reflected in income. The estimated useful lives of the Company's depreciable assets are as follows: Leasehold Improvements Life of the Lease Buildings and Improvements 10-30 Years Production and Other Equipment 3-15 Years Intangible Assets Intangible assets consist primarily of acquired patented and unpatented technology, trade names, and licenses and are recorded at cost. Intangible assets are amortized on a straight line basis over periods ranging from 5 to 30 years. The carrying value of intangible assets is periodically reviewed by the Company and, if necessary, impairments of values are recognized. If there is a permanent impairment in the carrying value of tradenames or other intangible assets, the amount of such impairment is computed by comparing the anticipated discounted future operating income of the acquired business or trademark to the carrying value of the assets. In performing this analysis, the Company considers current results and trends, future prospects and other economic factors. Marketable Securities The Company's investments in equity securities are categorized as available-for-sale as defined by Statement of Financial Accounting Standards No. 115, "Accounting for Certain Investments in Debt and Equity Securities". Equity securities are included in Other Assets in the accompanying consolidated balance sheets and are recorded at fair value. Unrealized holding gains and losses are reflected, net of income tax, as a separate component of shareholders' equity. Income Taxes Deferred tax assets and liabilities reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial statement purposes and the amounts used for income tax purposes. With respect to the unremitted earnings of the Company's foreign and Puerto Rican subsidiaries, deferred taxes are provided only on amounts expected to be repatriated. Stock Options In 1995, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards (SFAS) No. 123, "Accounting for Stock- Based Compensation," which became effective for the Company in 1996. SFAS 123 defines a fair-value method of accounting for employee stock option or similar equity instruments. However, SFAS 123 also allows companies to continue to use the intrinsic value method of accounting prescribed by APB Opinion 25 "Accounting for Stock Issued to Employees." The Company has elected to continue to account for stock options in accordance with APB 25 and has adopted the disclosure only aspects of SFAS 123. Treasury Stock Treasury stock is recorded at its cost on the date acquired and is relieved at its weighted average cost upon reissuance. The excess of cost over the proceeds of reissued treasury stock is charged to retained earnings. Net Income Per Common Share Net income per common share is calculated by dividing the net income for the period by the weighted average number of common shares outstanding for the period. The impact of common stock equivalents, principally outstanding stock options, is immaterial. Revenue Recognition Sales of products and services are recorded at the time of product shipment or performance of services. Use of Estimates in the Preparation of Financial Statements The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Reclassifications Certain reclassifications have been made to prior years' financial statements to conform with the 1996 presentation. Note B - Stock Split and Increase In Authorized Common Shares On June 8, 1995, the Company's Board of Directors authorized a two-for- one stock split in the form of a 100% stock dividend, payable on July 21, 1995 to shareholders of record as of June 23, 1995. Par value per share remained at $1.00. The stock split resulted in the issuance of 28,494,000 additional shares of common stock from authorized but unissued shares. The issuance of additional shares resulted in the transfer of $23,603 from additional paid in capital and $4,891 from retained earnings to common stock, representing the par value of the shares issued. Accordingly, all weighted average share and per share amounts, as well as stock plan data, have been restated to reflect the stock split. For purposes of presentation in the Consolidated Statements of Shareholders' Equity, the stock split has been accounted for as if it occurred on January 1, 1995. At the Company's Annual Meeting on April 18, 1996, shareholders voted to adopt an amendment to the Company's restated Articles of Incorporation, increasing the number of authorized common shares from 80,000,000 to 120,000,000. Note C - Acquisition of Amicon Separation Science Business On December 31, 1996, the Company acquired the net assets of the Amicon Separation Science Business of W.R. Grace & Co. (Amicon) for approximately $129,265 in cash, including transaction costs. Amicon manufactures protein purification tools for the research laboratory and for biotechnology manufacturing. The acquisition is accounted for as a purchase, and accordingly, the purchase price has been preliminarily allocated to the identifiable tangible and intangible assets based on estimated fair market values of those assets. The Company has accrued approximately $27,000 for additional costs associated with the acquisition. These costs include severance payable to Amicon employees, abandonment of duplicate Amicon manufacturing and sales facilities, and termination of certain Amicon contractual obligations. The Company expects that the integration of Amicon's operations into those of the Company will be substantially complete within one year. The ultimate execution of the Company's plans and costs incurred may result in an adjustment to the amounts preliminarily allocated to assets and liabilities and to amounts accrued for additional costs associated with the acquisition. The purchase included at estimated fair value current assets of $30,328, property plant and equipment of $15,474, other assets of $596 and the assumption of liabilities of $9,197. Identifiable intangible assets were valued at $50,753 and included tradenames and patented and unpatented complete technology. These intangible assets will be amortized over their estimated useful lives ranging from five to thirty years. The value of in process research and development for which technical feasibility has not been achieved was $68,311 and was charged to earnings in the fourth quarter of 1996. The purchase was financed through the Company's new revolving credit facility as discussed in Note J. On the basis of a pro forma consolidation of the results of operations as if the acquisition had taken place at the beginning of fiscal 1995 rather than at December 31, 1996, consolidated net sales would have been $651,000 in 1995 and $675,000 in 1996. Consolidated pro forma income before income taxes, net income and earnings per share would not have been materially different from the amounts reported for 1995 and 1996. Pro forma amounts are not necessarily indicative of what the actual consolidated results of operations might have been if the acquisition had been effective at the beginning of fiscal 1995. Note D - Subsequent Event On January 22 1997, the Company successfully completed a cash tender offer for all of the outstanding common shares of Tylan General, Inc. ("Tylan"). Tylan became a wholly-owned subsidiary on January 27, 1997. Tylan, which had annual sales of approximately $148,000 for its latest fiscal year ended October 31, 1996, supplies precision mass flow controllers, pressure and vacuum measurement and control equipment, and ultraclean gas panels to the microelectronics industry. The acquisition was financed through the Company's new revolving credit agreement discussed in Note J and will be accounted for as a purchase. Note E - Discontinued Operations On August 18, 1994, the Company sold its Waters Chromatography Division to Waters Holdings, Inc. for $330,000 in cash and $10,000 in stock. On August 23, 1994, the Company sold certain assets of its non-membrane bioscience business to PerSeptive Biosystems, Inc. for $10,000 in cash and four thousand shares of preferred stock redeemable in four equal annual installments of $10,000. The stock proceeds received from each sale were recorded at their estimated fair value at the date of receipt. Both sales were recorded in 1994 and resulted in a combined pre-tax loss of $5,667 ($3,400 or $0.06 per share net of income taxes). As of December 31, 1996, the Company holds 2,120,249 shares of PerSeptive Biosystems' common stock as a result of PerSeptive's preferred stock redemption requirement. These shares are considered available for sale securities and have been recorded at fair value in Other Assets, net of income tax, in accordance with SFAS No. 115. Remaining accruals associated with the divestitures consist primarily of costs to be incurred in providing future general and administrative support services for the divested businesses as specified in the sales agreements, costs associated with abandoning facilities operated under long-term leases, and employee costs. During 1996, the Company charged $1,100 of employee costs, $2,000 of contract support services and $4,839 of facilities and other costs against divestiture accruals. The Company periodically assesses the adequacy of the divestiture accruals, and the remaining accrual balances at December 31, 1996 are expected to be sufficient to satisfy the Company's future obligations with respect to discontinued operations. In accordance with each respective sales agreement, the Company retained certain customer accounts receivable balances generated from sales of Instrumentation Division products prior to and subsequent to the completion of the divestitures. These amounts were classified in Receivables arising from sales of businesses in the accompanying consolidated balance sheets. Note F - Concentration of Credit Risk Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of temporary cash and short-term investments, accounts receivable and hedging instruments. The Company places its temporary cash and short-term investments with high credit qualified financial institutions, and, by policy, limits the amount of credit exposure to any one financial institution. Concentrations of credit risk with respect to accounts receivable is limited due to the large number of customers comprising the Company's customer base, and their dispersion across different markets and geographies. The Company performs ongoing credit evaluations of its customers and generally does not require collateral. The Company is exposed to credit-related losses in the event of nonperformance by counterparties to hedging instruments. The counterparties to these contracts are major financial institutions. The Company continually monitors its positions and the credit ratings of its counterparties and limits the amount of contracts it enters into with any one party. Note G - Inventories Inventories at December 31 consisted of the following: 1996 1995 Raw materials $ 27,502 $ 21,357 Work in process 16,310 9,621 Finished goods 62,598 49,408 $ 106,410 $ 80,386 The value of inventories determined using the LIFO cost method was $41,458 or 39 percent of the total at December 31, 1996 and $43,101 or 54 percent of the total at December 31, 1995. If these inventories had been valued using the FIFO cost method, they would have been $44,395 at December 31, 1996 and $45,608 at December 31, 1995. Note H - Property, Plant and Equipment Property, plant and equipment at December 31 consisted of the following: 1996 1995 Land $ 9,002 $ 7,419 Leasehold improvements 9,587 9,214 Buildings and improvements 123,256 117,932 Production and other equipment 240,612 217,443 Construction in progress 15,957 21,932 398,414 373,940 Less: accumulated depreciation and 195,397 182,690 amortization $203,017 $ 191,250 Note I - Notes Payable Short-term borrowings and related lines of credit at December 31 are summarized as follows: 1996 1995 Notes payable $ 101,546 $ 80,768 Unused lines of credit $ 295,927 $ 266,350 Average amount outstanding at $ 115,461 $ 91,338 month-end during the year Maximum amount outstanding at $ 132,338 $ 116,721 month-end during the year Weighted average interest rate 5.6% 6.2% during the year Weighted average interest rate at 5.7% 6.1% year-end Notes payable generally consist of renewable, uncollateralized borrowings under lines of credit that are denominated in various currencies and bear interest at prevailing rates. The majority of borrowings outstanding, as well as available under lines of credit which existed at December 31, 1996 were incorporated into the revolving credit facility agreement discussed in Note J in the first quarter of 1997. Note J - Long-term Debt Long-term debt at December 31 consisted of the following: 1996 1995 Amounts outstanding under $ 124,397 $ - revolving credit agreement 6.78 % notes payable due in 2004 100,000 100,000 Unrealized (gain)/loss on revaluation of yen-denominated (3,727) 5,272 debt Other notes payable to banks 3,689 - Long-term debt $ 224,359 $ 105,272 The Company financed the acquisition of Amicon by drawing down funds on a 90 day $250,000 bridge loan which was made available to the Company as temporary financing pending finalization of a long-term revolving credit facility. On January 22, 1997, the Company entered into an unsecured revolving credit agreement ("the agreement") with a group of banks. The agreement allows for borrowings of up to $450,000 and expires on January 22, 2002. Interest is payable on outstanding borrowings at a floating rate defined in the agreement as LIBOR plus a margin (5.7 percent at January 22, 1997). The agreement also calls for a commitment fee at a rate ranging from .10 percent to .65 percent of the available facility. The exact amount of the margin and the commitment fee is dependent on the Company's debt rating. The agreement calls for the Company to maintain certain financial covenants in the areas of operating cash flow and interest coverage. The amount outstanding at December 31, 1996 of $124,397 reflects the adjusted purchase price paid to acquire Amicon. The $100,000 6.78 percent notes payable are due in 2004. Interest on these notes is payable semi-annually in March and September. The notes payable agreement calls for the Company to maintain a debt to total debt and equity ratio which does not exceed a specified threshold. At December 31, 1996, the Company is in compliance with this requirement. However, amounts borrowed by the Company in the first quarter of 1997 under the $450,000 credit facility to fund the acquisition of Tylan would have caused the Company to violate this covenant. However, the holder of these notes has waived the requirement that the Company comply with this covenant through March 21, 1997. The Company is currently negotiating to change the financial covenant included in this note agreement. If a revised agreement is not reached by March 21, 1997, the Company may redeem the notes using either proceeds from a planned public debt offering for up to $300,000 or borrowings potentially available upon request by the Company under the agreement discussed above. As of January 1, 1994, the Company had partially hedged its foreign currency net asset exposure by entering into a currency swap which was to mature in 1995. Under the terms of the original swap, the Company exchanged $100,000 of dollar debt service obligations for foreign obligations of 9,936,000 yen and 33,193 DM. In January, 1994, the Company closed out the yen denominated swap and simultaneously exchanged $80,000 of dollar debt service obligations for a yen denominated obligation of 8,760,000 yen, which bears interest at a rate of 4.49 percent. This swap matures in 2004. In March, 1995, the Company paid $3,546 to close out the DM swap. This cash payment represented the cumulative effect of the foreign currency rate fluctuations over the life of the swap. The Company's foreign currency obligations had effective weighted average interest rates of 4.86 and 5.39 percent in 1996 and 1995, respectively. The effect of foreign currency exchange rate fluctuations resulting from the yen swap agreement open at December 31, 1996 is included in translation adjustments. Other notes payable to banks represents borrowings outstanding at an Amicon subsidiary acquired by the Company on December 31, 1996. The Company expects to repay this balance in full in 1997 by drawing funds from the revolving credit facility discussed above. The Company capitalized interest costs associated with the acquisition of certain assets of $785 in 1996, $929 in 1995, and $890 in 1994. Interest paid on short-term and long-term debt during 1996, 1995, and 1994 amounted to $12,171, $11,481, and $8,946 respectively. Note K - Foreign Exchange A significant volume of the Companies business is transacted in currencies other than the U.S. dollar. This exposes the Company to risks associated with currency rate fluctuations which impact the Company's sales and net income. To partially mitigate this risk, the Company has entered into foreign currency transactions, forward and option contracts to sell yen, on a continuing basis in amounts and timing consistent with underlying currency exposure on inventory purchases so that the gains and losses or these transactions offset gains and losses on the underlying exposure. A realized gain of $2,687 in 1996, and realized losses of $2,287 in 1995, and $960 in 1994 relating to these contracts are included in cost of sales, partially offsetting the impact of foreign currency fluctuations. At December 31, 1996, the Company has open forward exchange contracts to sell yen aggregating $13,422 and open forward option contracts to sell yen aggregating $27,025. These open contracts have an unrealized gain of $1,700 at December 31, 1996. All open contracts mature within 15 months. Note L - Income Taxes Income taxes on both continuing and discontinued operations have been provided in accordance with the provisions of SFAS #109. The Company's provisions for income taxes are summarized as follows: 1996 1995 1994 Domestic and foreign income before income taxes: Domestic $ 195 $51,933 $ 23,042 Foreign 56,828 58,202 48,206 57,023 110,135 71,248 Loss on - - 5,667 disposal of discontinued operation Income from $57,023 $110,135 $76,915 continuing operations before income taxes Domestic and foreign provisions for income taxes: Domestic $(2,362) $ 9,039 $(1,894) Foreign 15,427 14,642 16,433 State 336 1,100 500 13,401 24,781 15,039 Less: portion applied to - - 2,267 discontinued operations $13,401 $24,781 $17,306 Current and deferred provisions for income taxes: Current $21,613 $ 23,409 $ 28,800 Deferred (8,212) 1,372 (13,761) $13,401 $ 24,781 $ 15,039 A summary of the differences between the Company's consolidated effective tax rate and the United States statutory federal income tax rate is as follows: 1996 1995 1994 U.S. statutory income tax rate 35.0% 35.0% 35.0% Puerto Rico tax rate benefits (6.4) (4.8) (6.0) Ireland tax rate benefits (11.0) (5.2) (4.0) State income tax, net of federal .4 .7 .5 income tax benefit Foreign Sales Corporation income not (4.0) (2.0) (3.0) taxed Tax credits - (1.2) - Change in valuation allowance 9.5 - - Effective tax rate applicable to 23.5% 22.5% 22.5% operations Tax exemptions relating to Puerto Rico and Ireland operations are effective through 2004 and 2010, respectively. Income taxes paid (net of refunds) during 1996, 1995, and 1994 were $24,228, $9,999, and $25,296, respectively. The Company has not recorded deferred income taxes applicable to undistributed earnings of foreign subsidiaries that are indefinitely reinvested in foreign operations. These earnings amounted to approximately $73,700 at December 31, 1996. If earnings of such foreign subsidiaries were not indefinitely reinvested, a deferred tax liability of approximately $18,425 would have been required. At December 31, 1996, the Company has foreign tax credit carryforwards of approximately $20,500 that expire in the years 1997 through 2001. General business credit carryforwards of approximately $7,300 expire in the years 2001 through 2010. In addition, the Company has alternative minimum tax credit carryforwards of approximately $10,800 which can be carried forward indefinitely. Significant components of the Company's net deferred tax assets are as follows: 1996 1995 Intercompany and inventory related $12,734 $13,943 transactions Postretirement benefits other than 3,500 3,421 pensions Tax credits (including foreign tax credits on unremitted earnings) 55,586 43,370 Divestiture related costs 5,109 7,435 Amortization of intangible assets 23,776 - Depreciation (3,381) (2,704) Other, net (6,103) 4,349 91,221 69,814 Valuation allowance (22,135) (16,635) Net deferred tax asset $69,086 $53,179 The valuation allowance is provided primarily against foreign tax credit carryforwards and foreign tax credits on unremitted earnings which can be utilized against future taxable income in the United States. The increase in the valuation allowance in 1996 results from the growth in foreign tax credits. Although realization is not assured, the Company believes it is more likely than not that the remainder of the deferred tax asset, net of the valuation allowance, will be realized. The amount of the deferred tax asset considered realizable, however, could be reduced in the near term if estimates of future taxable income are reduced. During 1995 the Internal Revenue Service ("IRS") completed its examination of the Company's federal income tax returns pertaining to its U.S. and Puerto Rican operations for the years 1991-1992 with no major adjustments. Note M - Legal Proceedings The settlement to date of all environmental claims against all participants at hazardous waste ("Superfund") sites in which the Company was named a potentially responsible party by the Environmental Protection Agency has been significant. Prior to 1995, the Company had paid $14,000 to settle claims at sites in which the Company was named a potentially responsible party. Due to the fact that Superfund sites at which the Company was named a potentially responsible party are in the late stages of remedy and a significant portion of the remedy cost has already been funded, the Company believes that its probable future financial obligation at December 31, 1996 will not materially affect its future operating results and liquidity. Amounts paid by the Company in 1996 and 1995 with respect to the Superfund obligations were insignificant. In 1994, the Company settled a lawsuit filed by Eastern Enterprises in connection with Eastern's purchase of the Company's Process Water Division in 1989. Total settlement costs of $10,800, including a $9,000 payment to Eastern Enterprises and $1,800 of related costs incurred by the Company, are included in Other expense in the accompanying consolidated statements of income. The Company and Waters Holdings, Inc. are engaged in a dispute with respect to the amount of assets to be transferred from the Company's Retirement Plan in connection with the divestitures. The Company believes that it has meritorious arguments and should prevail. In the opinion of the Company, although final settlement of this matter may impact the Company's financial statements in a particular period, it is not expected to have a material adverse effect on the Company's financial condition. Note N - Leases Lease agreements cover sales offices, warehouse space, computers and automobiles. These leases have expiration dates through 2006. Certain land and building leases contain renewal options for periods ranging from five to ten years and purchase options at fair market value. Rental expense was $12,547 in 1996, $11,397 in 1995, $12,114 in 1994. At December 31, 1996 future minimum rents payable under noncancelable leases with initial terms exceeding one year were as follows: 1997 $ 12,105 1998 8,669 1999 7,528 2000 5,980 2001 3,712 2002 - 2006 10,071 Note O - Stock Plans Stock Option Plans The Company has two fixed option plans which reserve shares of common stock for issuance to key employees and directors respectively. The Company also has a stock purchase plan which allows employees to purchase shares of the Company's common stock as discussed below. The Company has adopted the disclosure-only provisions of Statement of Financial Accounts Standards No. 123 "Accounting for Stock - Based Compensation." Accordingly, no compensation cost has been recognized for grants made in 1995 and 1996 under the stock option and stock purchase plans. Had compensation cost been determined based on the fair value at the grant date for awards in 1995 and 1996 consistent with the provisions of SFAS 123, the Company's net income and earnings per share would have been unchanged in 1995 and reduced by $1,015 or $.02 per share in 1996. The proforma expense amounts in 1995 and 1996 assume that the fair value assigned to the 1995 and 1996 option grants was amortized over the vesting period of the options, which is four years, while the fair value assigned to grants under the stock purchase plan is recognized in full at the date of grant. The fair value of each option grant is estimated on the date of the grant using the Black - Scholes model with the following weighted average assumptions in 1995 and 1996: expected life of five years; expected volatility of 25% and an expected annual dividend increase of $.04 per year. The risk free interest rate was 6.1 percent in 1996 and 5.5 percent in 1995. This rate approximated that of 5 year U.S. government interest bearing securities. Under the Company's Combined Stock Option Plan, stock options to purchase Millipore common stock may be granted to employees. During 1996, the Company adopted the "1995 Combined Stock Option Plan", which replaced the "1985 Combined Stock Option Plan". The terms of the 1995 Plan are substantially similar to those of the 1985 Plan. In conjunction with the adoption of the 1995 Plan, an additional 1,031,000 shares were authorized for issuance. The plan provides that the option price per share may not be less than the fair market value of the stock at the time the option is granted and that options must expire not later than 10 years from the date of grant. Plan data are summarized as follows: 1996 1995 1994 Option shares: Outstanding at beginning of 2,940,000 3,518,000 5,440,000 period Issued during period 461,000 373,000 534,000 Exercised during period (369,000) (885,000) (2,334,000) Canceled during period (62,000) (66,000) (122,000) Outstanding at end of period 2,970,000 2,940,000 3,518,000 Exercisable at end of period 1,850,000 1,747,000 2,088,000 Shares available for granting of 1,671,000 1,039,000 1,344,000 options at end of period Price range of outstanding options $14.50 - $13.56 - $9.72 - at end of period $42.00 $37.63 $23.69 Average price of outstanding $24.33 $20.82 $17.96 options at end of period Average price of exercised options $17.41 $16.70 $16.30 during the period In 1995, as part of the Company's broad-based open market stock repurchase program, the Company repurchased at market prices, 759,000 shares of common stock which had been issued to current employees and former employees of the divested businesses under the Company's stock option plan. The difference between the market price of the shares repurchased and the stock option exercise price was recognized as compensation expense and is included in the Company's 1995 consolidated statement of income or charged against accrued divestiture reserves. Non-Employee Director Stock Option Plan In 1990, a stock option plan for non-employee directors was approved by the Company's shareholders. Under this plan, each eligible director receives an option to purchase 4,000 shares of Millipore common stock on the date of his or her first election, and thereafter automatically receives an additional option to purchase 2,000 shares at the first board of directors meeting following the Annual Meeting of Shareholders. The plan provides that the option price per share may not be less then the fair market value of the stock at the time the option is granted. At December 31, 1996, 133,000 options have been issued and 118,000 are outstanding. Employees' Stock Purchase Plan Under the Company's Employees' Stock Purchase Plan, all employees of the Company and its subsidiaries who have 90 days continuous service prior to the beginning of the plan year, May 1, may purchase shares of Millipore common stock by payroll deduction. The purchase price per share during the plan year is the lesser of the fair market value of the common stock at the time of purchase or on May 1. In 1996, 1995, and 1994 shares issued under the Plan were 72,000, 33,000, and 192,000, respectively. As of December 31, 1996, 295,000 shares of Millipore common stock were available for sale to employees under the plan. Incentive Plan for Senior Management Under this plan, Millipore common stock is awarded to key members of senior management at no cost to them. The stock cannot be sold, assigned, transferred or pledged during a restriction period which is normally four years. Shares are subject to forfeiture should employment terminate during the restriction period. The stock issued under the plan is recorded at its fair market value on the award date; the related deferred compensation is amortized to selling, general and administrative expenses over the restriction period. At the end of 1996, 1995, and 1994, 119,000, 109,000, and 154,000 shares, respectively, were outstanding under the plan. Plan expense was $559 in 1996, $450 in 1995, and $596 in 1994. As of December 31, 1996, 92,000 shares of Millipore common stock were available for future awards under this plan. Note P - Employee Retirement Plans Participation and Savings Plan The Millipore Corporation Employees' Participation and Savings Plan (Participation and Savings Plan), maintained for the benefit of all full-time U.S. employees, combines both a defined contribution plan (Participation Plan) and an employee savings plan (Savings Plan). Contributions to the Participation Plan are allocated among the U.S. employees of the Company who have completed at least two years of continuous service on the basis of the compensation they received during the year for which the contribution is made. The Savings Plan allows employees with one year of continuous service to make certain tax-deferred voluntary contributions which the company matches with a 25 percent contribution (50 percent contribution for employees with 10 or more years of service). Total expense under the Participation and Savings Plan was $4,866 in 1996, $4,512 in 1995, $6,089 in 1994. Plan expense in 1994 includes amounts related to employees of the divested businesses through the date of the divestitures. Retirement Plan The Company's Retirement Plan for Employees of Millipore Corporation (Retirement Plan) is a defined benefit plan for all U.S. employees which provides benefits to the extent that assets of the Participation Plan, described above, do not provide guaranteed retirement income levels. Guaranteed retirement income levels are determined based on years of service and salary level as integrated with Social Security benefits. Employees are eligible under the Retirement Plan after one year of continuous service and are vested after 5 years of service. For accounting purposes, the Company uses the projected unit credit method of actuarial valuation. The actuarial method for funding purposes is the entry age normal method. The Company contributes annually to the Retirement Plan, subject to Internal Revenue Service and ERISA funding limitations. No contributions were required for 1996, 1995 and 1994. The following table summarizes the funded status of the plan and amounts reflected in the Company's consolidated balance sheets at December 31. The projected benefit obligation was calculated using a discount rate of 7.5 percent in 1996 and 7.0 percent in 1995, and a salary progression rate of 5.0 percent in both years. The pension income was determined based on an expected long-term rate of return on assets of 8.0 percent in both years. Plan assets are invested primarily in mutual funds and money market funds. Plan data as of December 31, 1996 and 1995 includes assets and obligations pertaining to employees of the Company's former Waters Division, as the assets subject to these former employees have not yet been transferred to Waters Holdings, Inc. 1996 1995 Actuarial present value of benefit obligations: Accumulated benefit obligation, including vested benefits of $5,990 on December 31, 1996 and $6,460 on $ 6,195 $ 6,693 December 31, 1995 Projected benefit obligation for $(7,022) $(7,595) service rendered to date Plan assets at fair value 7,657 7,391 Plan assets in excess of (less 635 (204) than) projected benefit obligation Unrecognized net actuarial loss 3,268 4,283 Unrecognized prior service cost 111 121 Unrecognized net asset being (495) (579) amortized over 16.7 years Prepaid pension cost included in $3,51 $ 3,621 financial statements 1996 1995 1994 Net pension (expense)/income includes the following components Service cost $ 29 $ 179 $ 376 Interest cost (499) (471) (361) Return on plan assets 788 942 36 Amortization and deferral (420) (630) 246 Net pension (expense)/income $(102) $ 20 $ 297 Postretirement Benefits Other Than Pensions The Company sponsors several unfunded defined benefit postretirement plans covering all U.S. employees. The plans provide medical and life insurance benefits and are, depending on the plan, either contributory or non-contributory. The Company recognized $4,007 as a termination settlement in 1994 as a result of its divestitures. The settlement was included as part of the net loss on disposal of discontinued operations. Net periodic postretirement benefit cost included the following components: 1996 1995 1994 Service cost-benefits attributed $298 $ 357 $ 610 to service during the year Interest cost on accumulated postretirement benefit obligation 453 548 662 Net amortization and deferral (205) (93) (62) Net periodic postretirement $546 $ 812 $1,210 benefit cost Summary information on the Company's plans as of December 31 is as follows: 1996 1995 Accumulated postretirement benefit obligation: Retirees and dependents $(4,029) $(3,272) Fully eligible active plan (176) (550) participants Other active plan participants (2,604) (5,056) Accrued postretirement benefit (6,809) (8,878) obligation Unrecognized gain from past experience different from that assumed and from (3,126) (897) changes in assumptions Accrued postretirement benefit $(9,935 $(9,775) cost The discount rate used in determining the accumulated postretirement benefit obligation was 7.5 percent as of December 31,1996 and 7.0 percent as of December 31, 1995. The assumed health care cost trend rate used in measuring the accumulated postretirement benefit obligation was 8.0 percent in 1996, declining gradually to 5.0 percent over 4 years, remaining level thereafter. The assumed health care cost trend rate used in measuring the accumulated postretirement benefit obligation was 7.8 percent in 1995, declining gradually to 5.5% over 8 years, remaining level thereafter. If the health care cost trend rate assumptions were increased by 1 percent, the accumulated postretirement benefit obligation as of December 31, 1996 would be increased by $862 while the aggregate of the service and interest cost components of net periodic postretirement benefit cost for 1996 would be increased by $121. Note Q - Business Segment Information Industry Segments The Company operates in one industry segment. Using primarily membrane technology, the Company develops, manufactures and markets products used for analysis and purification. Geographical Segments The Company operates in the geographical segments indicated in the table below. Sales are reflected in the segment from which the sales are made. The Americas segment includes North and South America. The European region includes Western and Central Europe, Russia, the Middle East and Africa. The Asia/Pacific region includes Japan, Korea, Taiwan, Hong Kong, China, Southeast Asia and Australia. Transfers between geographic areas are generally made at a discount from local in-market price. Operating profits for each geographical segment exclude general corporate expenses. Identifiable assets consist of those assets utilized within each respective geographic segment and exclude cash and short-term investments and receivables arising from sale of businesses, which are classified as corporate assets. Americas Europe Asia/Pacific Eliminations Total 1996 Sales: Unaffiliated $215,875 $192,838 $208,229 - $616,942 customers Unaffiliated export: Pacific customers 839 839 European customers 954 954 Total unaffiliated 217,668 192,838 208,229 - 618,735 Transfer between areas 112,474 68,535 10,880 (191,889) - Total sales $330,142 261,373 $219,109 $(191,889) $618,735 Operating profits $75,843 $45,341 $13,994 - $135,178 General corporate expenses (6,455) Purchased research & (68,311) development expenses Gain on sale of equity 5,329 securities Interest expense, net (8,718) Income from continuing operations before income taxes $57,023 Identifiable assets $496,742 $ 212,132 $ 142,882 $(215,734) $636,022 Corporate assets 46,870 Total assets $682,892 1995 Sales: Unaffiliated customers $202,717 $ 185,402 $ 204,895 $593,014 Unaffiliated export: Pacific customers 553 553 European customers 899 899 Total unaffiliated 204,169 185,402 204,895 594,466 Transfer between areas 95,267 46,602 14,267 (156,136) - Total sales $ 299,436 $ 232,004 $ 219,162 $(156,136) $594,466 Operating profits $ 75,663 $ 33,072 $ 20,973 $129,708 General corporate expenses (10,632) Interest expense, net (8,941) Income from continuing operations before income taxes $ 110,135 Identifiable assets $409,750 $219,681 $174,468 $(301,308) $ 502,591 Corporate assets 28,354 Total assets $ 530,945 Americas Europe Asia/Pacific Eliminations Total 1994 Sales: Unaffiliated $180,569 $154,196 $160,781 $ 495,546 customers Unaffiliated export: Pacific customers 806 806 European customers 900 900 Total 182,275 154,196 160,781 497,252 unaffiliated Transfer between areas 77,877 25,767 6,246 (109,890) - Total sales $260,152 $179,963 $167,027 $(109,890) $ 497,252 Operating profits $54,301 $ 23,908 $24,879 $ 103,088 General corporate expenses (12,429) Other expense (10,800) Interest expense, net (2,944) Income from continuing operations before income taxes $ 76,915 Identifiable assets $341,057 $187,132 $144,890 $(181,285) $491,794 Corporate assets 45,186 Total assets $536,980 Report of Independent Accountants To the Shareholders and Directors of Millipore Corporation: We have audited the accompanying consolidated balance sheets of Millipore Corporation as of December 31, 1996 and 1995, and the related consolidated statements of income, shareholders' equity, and cash flows for each of the three years in the period ended December 31, 1996. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with generally accepted auditing standards. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Millipore Corporation at December 31, 1996 and 1995, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 1996 in conformity with generally accepted accounting principles. Boston, Massachusetts Coopers & Lybrand L.L.P. January 22, 1997 Quarterly Results (Unaudited) The Company's unaudited quarterly results are summarized below. First Second Third Fourth (In thousands, except per Quarter Quarter Quarter Quarter Year share data) 1996 Net sales $156,476 $161,928 $148,913 $151,418 $618,735 Cost of sales 61,946 65,412 60,774 61,311 249,443 Gross profit 94,530 96,516 88,139 90,107 369,292 Selling, general and 50,140 52,059 50,226 49,715 202,140 administrative expenses Research and development 9,409 9,741 9,610 9,669 38,429 expenses Purchased research & - - - 68,311 68,311 development expense Operating income (loss) 34,981 34,716 28,303 (37,588) 60,412 Gain on sale of equity - - 2,858 2,471 5,329 securities Interest income 713 661 660 746 2,780 Interest expense (2,710) (2,945) (2,995) (2,848) (11,498) Income (loss) 32,984 32,432 28,826 (37,219) 57,023 before income taxes Provision benefit for 7,751 7,622 6,774 (8,746) 13,401 income taxes Net income/(loss) $ 25,233 $ 24,810 $22,052 $(28,473) $43,622 Per share information Net income/(loss) $ 0.57 $ 0.57 $0.51 $ (0.66) $ 1.00 (loss) Weighted average common 44,163 43,642 43,335 43,284 43,602 shares outstanding 1995 Net sales $141,427 $150,508 $147,547 $154,984 $594,466 Cost of sales 58,509 60,779 61,293 63,268 243,849 Gross profit 82,918 89,729 86,254 91,716 350,617 Selling, general and 45,795 49,610 48,842 50,779 195,026 administrative expenses Research and development 8,513 9,155 9,352 9,495 36,515 expenses Operating income 28,610 30,964 28,060 31,442 119,076 Interest income 386 337 427 532 1,682 Interest expense (2,318) (2,851) (2,616) (2,838) (10,623) Income before 26,678 28,450 25,871 29,136 110,135 income taxes Provision for income taxes 6,003 6,401 5,821 6,556 24,781 Net income $ 20,675 $ 22,049 $ 20,050 $ 22,580 $ 85,354 Per share information Net income $ 0.45 $ 0.49 $ 0.45 $ 0.51 $ 1.90 Weighted average common 45,960 44,998 44,642 44,348 44,985 shares outstanding SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ANNUAL REPORT OF MILLIPORE CORPORATION For the Fiscal Year Ended December 31, 1996 **************** EXHIBITS **************** INDEX TO EXHIBITS Exhibit No. Description Tab No. 2.1 Amicon Worldwide Purchase and Sale, ** Agreement, dated November 18, 1996, dated December 31, 1996, as Amended by Amendment Agreement, dated December 31, 1996, by and amongCompany and W. R. Grace & Co.-Conn. 2.2 Agreement and Plan of Merger, dated ** as of December 16, 1996, by and among Company and its wholly owned subsidiary MCTG Acquisition Corp. and Tylan General, Inc. 3.1 Restated Articles of Organization, 1 as amended May 6, 1996 3.2 By Laws, as amended ** 4.1 Indenture dated as of May 3, 1995, ** relating to the issuance of $100,000,000 principal amount of Company's 6.78% Senior Notes due 2004 10.1 Distribution Agreement, dated as of July 1, 2 1996, by and among Company and Fisher Scientific Company (all schedules and Exhibits have been omitted; Company agrees to furnish the Commission with a copy of any such schedule or exhibit upon request) 10.2 Revolving Credit Agreement, dated as of 3 January 22, 1997, among Millipore Corporation and The First National Bank of Boston, ABM AMRO Bank N.V. and certain other lending institutions which are or become parties thereto 10.3 Shareholder Rights Agreement, dated as of ** April 15, 1988, between Millipore and The First National Bank of Boston 10.4 Long Term Restricted Stock (Incentive) Plan ** for Senior Management ** Incorporated by Reference to a prior filing with the Commission Exhibit No. Description Tab No. 10.5 1985 Combined Stock Option Plan ** 10.6 Supplemental Savings and Retirement Plan ** for Key Salaried Employees of Millipore Corporation 10.7 Executive Termination Agreement ** 10.8 Executive "Sale of Business" Incentive ** Termination Agreements 10.9 1995 Employee Stock Purchase Plan ** 10.10 1995 Management Incentive Plan ** 11 Computation of Per Share Earnings 4 21 Subsidiaries of Millipore 5 23 Consent of Coopers & Lybrand L.L.P. 6 24 Power of Attorney 7 ** Incorporated by Reference to a prior filing with the Commission Millipore Corporation Exhibit 11 Computation of Earnings Per Share (In Thousands Except Per Share Data) Years Ended December 31, Calculation of shares: 1996 1995 1994 Weighted average of shares outstanding during the year 43,602 (b) 44,985 (b) 54,726 (b) Shares outstanding from assumed exercise of stock 2,831 3,129 4,325 option (Treasury Method) (1,494) (1,736) (2,969) (NQ tax benefit) (452) (465) (438) Weighted average shares and common stock equivalents outstanding during the year 44,487 (a) 45,913 (a) 55,644 (a) Additional shares assumed exercised with full - - - dilution Weighted average of shares used in calculation of fully diluted earnings per share 44,487 (a) 45,913 (a) 55,644 (a) Net Income $ 43,622 $ 85,354 $56,209 Earnings per common share as reported in the Consolidated Financial Statements $ 1.00 $ 1.90 $ 1.03 Primary earnings per common $ 0.98 $ 1.86 $ 1.01 (a) share (a) (a) Net fully diluted earnings per common share $ 0.98 $ 1.86 $ 1.01 (a) (a) (a) (a) These calculations are submitted in accordance with Securities Exchange Act of 1934 Release N. 9083 although not required by APB No. 15 because they result in dilutions of less than 3%. (b) Represents weighted average of shares outstanding used in the earnings per share calculations. Common stock equivalents for 1996, 1995, and 1994 were not included in the weighted average share computation as they were less than 3% dilutive Exhibit 21 Subsidiaries Of Millipore Corporation Pursuant to Item 601, Paragraph 21, clause (ii) of Regulation S-K,the following list excludes subsidiaries who conduct no business operations or which have no significant assets. Company Name Jurisdiction of Organization Millipore Asia Ltd. Delaware Millipore Korea Ltd. Korea Millipore Cidra, Inc. Delaware Millipore Intertech, (V.I.), Inc. U.S. Virgin Is. Millipore (Canada) Ltd. Canada Amicon Canada Limited Canada Millipore S.A. de C.V. Mexico Millipore GesmbH Austria Millipore Kft Hungary Millipore S.R.O. Czech Republic Millipore Investment Holdings Ltd. Delaware Millipore International Holding Company B.V. Netherlands Millipore Japan Company L.L.C. Delaware Nihon Millipore Limited Japan Millipore S.A./N.V. Belgium Millipore (U.K.) Ltd. United Kingdom Amicon Limited United Kingdom Millipore S.A. France Prochrom S.A. France Prochrom Recherche et Development S.A. France Prochrom, Inc. Indiana Prochrom OY Finland Millipore Ireland B.V. Netherlands Millipore Dublin International Finance Company Ireland Millipore GmbH West Germany Amicon GmbH West Germany Millipore S.p.A. Italy Millipore A.B. Sweden Millipore AS Norway Millipore A.G. Switzerland Millipore A/S Denmark Millipore Australia Pty. Ltd. Australia Millipore Iberica S.A. Spain Millipore I.E.C., Ltda. Brazil Millipore OY Finland Millipore B.V. The Netherlands Millipore China Ltd. Hong Kong Exhibit 21 [Cont'd] Millipore Pacific Limited Delaware Millipore (Suzhou) Filter Company Limited Peoples Republic of China Millicorp, Inc. Delaware Minerva Insurance Corp. Ltd. Bermuda Tylan General, Inc. Delaware Tylan General GmbH Germany Tylan General U.K. Ltd. United Kingdom TG SARL France Tylan General K.K. Japan TG Korea Ltd. Korea Span Instruments, Inc. Texas Ocala, Inc. Texas Span Instruments Singapore, Pte. Ltd. Singapore Vermeer Ireland EXHIBIT 23 Consent of Independent Accountants CONSENT OF INDEPENDENT ACCOUNTANTS We consent to the incorporation by reference in the registration statements of Millipore Corporation on Form S-8 (File Nos. 2- 91432, 2-72124, 2-85698, 2-97280, 33-37319, 33-37323, 33-59005, 33- 10801, 33-11-790), on Form S-3 (File Nos. 2-84252, 33-9706, 33- 22196, 33-47213) and on Form S-4 (File No. 33-58117) of our report dated January 22, 1997 on our audits of the consolidated financial statements of Millipore Corporation as of December 31, 1996 and 1995, and for the years ended December 31, 1996, 1995, and 1994, which report is incorporated by reference in this Annual Report on Form 10-K. COOPERS & LYBRAND L.L.P. Boston, Massachusetts March 7, 1997 EXHIBIT 24 Power of Attorney KNOW ALL MEN BY THESE PRESENTS, that the undersigned Directors and Officers of Millipore Corporation (the "Corporation"), do hereby constitute and appoint C. William Zadel and Jeffrey Rudin and each of them individually, their true and lawful attorneys and agents to execute on behalf of the Corporation the Form 10-K Annual Report of the Corporation for the fiscal year ended December 31, 1996, and all such additional instruments related thereto which such attorneys and agents may deem to be necessary and desirable to enable the Corporation to comply with the requirements of the Securities Exchange Act of 1934, as amended, and any regulations, orders, or other requirements of the United States Securities and Exchange Commission thereunder in connection with the preparation and filing of said Form 10-K Annual Report, including specifically, but without limitation of the foregoing, power and authority to sign the names of each of such Directors and Officers on his behalf, as such Director or Officer, as indicated below to the said Form 10-K Annual Report or documents filed or to be filed as a part of or in connection with such Form 10-K Annual Report; and each of the undersigned hereby ratifies and confirms all that said attorneys and agents shall do or cause to be done by virtue thereof. SIGNATURE TITLE DATE /s/C. William Zadel Chairman, President March 7, 1997 C. William Zadel Chief Executive Officer and Director /s/Charles D. Baker Director March 7, 1997 Charles D. Baker /s/Samuel C. Butler Director March 7, 1997 Samuel C. Butler /s/Robert E. Caldwell Director March 7, 1997 1997 Robert E. Caldwell /s/Maureen A. Hendricks Director March 7, 1997 Maureen A. Hendricks /s/Mark Hoffman Director March 7, 1997 Mark Hoffman /s/Steven Muller Director March 7, 1997 Steven Muller /s/Thomas O. Pyle Director March 7, 1997 Thomas O. Pyle /s/John F. Reno Director March 7, 1997 John F. Reno
EX-3 2 THE COMMONWEALTH OF MASSACHUSETTS MICHAEL JOSEPH CONNOLLY Secretary of State ONE ASHBURTON PLACE, BOSTON, MASS 02108 Federal Identification No. 04-2170233 RESTATED ARTICLES OF ORGANIZATION General Laws, Chapter 158B, Section 74 This certificate must be submitted to the Secretary of the Commonwealth within sixty days after the date of the vote of stockholders adopting the restated articles of organization. The fee for filing this certificate is prescribed by General Laws, Chapter 156B, Section 114. Make check payable to the Commonwealth of Massachusetts. _________________ We, John G. Mulvany, President, and Geoffrey Nunes, Assistant Clerk of MILLIPORE CORPORATION located at 80 Ashby Road, Bedford, Massachusetts 01730 do hereby certify that the following restatement of the articles of organization of the corporation was duly adopted at a meeting held on May 2, 1985, by vote of 10,072,345 shares of Common out of 13,773,701 shares outstanding, being at least two-thirds of each class of stock outstanding and entitled to vote and of each class or series of stock adversely affected thereby - 1. The name by which the corporation shall be known is Millipore Corporation. 2. The purposes for which the corporation is formed are as follows: To manufacture, develop, buy, sell, assemble, install and in any way deal in and with all kinds of filters and filtration and sterilization systems and products and all kinds of laboratory equipment and accessories; to carry on research in the compounding of chemicals and in the fields of concentrating, sterilizing, culturing and filtering microscopic and sub-microscopic particles in and from liquid and gaseous systems and to use, manufacture and sell any products or processes which may result from such research; to use, manufacture, develop, buy, sell, assemble, install and otherwise deal in and with tangible personal property of all kinds and description; to purchase or otherwise acquire all patents, patent rights, privileges, trade marks, trade names and privileges of any country which might seem capable of being used for or in connection with any of the See Continuation Sheet 2A 3. The total number of shares and the par value, if any, of each class of stock which the corporation is authorized to issue as follows: WITHOUT PAR VALUE WITH PAR VALUE CLASS OF STOCK NUMBER OF SHARES NUMBER OF SHARES PAR VALUE Preferred NONE NONE Common NONE 40,000,000 $1.00 *4. If more than one class is authorized, a description of each of the different classes of stock with, if any, the preferences, voting powers, qualifications, special or relative rights or privileges as to each class thereof and any series now established: NONE *5. The restrictions, if any, imposed by the articles of organization upon the transfer of shares of stock of any class are as follows: NONE *6. Other lawful provisions, if any, for the conduct and regulation of the business and affairs of the corporation, for its voluntary dissolution, or for limiting, deriving, or regulating the powers of the corporation, or of its directors or stockholders, or any class of stockholders: The Directors may make, amend or repeal the By-Laws in whole or in part, except with respect to any provision thereof which by law or by the By-Laws requires action by the Stockholders. Meetings of the Stockholders may be held anywhere in the United States. *if there are no such provisions, state "None". Continuation Sheet 2A objects or purposes of this corporation, and to grant licenses for the use of and to sell or otherwise dispose of such patents, patent rights, trade marks, trade names and privileges in any country; to carry on any business permitted by the law of the Commonwealth of Massachusetts to a corporation organized under the Business Corporation Law; and to do each and every thing necessary, suitable or proper for the accomplishment of any of the purposes or the attainment of any one or more of the objects herein enumerated or which shall at any time appear conducive to or expedient for this corporation. *We further certify that the foregoing restated articles of organization effect no amendments to the articles of organization of the corporation as heretofore amended, except amendments to the following articles - Article 3. (*if there are no such amendments, state "None".) Briefly describe amendments in space below: Article 3. Amended to increase the authorized capital from 20,000,000 shares of Common Stock, $1.00 Par Value, to 40,000,000 shares of Common Stock, $1.00 Par Value. IN WITNESS WHEREOF AND UNDER THE PENALTIES OF PERJURY, we have hereto signed our names this 6th day of June in the year 1985. John G. Mulvany, President Geoffrey Nunes, Assistant Clerk THE COMMONWEALTH OF MASSACHUSETTS RESTATED ARTICLES OF ORGANIZATION (General Laws, Chapter 156B, Section 74) I hereby approve the within restated articles of organization and the filing fee in the amount of $10,150.00 having been paid, said articles are deemed to have been filed with me this 11th day of June, 1985. MICHAEL JOSEPH CONNOLLY Secretary of State TO BE FILLED IN BY CORPORATION Photo Copy of Restated Articles of Organization to be Sent TO: Peter W. Walcott, Esquire Millipore Corporation 80 Ashby Road Bedford, MA 01730 Telephone - 275-9200, X8496 THE COMMONWEALTH OF MASSACHUSETTS MICHAEL JOSEPH CONNOLLY Secretary of State ONE ASHBURTON PLACE, BOSTON, MASS. 02108 Federal Identification No. 04-21702333 ARTICLES OF AMENDMENT General Laws, Chapter 156B, Section 72 This certificate must be submitted to the Secretary of the Commonwealth within sixty days after the date of the vote of stockholders adopting the amendment. The fee for filing this certificate is prescribed by General Laws, Chapter 156B, Section 114. Make check payable to the Commonwealth of Massachusetts. We, John A. Gilmartin, President and Geoffrey Nunes, Assistant Clerk of Millipore Corporation located at 80 Ashby Road, Bedford, MA 01730 do hereby certify that the following amendment to the articles of organization of the corporation was duly adopted at a meeting held on April 24, 1986, by vote of 9,835,427 shares of common stock out of 13,860,217 shares outstanding, being at least a majority of each class outstanding and entitled to vote thereon. Note: If the space provided under any Amendment or item on this form is insufficient, additions shall be set forth on separate 8 1/2 x 11 sheets of paper leaving a left hand margin of at least 1 inch for binding. Additions to more than one Amendment may be continued on single sheet of paper leaving a left hand margin of at least 1 inch for binding. Additions to more than one Amendment may be continued on a single sheet so long as each Amendment requiring each such addition is clearly indicated. FOR INCREASE IN CAPITAL FILL IN THE FOLLOWING: The total amount of capital stock already authorized is 40 Million shares common with par value. The amount of additional capital stock authorized is 80 Million shares common with par value. Voted:That the increase in this Corporation's authorized capital stock to 80 million shares of common stock, par value $1.00 per share, and the amendment of the Articles of Organization to reflect such increase, all as adopted by the Board of Directors, and as described in full in the Corporation's Proxy Statement, dated March 17, 1986, be, and it hereby is, approved and adopted. The foregoing amendment will become effective when these articles of amendment are filed in accordance with Chapter 156B, Section 6 of The General Laws unless these articles specify, in accordance with the vote adopting the amendment, a later effective date not more than thirty days after such filing, in which event the amendment will become effective on such later date. IN WITNESS WHEREOF AND UNDER THE PENALTIES OF PERJURY, we have hereto signed our names this 9th day of May, in the year 1986. John A. Gilmartin, President Geoffrey Nunes, Assistant Clerk THE COMMONWEALTH OF MASSACHUSETTS ARTICLES OF AMENDMENT (General Laws, Chapter 156B, Section 72) I hereby approve the within articles of amendment and, the filing fee in the amount of $20,000.00 having been paid, said articles are deemed to have been filed with me this 12th day of May, 1986. MICHAEL JOSEPH CONNOLLY Secretary of State TO BE FILLED IN BY CORPORATION Photo Copy of Amendment to be Sent to: Peter W. Walcott, Esquire Millipore Corporation 80 Ashby Road Bedford, MA 01730 Telephone (617) 275-9200, Ext. 8496 THE COMMONWEALTH OF MASSACHUSETTS MICHAEL JOSEPH CONNOLLY Secretary of State ONE ASHBURTON PLACE, BOSTON, MASS. 02108 Federal Identification No. 04-21702333 ARTICLES OF AMENDMENT General Laws, Chapter 156B, Section 72 This certificate must be submitted to the Secretary of the Commonwealth within sixty days after the date of the vote of stockholders adopting the amendment. The fee for filing this certificate is prescribed by General Laws, Chapter 156B, Section 114. Make check payable to the Commonwealth of Massachusetts. We, John A. Gilmartin, President and Geoffrey Nunes, Assistant Clerk of Millipore Corporation located at 80 Ashby Road, Bedford, MA 01730 do hereby certify that the following amendment to the articles of organization of the corporation was duly adopted at a meeting held on April 23, 1987, by vote of 19,548,103 shares of Common Stock out of 28,172,481 shares outstanding, being at least two-thirds of each class outstanding and entitled to vote thereon and of each class or series of stock whose rights are adversely affected thereof. Note: If the space provided under any Amendment or item on this form is insufficient, additions shall be set forth on separate 8 1/2 x 11 sheets of paper leaving a left hand margin of at least 1 inch for binding. Additions to more than one Amendment may be continued on single sheet of paper leaving a left hand margin of at least 1 inch for binding. Additions to more than one Amendment may be continued on a single sheet so long as each Amendment requiring each such addition is clearly indicated. To add to Article 6 of the corporation's Restated Articles of Organization the following new paragraph (c): (c) No director of the corporation shall be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director to the extent provided by applicable law notwithstanding any provision of law imposing such liability; provided, however, that this Article 6(c) shall not eliminate the liability of a director 9I) for any breach of the director's duly of loyalty to the corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) under Section 61 or 62 of the Business Corporation Law of The Commonwealth of Massachusetts, or (iv) for any transaction from which the director derived any improper personal benefit. The foregoing provisions of this Article 6(c) shall not eliminate the liability of a director for any act or omission occurring prior to the date on which this Article 6(c) becomes effective. No amendment to or repeal of this Article 6(c) shall apply to or have any effect on the liability or alleged liability of any director of the corporation for or with respect to any acts or omissions of such director occurring prior to such amendment or repeal. The foregoing amendment will become effective when these articles of amendment are filed in accordance with Chapter 156B, Section 6 of the General Laws unless there articles specify, in accordance with the vote adopting the amendment, a later effective date not more than thirty days after such filing, in which event the amendment will become effective on such later date. IN WITNESS WHEREOF AND UNDER THE PENALTIES OF PERJURY, we have hereto signed our names this 15th day of May, in the year 1987. John A. Gilmartin, President Geoffrey Nunes, Assistant Clerk THE COMMONWEALTH OF MASSACHUSETTS ARTICLES OF AMENDMENT (General Laws, Chapter 156B, Section 72) I hereby approve the within articles of amendment and, the filing fee in the amount of $75.00 having been paid, said articles are deemed to have been filed with me this 22nd day of May, 1987. MICHAEL JOSEPH CONNOLLY Secretary of State TO BE FILLED IN BY CORPORATION Photo Copy of Amendment to be Sent To: Peter W. Walcott, Esq. MILLIPORE CORPORATION 80 Ashby Road Bedford, MA 01730 Telephone (617) 275-9200 THE COMMONWEALTH OF MASSACHUSETTS MICHAEL JOSEPH CONNOLLY Secretary of State ONE ASHBURTON PLACE BOSTON, MASS. 02108 Federal Identification No. 042170233 ARTICLES OF MERGER OF PARENT AND SUBSIDIARY CORPORATIONS Pursuant to General Laws, Chapter 156B, Section 82 The fee for filing this certificate is prescribed by General Laws, Chapter 156B, Section 114. Make check payable to the Commonwealth of Massachusetts We, Geoffrey Nunes and Patricia A. Powers, Vice President and Assistant Clerk of Millipore Corporation, organized under the laws of Massachusetts and herein called the parent corporation, do hereby certify as follows: 1. That the subsidiary corporation to be merged into the parent corporations is as follows: State of Date of Name Organization Organization Dynamic Solutions Corporation California 10/23/81 2. That the parent corporation owns at least ninety per cent of the outstanding shares of each class of the stock of each subsidiary corporation to be merged into the parent corporation. 3. That in the case of each of the above-named corporations the laws of the state of its organization, if other than Massachusetts, permit the merger herein provided for and that all action required under the laws of each such state in connection with this merger has been duly taken. (If all the corporations are organized under the laws of Massachusetts and if General Laws, Chapter 156B is applicable to them, then Paragraph 3 may be deleted). 4. That at a meeting of the directors of the parent corporation the following vote, pursuant to subsection (a) of General Laws, Chapter 156B, Section 82, was duly adopted: VOTES OF MILLIPORE BOARD MEETING BOARD MEETING February 17, 1989 VOTED: That the President and the other officers of this Corporation hereby are authorized together or singly to effect the merger of Millipore's wholly- owned subsidiary, Dynamic Solutions Corporation into Millipore Corporation; and further VOTED: That in connection with this merger of Dynamic Solutions Corporation with Millipore Corporation, the Officers of this Corporation hereby are, and each of them singly is, authorized to take all such action and to execute and deliver such documents, instruments, and opinions as they in their discretion may deem necessary or appropriate to carry out the intent of these resolutions and to effectuate said merger. NOTE: Votes for which the space provided above is not sufficient should be set out on continuation sheets to be numbered 2A, 2B, etc. Continuation sheets must have a left- hand margin 1 inch wide for binding. Only one side should be used. 5. The effective date of the merger as specified in the vote set out under Paragraph 4 is March 31, 1989. 6. (This Paragraph 6 may be deleted if the parent corporation is organized under the laws of Massachusetts). The parent corporation hereby agrees that it may be sued in the Commonwealth of Massachusetts for any prior obligation of any subsidiary corporation organized under the laws of Massachusetts with which is has merged, and nay obligation hereafter incurred by the parent corporation, including the obligation created by subsection (e) of General Laws, Chapter 156B, Section 82, so long as any liability remains outstanding against the parent corporation in the Commonwealth of Massachusetts and it hereby irrevocably appoints the Secretary of the commonwealth as its agent to accept service of process for the enforcement of any such obligations, including taxes, in the same manner as provided in Chapter 181. IN WITNESS WHEREOF and under the penalties of perjury we have hereto signed our names this 30th day of March, 1989. Geoffrey Nunes, Vice President Patricia A. Powers, Assistant Clerk COMMONWEALTH OF MASSACHUSETTS ARTICLES OF MERGER OF PARENT AND SUBSIDIARY CORPORATIONS (General Laws, Chapter 156B, Section 82) I hereby approve the within articles of merger of parent and subsidiary corporations and, the filing fee in the amount of $250.00 having been paid, said particles are deemed to have been filed with me this 31st day of March, 1989. MICHAEL JOSEPH CONNOLLY Secretary of State TO BE FILLED IN BY CORPORATION Photo Copy of Merger To Be Sent TO: Millipore Corporation 80 Ashby Road Bedford, MA 01730 Telephone (617) 275-9200 Attn: Geoffrey Nunes THE COMMONWEALTH OF MASSACHUSETTS MICHAEL JOSEPH CONNOLLY Secretary of State ONE ASHBURTON PLACE BOSTON, MASS. 02108 Federal Identification No. 042170233 ARTICLES OF MERGER OF PARENT AND SUBSIDIARY CORPORATIONS Pursuant to General Laws, Chapter 156B, Section 82 The fee for filing this certificate is prescribed by General Laws, Chapter 156B, Section 114. Make check payable to the Commonwealth of Massachusetts We, John A. Gilmartin and Geoffrey Nunes, President and Assistant Clerk of Millipore Corporation, organized under the laws of Massachusetts and herein called the parent corporation, do hereby certify as follows: 1. That the subsidiary corporation to be merged into the parent corporations is as follows: State of Date of Name Organization Organization Waters Associates, Inc. Delaware January 2, 1962 2. That the parent corporation owns at least ninety per cent of the outstanding shares of each class of the stock of each subsidiary corporation to be merged into the parent corporation. 3. That in the case of each of the above-named corporations the laws of the state of its organization, if other than Massachusetts, permit the merger herein provided for and that all action required under the laws of each such state in connection with this merger has been duly taken. (If all the corporations are organized under the laws of Massachusetts and if General Laws, Chapter 156B is applicable to them, then Paragraph 3 may be deleted). 4. That at a meeting of the directors of the parent corporation the following vote, pursuant to subsection (a) of General Laws, Chapter 156B, Section 82, was duly adopted: VOTED: That it is in the best interests of MILLIPORE CORPORATION to dissolve its wholly-owned subsidiary, WATERS ASSOCIATES, INC., a Delaware corporation, by the merger of the said WATERS ASSOCIATES, INC. into MILLIPORE CORPORATION, with MILLIPORE CORPORATION to be the surviving corporation; said merger to become effective December 31, 1989. NOTE: Votes for which the space provided above is not sufficient should be set out on continuation sheets to be numbered 2A, 2B, etc. Continuation sheets must have a left- hand margin 1 inch wide for binding. Only one side should be used. 5. The effective date of the merger specified in the vote set out under Paragraph 4 is December 31, 1989. IN WITNESS WHEREOF and under the penalties of perjury we have hereto signed our names this 27th day of December, 1989. John A. Gilmartin, President Geoffrey Nunes, Assistant Clerk COMMONWEALTH OF MASSACHUSETTS ARTICLES OF MERGER OF PARENT AND SUBSIDIARY CORPORATIONS (General Laws, Chapter 156B, Section 82) I hereby approve the within articles of merger of parent and subsidiary corporations and, the filing fee in the amount of $250.00 having been paid, said articles are deemed to have been filed with me this 28th day of December, 1989. Effective Date: December 31, 1989 MICHAEL JOSEPH CONNOLLY Secretary of State TO BE FILLED IN BY CORPORATION Photo Copy of Merger to be Sent TO: Peter W. Walcott, Esq. Millipore Corporation 80 Ashby Road Bedford, MA 01730 Telephone (617) 275-9200 THE COMMONWEALTH OF MASSACHUSETTS MICHAEL JOSEPH CONNOLLY Secretary of State ONE ASHBURTON PLACE BOSTON, MASS. 02108 Federal Identification No. 042170233 ARTICLES OF MERGER OF PARENT AND SUBSIDIARY CORPORATIONS Pursuant to General Laws, Chapter 156B, Section 82 The fee for filing this certificate is prescribed by General Laws, Chapter 156B, Section 114. Make check payable to the Commonwealth of Massachusetts We, John A. Gilmartin and Geoffrey Nunes, President and Assistant Clerk of Millipore Corporation, organized under the laws of Massachusetts and herein called the parent corporation, do hereby certify as follows: 1. That the subsidiary corporation(s) to be merged into the parent corporations is as follows: State of Date of Name Organization Organization MILLIPORE SECURITIES Massachusetts 3/16/82 CORPORATION 2. That the parent corporation owns at least ninety per cent of the outstanding shares of each class of the stock of each subsidiary corporation to be merged into the parent corporation. 3. That in the case of each of the above-named corporations the laws of the state of its organization, if other than Massachusetts, permit the merger herein provided for and that all action required under the laws of each such state in connection with this merger has been duly taken. (If all the corporations are organized under the laws of Massachusetts and if General Laws, Chapter 156B is applicable to them, then Paragraph 3 may be deleted). 4. That at a meeting of the directors of the parent corporation the following vote, pursuant to subsection (a) of General Laws, Chapter 156B, Section 82, was duly adopted: VOTED: That it is in the best interest of MILLIPORE CORPORATION to dissolve its wholly-owned subsidiary, MILLIPORE SECURITIES CORPORATION, a Massachusetts corporation, by the merger of the said MILLIPORE SECURITIES CORPORATION into MILLIPORE CORPORATION, with MILLIPORE CORPORATION to be the surviving corporation; said merger to become effective upon the filing of Articles of Merger with the Secretary of the Commonwealth of Massachusetts. 5. The effective date of the merger as specified in the vote set out under Paragraph 4 is 6. (This Paragraph 6 may be deleted if the parent corporation is organized under the laws of Massachusetts). The parent corporation hereby agrees that it may be used in the Commonwealth of Massachusetts for any prior obligation of any subsidiary corporation organized under the laws of Massachusetts with which it has merged, and any obligation hereafter incurred by the parent corporation, including the obligation created by subsection (e) of General Laws, Chapter 156B, Section 82, so long as any liability remains outstanding against the parent corporation in the Commonwealth of Massachusetts and it hereby irrevocably appoints the Secretary of the Commonwealth as its agent to accept service of process for the enforcement of any such obligations, including taxes, in the same manner as provided in Chapter 181. IN WITNESS WHEREOF and under the penalties of perjury we have hereto signed our names this 14th day of November, 1991. John A. Gilmartin, President Geoffrey Nunes, Assistant Clerk COMMONWEALTH OF MASSACHUSETTS ARTICLES OF MERGER OF PARENT AND SUBSIDIARY CORPORATIONS (General Laws, Chapter 156B, Section 82) I hereby approve the within articles of merger of parent and subsidiary corporations and, the filing fee in the amount of $250.00 having been paid, said articles are deemed to have been filed with me this 21st day of November, 1991. MICHAEL JOSEPH CONNOLLY Secretary of State TO BE FILLED IN BY CORPORATION Photo Copy of Merger to be Sent To: Peter W. Walcott, Esquire Millipore Corporation 80 Ashby Road Bedford, MA 01730 Telephone (617) 275-9200, Ext. 8496 THE COMMONWEALTH OF MASSACHUSETTS MICHAEL JOSEPH CONNOLLY Secretary of State ONE ASHBURTON PLACE BOSTON, MASS. 02108 Federal Identification No. 042170233 ARTICLES OF MERGER OF PARENT AND SUBSIDIARY CORPORATIONS Pursuant to General Laws, Chapter 156B, Section 82 The fee for filing this certificate is prescribed by General Laws, Chapter 156B, Section 114. Make check payable to the Commonwealth of Massachusetts We, John A. Gilmartin and Geoffrey Nunes, President and Assistant Clerk of Millipore Corporation, organized under the laws of Massachusetts and herein called the parent corporation, do hereby certify as follows: 1. That the subsidiary corporation to be merged into the parent corporation is as follows: State of Date of Name Organization Organization SEQUEMAT, INC. Massachusetts 5/15/73 2. That the parent corporation owns at least ninety per cent of the outstanding shares of each class of the stock of each subsidiary corporation to be merged into the parent corporation. 3. That in the case of each of the above-named corporations the laws of the state of its organization, if other than Massachusetts, permit the merger herein provided for and that all action required under the laws of each such state in connection with this merger has been duly taken. (If all the corporations are organized under the laws of Massachusetts and if General Laws, Chapter 156B is applicable to them, then Paragraph 3 may be deleted). 4. That at a meeting of the directors of the parent corporation the following vote, pursuant to subsection (a) of General Laws, Chapter 156B, Section 82, was duly adopted: VOTED: That it is in the best interests of Millipore Corporation to dissolve its wholly-owned subsidiary, Sequemat, Inc., a Massachusetts corporation, by the merger of Sequemat, Inc. into Millipore Corporation, with Millipore Corporation to be the surviving corporation, said merger to become effective upon the filing of the Articles of Merger with the Secretary of State of the Commonwealth of Massachusetts. 5. The effective date of the merger as specified in the vote under Paragraph 1 is upon the filing of the Articles of Merger. IN WITNESS WHEREOF and under the penalties of perjury we have hereto signed our names this 90th day of September, 1993. John A. Gilmartin, President Geoffrey Nunes, Assistant Clerk COMMONWEALTH OF MASSACHUSETTS ARTICLES OF MERGER OF PARENT AND SUBSIDIARY CORPORATIONS (General Laws, Chapter 156B, Section 82) I hereby approve the within articles of merger of parent and subsidiary corporation and, the filing fee in the amount of $250.00 having been paid, said articles are deemed to have been filed with me this 15th day of September, 1993. MICHAEL JOSEPH CONNOLLY Secretary of State TO BE FILLED IN BY CORPORATION Photo Copy of Merger to be Sent TO: Cynthia A. Bacon, Legal Assistant Millipore Corporation 80 Ashby Road, Mail Stop E10D Bedford, MA 01730 Telephone (617) 275-9200, Ext. 2043 THE COMMONWEALTH OF MASSACHUSETTS MICHAEL JOSEPH CONNOLLY Secretary of State ONE ASHBURTON PLACE BOSTON, MASS. 02108 Federal Identification No. 042170233 ARTICLES OF MERGER OF PARENT AND SUBSIDIARY CORPORATIONS Pursuant to General Laws, Chapter 156B, Section 82 The fee for filing this certificate is prescribed by General Laws, Chapter 156B, Section 114. Make check payable to the Commonwealth of Massachusetts We, Geoffrey Nunes and Patricia A. Powers, Vice President and Assistant Clerk of Millipore Corporation, organized under the laws of Massachusetts and herein called the parent corporation, do hereby certify as follows: 1. That the subsidiary corporation(s) to be merged into the parent corporations is as follows: State of Date of Name Organization Organization Waters Puerto Rico, Inc. Delaware 12/23/76 2. That the parent corporation owns at least ninety per cent of the outstanding shares of each class of the stock of each subsidiary corporation to be merged into the parent corporation. 3. That in the case of each of the above-named corporations the laws of the state of its organization, if other than Massachusetts, permit the merger herein provided for and that all action required under the laws of each such state in connection with this merger has been duly taken. (If all the corporations are organized under the laws of Massachusetts and if General Laws, Chapter 156B is applicable to them, then Paragraph 3 may be deleted). 4. That at a meeting of the directors of the parent corporation the following vote, pursuant to subsection (a) of General Laws, Chapter 156B, Section 82, was duly adopted: VOTED: That it is in the best interests of this Corporation that its wholly-owned subsidiary, Waters Puerto Rico, Inc. be liquidated and dissolved by the merger of Waters Puerto Rico, Inc. with and into this Corporation, with this Corporation to be surviving corporation, said merger to be effective as of June 30, 1994. 5. The effective date of the merger as specified in the vote set out under Paragraph 4 is June 30, 1994. IN WITNESS WHEREOF and under the penalties of perjury we have hereto signed our names this 9th day of June, 1994. Geoffrey Nunes, Vice President Patricia A. Powers, Assistant Clerk COMMONWEALTH OF MASSACHUSETTS ARTICLES OF MERGER OF PARENT AND SUBSIDIARY CORPORATIONS (General Laws, Chapter 156B, Section 82) I hereby approve the within articles of merger of parent and subsidiary corporations and, the filing fee in the amount of $250.00 having been paid, said articles are deemed to have been filed with me this 10th day of June, 1994. MICHAEL JOSEPH CONNOLLY Secretary of State TO BE FILLED IN BY CORPORATION Photo Copy of Merger to be Sent TO: Cynthia A. Bacon Senior Paralegal Millipore Corporation 80 Ashby Road Bedford, MA 01730 Telephone (617) 275-9200, Ext. 2043 THE COMMONWEALTH OF MASSACHUSETTS William Francis Galvin Secretary of the Commonwealth ONE ASHBURTON PLACE, BOSTON, MASSACHUSETTS 02108 ARTICLES OF AMENDMENT General Laws, Chapter 156B, Section 72 Federal Identification No. 04-21702333 We, Geoffrey Nunes, Vice President, and Patricia A. Powers, Assistant Clerk of Millipore Corporation located at 80 Ashby Road, Bedford, Massachusetts 01730, do hereby certify that these ARTICLES OF AMENDMENT affecting Articles NUMBERED 3 of the Articles of Organization were duly adopted at a meeting held on April 18, 1996, by vote of 33,685,855 shares of Common Stock out of 44,270,089 shares outstanding, being at least a majority of each type, class or series outstanding and entitled to vote thereon. Note: If the space provided under any Amendment or item on this form is insufficient, additions shall be set forth on separate 8 1/2 x 11 sheets of paper leaving a left hand margin of at least 1 inch for binding. Additions to more than one Amendment may be continued on single sheet of paper leaving a left hand margin of at least 1 inch for binding. Additions to more than one Amendment may be continued on a single sheet so long as each Amendment requiring each such addition is clearly indicated. To CHANGE the number of shares and the par value (if any) of any type, class or series of stock which the corporation is authorized to issue, fill in the following: The total presently authorized is: Common 80,000,000 shares $1.00 par value (with par value stocks) CHANGE the total authorized to: Common 120,000,000 shares $1.00 par value (with par value stocks) VOTED: That the increase in this Corporation's authorized capital stock to 120 million shares of common stock, $1.00 par value, and the amendment to the Restated Articles of Organization to reflect such increase, all as adopted by the Board of Directors, and as described in full in the Corporation's proxy statement, dated March 15, 1996, be and it hereby is, approved and adopted. The foregoing amendment will become effective when these articles of amendment are filed in accordance with Chapter 156B, Section 6 of The General Laws unless these articles specify, in accordance with the vote adopting the amendment, a later effective date not more than thirty days after such filing, in which event the amendment will become effective on such later date. EFFECTIVE DATE: IN WITNESS WHEREOF AND UNDER THE PENALTIES OF PERJURY, we have hereunto signed our names this 6th day of May, in the year 1996. Geoffrey Nunes, Vice President Patricia A. Powers, Assistant Clerk THE COMMONWEALTH OF MASSACHUSETTS ARTICLES OF AMENDMENT General Laws, Chapter 156B, Section 72 I hereby approve the within articles of amendment and, the filing fee in the amount of $40,000 having been paid, said articles are deemed to have been filed, with me this 15th day of May, 1996. William Francis Galvin Secretary of the Commonwealth TO BE FILLED IN BY CORPORATION PHOTOCOPY OF ARTICLES OF AMENDMENT TO BE SENT TO: Patricia A. Powers, Esquire c/o Millipore Corporation 80 Ashby Road Bedford, MA 01730 Telephone (617) 533-2272 EX-10.1 3 18 DISTRIBUTORSHIP AGREEMENT This Agreement, made and entered into to be effective as of the 1st day of July by and between: MILLIPORE CORPORATION Analytical Division 80 Ashby Road Bedford, MA 01730 a corporation organized under the laws of the state of Massachusetts, hereinafter referred to as SUPPLIER; and FISHER SCIENTIFIC COMPANY 711 Forbes Avenue Pittsburgh, PA 15219 a corporation organized under the laws of the state of Delaware, hereinafter referred to as DISTRIBUTOR. W I T N E S S E T H WHEREAS, SUPPLIER desires to sell and/or market certain selected products to the laboratory market through the use of an exclusive distributor; and WHEREAS, DISTRIBUTOR desires to purchase such selected products of SUPPLIER for resale to customers in the laboratory market; and WHEREAS, the Parties desire to enter into a distributorship agreement governing their relationship; NOW, THEREFORE, in consideration of the mutual terms and conditions set forth herein, and intending to be legally bound hereby, the Parties hereto agree as follows: 1. PRODUCTS 1.1 Products: The products covered by this Agreement are those products set forth on Exhibit A attached hereto (the "Products"), manufactured by or for SUPPLIER, and any improved or updated versions thereof, as well as all replacements and/or modifications, together in each case with accessories, parts and components SUPPLIER deems necessary for their maintenance and repair. Exhibit A may be amended from time to time by mutual consent of the Parties and shall be amended from time to time to include replacement and/or enhancing Products. 1.2 New Products: SUPPLIER shall offer to DISTRIBUTOR in writing the ability to distribute any new filtration product (developed or acquired by SUPPLIER) with same or substantially similar application in analytical laboratories as the Products. Excepted from this requirement to offer are SUPPLIER's EZ-PAK line of products as well as all its products for microbiological detection and/or analysis. If such "New Product" is a direct replacement or modification of a Product, the discount will be consistent with the discounts, by product group, of Exhibit A; otherwise the discount shall be mutually agreed upon by the parties. 2. GRANT OF RIGHTS 2.1 Distribution Rights: SUPPLIER hereby appoints DISTRIBUTOR and DISTRIBUTOR accepts the appointment as the exclusive (except as otherwise provided in this Agreement) Distributor of the Products during the term of this Agreement. DISTRIBUTOR shall have the right to appoint sub-distributors and/or "resellers" if it so chooses. 2.2 Territory: The territory in which the DISTRIBUTOR has the exclusive right to sell and distribute the Products shall be the United States, Canada and Puerto Rico (the "Territory"). The Territory can be expanded only by a mutual written agreement. DISTRIBUTOR is not authorized to resell Products to customers outside the Territory. 2.3 Reserved Rights: SUPPLIER reserves the right to sell the Products directly to end users in the Territory (hereinafter "Supplier Direct Sales"). The Parties shall promote conversion of such Direct Sales to sales through DISTRIBUTOR (hereinafter, when combined with all other sales by DISTRIBUTOR, "Distributor Product Sales"). In addition, SUPPLIER reserves the right to sell Products to the following specific distributors with which it has existing relationships, as follows (hereinafter "Supplier Indirect Sales"): 2.3.1 Certain specific Products to Sigma Aldrich Company, Inc. (SUPPLIER has disclosed to DISTRIBUTOR's counsel in confidence the products included in this agreement); 2.3.2 Certain specific Products to Varian Corporation (SUPPLIER has disclosed to DISTRIBUTOR's counsel in confidence the products included in this agreement); 2.3.3 Certain specific Products to Cole-Parmer Inc. (SUPPLIER has disclosed to DISTRIBUTOR's counsel in confidence the products included in this agreement); 2.3.4 Some or all Products to VWR Scientific Products Company ("VWR") and/or its affiliate IBS, for Dupont and nine other specific corporate customers who have integrated supply arrangements with VWR and/or IBS ("Supply Customers"); 2.3.5 some or all of the Products to VWR and/or IBS for one or more additional Supply Customers, provided that SUPPLIER has given DISTRIBUTOR a reasonable opportunity to demonstrate to SUPPLIER's reasonable satisfaction that DISTRIBUTOR can fulfill the particular Supply Customer's requirements for Products either by direct sale from DISTRIBUTOR to the customer or by sale from DISTRIBUTOR to the customer through VWR and/or IBS. It is SUPPLIER's current intention not to extend its relationship with Cole Parmer beyond the end of the life cycle of their catalog listing SUPPLIER's products, or the relationship with Sigma Aldrich beyond the end of 1997, if at those times SUPPLIER believes DISTRIBUTOR can fulfill the related customer demand for Product directly or though sales by DISTRIBUTOR to Sigma Aldrich or Cole-Parmer. 2.4 Small Business Resellers: SUPPLIER further reserves the right to sell Products to Government Scientific Source and certain other small business resellers; such current small business resellers are on a list that SUPPLIER has provided to DISTRIBUTOR's counsel in confidence. Such sales by SUPPLIER to small business resellers shall also be considered Supplier Indirect Sales. Supplier agrees (i) not to knowingly add additional resellers, and (ii) to use its reasonable best efforts to redirect business with existing resellers to and/or through DISTRIBUTOR. 2.5 Aggregate Net In-Market Sales: As used in this Agreement and in Exhibit B hereto, "Aggregate Net In-Market Sales" shall mean the sum of (a) Distributor Product Sales, (b) Distributor Private-Label Sales (those sales of SUPPLIER's products made by DISTRIBUTOR in accordance with the Agreement between SUPPLIER and DISTRIBUTOR dated August 1, 1995, at the prices as provided therein), (c) Supplier Direct Sales and (d) Supplier Indirect Sales, measured in each case except (b) above at "Dealer Cost" which shall be determined by SUPPLIER's list price for that unit minus any discount granted to DISTRIBUTOR in accordance with Exhibit A and as set forth in Section 6.2. In the event that Distributor Product Sales are reduced because of SUPPLIER's discontinuation of a Product or group of Products or because of SUPPLIER's failure or delay in filling purchase orders accepted under Section 3.2, the parties shall negotiate an adjustment to the Aggregate Net In-Market Sales to compensate for such reduction as provided in Section 4.1. 2.6 Conversion of Distributorship to Non-Exclusive: DISTRIBUTOR's limited exclusivity under Section 2.1 may be terminated by written notice from SUPPLIER to DISTRIBUTOR, given in the first calendar quarter of 1999, if the Aggregate Net In- Market Sales for 1998 are less than the Exclusivity Threshold set forth in Exhibit B (for 1997, 1998 and 1999). If the Aggregate Net In-Market Sales for 1998 have equaled or exceeded the Exclusivity Threshold for 1998, the limited exclusivity, granted in Section 2.1 shall be automatically renewed for an additional two years in which event the Parties shall negotiate in good faith during the first quarter of 1999 an Exclusivity Threshold, a Clawback Threshold and a Bonus Threshold for 2000. If the limited exclusivity under Section 2.1 remains in effect at the end of 1999 and the Aggregate Net In-Market Sales for 1999 have equaled or exceeded the Exclusivity Threshold for 1999, then the parties shall negotiate in good faith during the first quarter of 2000 an Exclusivity Threshold, a Clawback Threshold and a Bonus Threshold for 2001. Such procedure to continue as long as this Agreement is in force. Failure of the parties to agree upon such targets for any year after 2001 shall cause the limited exclusivity of Section 2.1 to end automatically on June 30 of the following year. 2.7 Clawback for failure to achieve Clawback Thresholds: DISTRIBUTOR agrees that, in each of the annual periods in which the limited exclusivity of Section 2.1 is in effect and in which the Aggregate Net In-Market Sales have not achieved the Clawback Threshold as set forth in Exhibit B or as established pursuant to Section 2.6, SUPPLIER shall be entitled to invoice DISTRIBUTOR in an amount which is fifty percent (50%) of the amount by which Aggregate Net In-Market Sales fell short of the Clawback Threshold, provided, however, that this percentage is subject to downward adjustment of one percent (1%) for each one percent (1%) reduction in the conversion of Millipore Direct Sales and Millipore Indirect Sales to Distributor Sales, all as reflected on Exhibit B. 2.8 Bonus for exceeding Exclusivity Thresholds: SUPPLIER agrees that, in each of the annual periods in which the limited exclusivity of Section 2.1 is in effect and in which the Aggregate Net In-Market Sales have exceed the Exclusivity Threshold as set forth in Exhibit B or as established pursuant to Section 2.6, DISTRIBUTOR shall be entitled to deduct from payments otherwise due to SUPPLIER an amount which is fifty percent (50%) of the amount by which Aggregate Net In-Market Sales have exceeded the Exclusivity Threshold. 2.9 Penalty for Sales Outside the Territory: DISTRIBUTOR agrees that should it, or any of its sub-distributors or "resellers" sell or transfer any of the Products outside the Territory, SUPPLIER will be entitled to invoice DISTRIBUTOR for the full amount of the discount allowed to DISTRIBUTOR in connection with the original sale to it by SUPPLIER. This right to invoice shall not apply if DISTRIBUTOR has obtained in advance of the relevant sale of Product written approval of SUPPLIER's Analytical Division Vice President either to make the particular sale of Product or to make a class of Product sales which includes the particular sale. None of such sales shall be counted towards the Bonus Threshold unless otherwise agreed to at the time of the approval of such sale or sales. 3. FORECASTS; ORDERS 3.1 Forecasts: DISTRIBUTOR shall provide SUPPLIER with non- binding forecasts of anticipated purchases of Products by DISTRIBUTOR and DISTRIBUTOR's Canadian subsidiary a minimum of two quarters prior to anticipated delivery dates. The forecasts will be revised and extended in each succeeding quarter. 3.2 Orders: DISTRIBUTOR agrees to initiate purchase of Products hereunder by issuing SUPPLIER non-cancelable purchase orders not less than ten (10) days for Products designated as "A Products" in Exhibit A and twenty (20) days for Products not so designated prior to the delivery date set forth therein. DISTRIBUTOR further agrees to spread its delivery dates over the applicable calendar quarter in a reasonable fashion reasonably consistent with its previously submitted forecasts. SUPPLIER agrees subject to provisions of Section 4.1 to accept and ship against any order issued in accordance with this Section 3.2 which specifies quantities consistent with those set forth in the purchase forecasts for such quarter and to use its reasonable best efforts to meet the delivery dates specified therein, and to promptly notify DISTRIBUTOR's designated purchasing agent as soon as SUPPLIER determines that a delivery date will not be met. SUPPLIER shall also make reasonable efforts to accept and ship quantities ordered in excess of those forecasted, subject to Product availability and other sources of Product demand, and shall promptly notify DISTRIBUTOR's designated purchasing agent as to each order which SUPPLIER does not accept as issued, including any proposed delivery date for the excess quantities ordered for such purchasing agent to include in an amended or new order. All purchase orders shall be on DISTRIBUTOR's standard purchase order form (a copy of which has been delivered to SUPPLIER). The terms and conditions of purchase enumerated on the reverse side of such standard purchase order form shall prevail over any inconsistent or conflicting language as may exist on invoices, confirmation or order acknowledgment forms of SUPPLIER, provided, however, that in the event any terms thereof are in conflict, or are inconsistent with any terms of this Agreement, the terms and conditions hereof shall prevail. 4. SHIPPING AND DELIVERY 4.1 Shipping: SUPPLIER shall ship all Products F.O.B. point of origin, freight collect, to any one of DISTRIBUTOR's five (5) locations listed on Exhibit A-1 attached hereto, and to the single designated location of DISTRIBUTOR's Canadian subsidiary (also listed on Exhibit A-1), palletized in accordance with DISTRIBUTOR's instructions. DISTRIBUTOR's Canadian subsidiary shall be responsible for all duty due on Products shipped to DISTRIBUTOR's Canadian subsidiary. In addition, those Products identified as "Non-Stocking" on Exhibit A shall also be shipped F.O.B. point of origin freight collect to those locations of DISTRIBUTOR as specified in DISTRIBUTOR's Purchase Order. New Products added to this Agreement under Section 1.2 shall be considered "Non-Stocking" unless and until a date five (5) days after SUPPLIER has filled DISTRIBUTOR's initial stocking order for the new Product at two (2) or more of the locations listed in Exhibit A-1. SUPPLIER shall drop ship Products not so labeled as Non-Stocking to DISTRIBUTOR's customers and to Distributor locations not listed in Exhibit A-1 up to fifty (50) times each calendar quarter through March 31, 1997 and up to twenty five (25) times in each subsequent calendar quarter at no extra charge to DISTRIBUTOR, provided that the following drop shipments shall not apply against such thresholds: (a) shipments to a customer who has placed on a single order Products designated as Non-Stocking and Products not designated as Non-Stocking, (b) shipments to a customer of a Product not designated Non- Stocking for which delivery against DISTRIBUTOR's accepted restocking order for the location on Exhibit A-1 serving the particular customer is overdue, and (c) shipments to a customer of replacement Products or sample Products under circumstances in which DISTRIBUTOR is not charged for the Products. All drop shipments in a quarter above such threshold shall be billed at fifty dollars ($50) per drop shipment. SUPPLIER will not be liable for any failure or delay in delivering Products ordered by DISTRIBUTOR based upon shortages of supply, whether caused by unanticipated demand or any other reason, but the Parties shall in such situations make an appropriate mutually- agreed adjustment to Aggregate Net In-Market Sales pursuant to Section 2.1. In periods of short supply of any Product SUPPLIER will allocate such Products to DISTRIBUTOR and SUPPLIER's other customers in a manner which SUPPLIER determines to be equitable under the circumstances. 4.2 Overstocked Inventory: To the extent, but only to the extent, SUPPLIER has recommended in writing to DISTRIBUTOR that DISTRIBUTOR carry, for a specified period of time, a certain level of inventory with respect to one or more Products, and DISTRIBUTOR upon review of the level of such inventory at the end of such period of time shall determine that it has excess inventory of such Product or Products, then DISTRIBUTOR shall notify the SUPPLIER in writing, describing such Products, and SUPPLIER shall, at DISTRIBUTOR 's election, either: (i) credit DISTRIBUTOR with the full purchase price paid by DISTRIBUTOR for each such Product upon return of the Product; or (ii) exchange, at SUPPLIER's expense, all such Products for Products which are selected by DISTRIBUTOR. 4.3 Obsolete Inventory: (a) In the event that SUPPLIER determines to make a material change to the Specification of any Product or to release an improved or updated version of any Product it shall give DISTRIBUTOR ninety (90) days notice of any such proposed change or release; (b) In the event SUPPLIER determines to discontinue or eliminate any Product from Exhibit A it shall give DISTRIBUTOR one hundred twenty (120) days notice of any such discontinuance or elimination; and in the event SUPPLIER shall not have given DISTRIBUTOR less than such ninety (90) or one hundred and twenty (120) days of advanced notice respectively, or have given DISTRIBUTOR no advance notice, and the respective event shall make any Products owned by DISTRIBUTOR unsalable in DISTRIBUTOR's reasonable opinion then any such Products shall be repurchased from DISTRIBUTOR by SUPPLIER within thirty (30) days following DISTRIBUTOR 's request therefor at the price paid for such Product(s) by DISTRIBUTOR. SUPPLIER shall additionally pay for return freight and related transportation and insurance charges for all such Products. Nothing contained in this Section 4.3 shall give SUPPLIER, so long as DISTRIBUTOR has maintained its exclusive rights hereunder, the unilateral right to remove any Product from Exhibit A which it shall continue to market directly or otherwise. 4.4 Delivery: SUPPLIER reserves the right to ship to DISTRIBUTOR direct from any of its overseas locations should it deem it advisable and in its best interests, provided only that DISTRIBUTOR will not incur any more costs than if shipment had been from Burlington, Massachusetts. 5. MARKETING PLAN; SALES & MARKETING SUPPORT 5.1 Marketing Plan: Attached hereto as Exhibit C is the initial marketing plan jointly prepared by the Parties (the "Marketing Plan"). Among others the Marketing Plan covers the following issues: (a) The training and travel plans of the DISTRIBUTOR's sales force and marketing organization; (b) The specific technical support which SUPPLIER is prepared to provide to DISTRIBUTOR's sales personnel and customers; (c) The promotion program with respect to the marketing of the Products to be implemented by DISTRIBUTOR, the initial announcement of the alliance evidenced by this Agreement and the procedure for the use by DISTRIBUTOR's of SUPPLIER's catalog; (d) The initial inventory levels to be purchased by DISTRIBUTOR and the terms of payment with respect thereto; (e) The methodology for determining which Products will be considered "Stocking Inventory" by DISTRIBUTOR, as well as the methodology for determining what Products shall be "A Products," "B Products" and "C Products;" (f) The procedure for determining the number of samples DISTRIBUTOR shall be entitled to; (g) The procedure to be followed to comply with the request of DISTRIBUTOR's Canadian subsidiary that catalogs and other material supplied in Canada either carry no prices or prices in Canadian dollars; (h) The procedure for the mailing by Distributor of certain of SUPPLIER's literature; (i) The procedure to be followed in dealing with the GSA and GSA contracts; and (j) Such other items as the Parties shall mutually agree as being appropriate for inclusion therein. 5.2 Technical Support: SUPPLIER shall provide the technical support and samples to DISTRIBUTOR in accordance with specifics set forth in the "Marketing Plan" (Exhibit C). In addition, SUPPLIER shall provide at its own expense a toll free long distance telephone service for sales and customer support. 5.3 Promotion: DISTRIBUTOR shall make reasonable best efforts to market, sell and distribute the Products during the term. 5.4 Sales Reports: DISTRIBUTOR shall submit to SUPPLIER on a monthly basis copies of a first report summarizing Distributor Product Sales in sufficient detail to enable SUPPLIER to compensate SUPPLIER's sales representatives on Distributor Product Sales in the United States, Canada and Puerto Rico. DISTRIBUTOR shall further submit to SUPPLIER, on a monthly basis during the period of limited exclusivity under Section 2.1, a second report, indicating DISTRIBUTOR's Product sales by customer in the United States, Canada and Puerto Rico. SUPPLIER shall treat the information in both reports as confidential under the provisions of Section 12.1 and shall not use such information to promote direct sales of Products or sales of Products through other distributors either during the term of this Agreement or for two (2) years thereafter. In addition, so long as the limited exclusivity of Section 2.1 remains in effect and there is an Exclusivity Threshold, Clawback Threshold and/or Bonus Threshold in effect, DISTRIBUTOR shall monthly disclose to SUPPLIER the total amount of Distributor Product Sales at Dealer Cost and SUPPLIER shall monthly disclose to DISTRIBUTOR at Dealer Cost the total amount of Supplier Direct Sales and the total amount of Supplier Indirect Sales; each such report shall provide separate totals for the United States and Puerto Rico and for Canada. 5.5 Sales Commissions. SUPPLIER shall compensate its sales representatives for Distributor Product Sales at an amount no less favorable than the compensation for such Product sales if sold directly by SUPPLIER. 6. PRICE AND PAYMENT TERMS 6.1 Price: SUPPLIER shall supply and ship Products to DISTRIBUTOR's U.S. and Canadian locations at the Dealer Cost therefor (determined in accordance with Section 2.5) through December 31, 1996 ("Firm Price Period"). 6.2 DISTRIBUTOR Discount: DISTRIBUTOR's cost (the "Dealer Cost") for the Products shall be the list price as reflected on Exhibit A less the discount specified thereon with respect to the applicable Product category as indicated thereon. This discount may not be reduced except with prior written approval by DISTRIBUTOR. 6.3 Price Increases: After the expiration of the Firm Price Period, list prices may be increased by SUPPLIER at its discretion no more than once in any calendar year to be effective January 1 of the next following calendar year. Provided, however, in situations where SUPPLIER can demonstrate to DISTRIBUTOR's reasonable satisfaction that SUPPLIER's costs to produce or obtain a Product have increased due to circumstances beyond SUPPLIER's control by more than five percent (5%), then SUPPLIER may increase DISTRIBUTOR's cost for the affected Product on sixty (60) day prior written notice by an amount not to exceed the amount of SUPPLIER's cost increase. The parties shall promptly confer during the first thirty (30) days of such sixty (60) day notice period to resolve any disagreements about the amount of the cost increase. Supplier shall with respect to any January 1 increase give DISTRIBUTOR at least sixty (60) day period written notice. Shipments shall be billed at the price in effect at time of order placement. Notice of price changes shall be sent to: PRICING DEPARTMENT Fisher Scientific 711 Forbes Avenue Pittsburgh, PA 15219 With a copy to: CENTRAL PURCHASING. In addition, prices changes affecting Canada shall be sent to: Purchasing Department Fisher Scientific Ltd. 112 Colonnade Road Nepean, Ontario, Canada K2E 7L6 6.4 Payment Terms: Payment terms shall be two percent (2%) ten net forty-five (45) days from the date of receipt of the invoice. DISTRIBUTOR shall not be in breach of this Agreement unless payment from the DISTRIBUTOR is more than thirty (30) days overdue. 6.5 Resale: DISTRIBUTOR shall be entitled to resell Products on such terms as it may, in its sole discretion, determine, including without limitation price, returns, credit and discounts. 6.6 Special Pricing: If DISTRIBUTOR reasonably determines that it is entitled to special pricing, it shall request the same from SUPPLIER stating the reasons therefore, and SUPPLIER shall in its discretion determine whether or not such special pricing is, in all the circumstances, appropriate. 6.7 Information Exchange: All price changes and additions, deletions, modifications, etc., of the Products shall be sent to DISTRIBUTOR at the address set forth in Section 6.4 hereof in an electronic format as provided to SUPPLIER. In addition, SUPPLIER shall use its reasonable best efforts, with appropriate assistance from DISTRIBUTOR to implement as soon as practicable full Electronic Data Interchange (EDI) capability in a format compatible with DISTRIBUTOR's systems for receipt of purchase orders and transmission of invoices. 7. PACKAGING 7.1 Packaging: SUPPLIER shall supply Products in packaging configurations corresponding to those such as may be set forth in Exhibit A as it may be amended from time to time. DISTRIBUTOR agrees to use SUPPLIER's catalog numbers with respect to all the Products. 7.2 Bar Coding: At DISTRIBUTOR's request, and with DISTRIBUTOR's assistance SUPPLIER agrees to use its reasonable best efforts to bar code the Products in a manner acceptable to the DISTRIBUTOR. 7.3 Lot Numbers and Expiration Date: DISTRIBUTOR agrees to accept SUPPLIER's methodology for designating and displaying lot numbers and expiration dates, if any. 8. TERM AND TERMINATION 8.1 Term: This Agreement will become effective on the date of execution by the last signing Party (the "Effective Date"), and unless terminated sooner by mutual consent or in accordance with the provisions of this Agreement will remain in effect through December 31, 2001, (the "Initial Term"). In the event that the Parties establish an Exclusivity Threshold, Clawback Threshold and Bonus Threshold under Section 2.6 for the year 2001, then the term shall automatically be extended through December 31, 2002. In similar fashion, if such target and thresholds are established pursuant to Section 2.6 for any subsequent year (X+1) then the term shall automatically extend to the end of the second year (X+2). 8.2 Termination: Notwithstanding the foregoing, this Agreement may be terminated for cause at any time as follows: (i) In the event of default or material breach of the terms of this Agreement by either Party, written notice thereof may be given to the defaulting Party. Thereafter, the defaulting Party shall have thirty (30) days to cure said breach. In the event that said breach has not been cured within said thirty (30) day period, the non-defaulting Party may, at its sole discretion, terminate this Agreement upon ten (10) days written notice. (ii) By SUPPLIER on one hundred eighty (180) days written notice in the event that DISTRIBUTOR failed to meet the Exclusivity Threshold in all of the years 1997, 1998 and 1999. (iii) In the event of nationalization, expropriation, liquidation or bankruptcy of, or an assignment for the benefit of creditors or insolvency of either Party. 9. PROCEDURES ON TERMINATION 9.1 Procedures: On the termination of this Agreement, except pursuant to Sections 8.2(i) and 8.2 (ii), SUPPLIER shall continue to honor DISTRIBUTOR's orders for Products up to the effective date of termination and for a period of sixty (60) days thereafter, provided such orders are no greater than ten percent (10%) above the quantities established during the sixty (60) days prior to the date of the notice of termination, and DISTRIBUTOR shall pay for all such Products on the terms and conditions of this Agreement. The foregoing proviso shall also apply to all orders received during the one hundred eighty (180) day period set forth in Section 8.2(ii) above. 9.2 Survival: The rights and duties of each Party under this Agreement and the Exhibits hereto in respect of performance prior to termination or non-renewal shall survive and be enforceable in accordance with the terms of this Agreement. 9.3 Existing Inventory: Within fifteen (15) days following termination or non-renewal of this Agreement, DISTRIBUTOR may and, at SUPPLIER's request shall, disclose to SUPPLIER in confidence the amounts of inventory that DISTRIBUTOR and/or its Canadian affiliate hold of each Product. The parties shall then negotiate in good faith concerning what portion, if any, of that inventory DISTRIBUTOR and/or its Canadian affiliate shall return to SUPPLIER for credit, giving due consideration to the salability of the returned inventory by SUPPLIER relative to its inventory levels and production plans and to the amounts projected to be needed by DISTRIBUTOR's customers for various Products in the ninety (90) day period after termination or non- renewal relative to the amounts of such Products in DISTRIBUTOR's inventory. Once agreement is reached, DISTRIBUTOR and/or its Canadian affiliate shall deliver the designated amounts of Product to SUPPLIER, F.O.B. origin, freight collect and shall be reimbursed by SUPPLIER within ten (10) days at DISTRIBUTOR's current cost for each Product. SUPPLIER shall not be obligated, under this Paragraph, to take back inventory in excess of ten percent (10%) of the prior year's purchases by DISTRIBUTOR and its Canadian subsidiary, measured at cost to DISTRIBUTOR. 10. WARRANTIES, INDEMNITY, RECALL, AND INSURANCE 10.1 Warranties: In addition to the warranties of SUPPLIER to DISTRIBUTOR set forth in the Continuing Guaranty which is attached hereto as Exhibit D, SUPPLIER warrants to DISTRIBUTOR that the Products will conform to the specifications set forth in SUPPLIER's product literature, and that they will comply and be manufactured, packaged, sterilized (if applicable), labeled and shipped by SUPPLIER in compliance with all applicable federal, state and local laws, orders, regulations and standards. SUPPLIER warrants the Products to DISTRIBUTOR's customers against defects in materials and workmanship when used in accordance with the applicable instructions for a period of one (1) year from the date of shipment of the Products. SUPPLIER MAKES NO OTHER END USER WARRANTY, EXPRESS OR IMPLIED. THERE IS NO WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. The warranty provided herein and the data, specifications and descriptions of SUPPLIER Products appearing in SUPPLIER's published catalogs and product literature may not be altered except by express written agreement signed by an officer of SUPPLIER. Representations, oral or written, which are inconsistent with this warranty or such publications are not authorized. In the event of a breach of the foregoing warranty, SUPPLIER asserts that its sole obligation to the end user shall be to repair or replace, at its option, any Product or part thereof that proves defective in materials or workmanship within the warranty period, provided the customer notifies SUPPLIER or DISTRIBUTOR promptly of such defect. The exclusive remedy provided herein shall not be deemed to have failed of its essential purpose so long as SUPPLIER is willing and able to repair or replace any nonconforming SUPPLIER Product or part. SUPPLIER disclaims liability for special, direct, indirect, incidental or consequential damages resulting from economic loss or property damages of any nature (including without limitation, loss of property, goodwill, reverse or disruption of any person's business or operations as appropriate) sustained by any customer from the use of its Products. SUPPLIER shall include notice of the foregoing Product Warranty and limitation of liability, together with notice that oral or written representations inconsistent with such warranty are unauthorized and should not be relied upon, in product literature directed primarily or exclusive to Products; DISTRIBUTOR shall cooperate in such inclusion to the extent that DISTRIBUTOR controls the preparation of such literature, or contacts with subdistributors or resellers. 10.2 Continuing Guaranty: SUPPLIER shall execute and abide by the terms of DISTRIBUTOR 's Continuing Guaranty, a copy of which is attached hereto as Exhibit D and incorporated herein by reference. The terms and provisions of the Continuing Guaranty shall survive the termination of this Agreement, but to the extent any of the terms of the Continuing Guaranty are in conflict, or are inconsistent with the terms of this Agreement, the terms and conditions hereof shall prevail. 10.3 Insurance: SUPPLIER has provided DISTRIBUTOR with a Certificate of Insurance which meets the requirements of paragraph D of the Continuing Guaranty. SUPPLIER shall provide DISTRIBUTOR with renewal insurance certificates in the form mandated by paragraph D of the Continuing Guaranty during the term of this Agreement, upon request therefor by DISTRIBUTOR. 10.4 Recall: In the event of a Product failure confirmed by SUPPLIER, or a recall required by a government agency or requested by SUPPLIER, SUPPLIER agrees to pay the costs of any mailing it makes as well as return freight costs. SUPPLIER will also bear the costs of supplying replacement Products, including Products already delivered to DISTRIBUTOR's customers. All other costs will be for the account of DISTRIBUTOR. In addition, SUPPLIER shall notify DISTRIBUTOR immediately in writing should SUPPLIER become aware of any defect or condition which may render any of the Products in violation of any statute or regulation, or which in any way alters the specifications or quality of the Products. 11. TRADEMARKS 11.1 Trademarks and Trade Names: SUPPLIER recognizes that DISTRIBUTOR is the owner of the trademarks and trade names connoting DISTRIBUTOR or DISTRIBUTOR products which it may elect to use in the promotion and sale of the Products. Nonetheless DISTRIBUTOR acknowledges that SUPPLIER may use such trademarks and trade names in connection with the advice to SUPPLIER's existing and proposed customers of the existence of and the limited exclusive distribution status created by this Agreement. 11.2 Trademark License: SUPPLIER hereby grants to DIS TRIBUTOR the royalty-free right to use SUPPLIER's trademarks on SUPPLIER's Products during the term of this Agreement, it being expressly understood that DISTRIBUTOR must use SUPPLIER's trademarks on SUPPLIER's Products which are the subject of this Agreement and must use them properly (i.e., shall not delete, alter, deface or conceal any trademark, trade name, logo, or copyright notice appearing on any Products or containers or related documents) and shall discontinue the use of such trademarks in any new published material following the termination hereof. Following the termination of this Agreement, SUPPLIER grants DISTRIBUTOR the right to continue to use for a reasonable period of time not to exceed one hundred eighty (180) days its trademarks in connection with sale or service of Products purchased by DISTRIBUTOR during the term of this Agreement. DISTRIBUTOR disclaims any rights to SUPPLIER's trade marks other than the said license. DISTRIBUTOR agrees that it will display SUPPLIER's trademark in such a manner so as it shall appear prominently and be readily read. Any proposed usage of SUPPLIER's trademarks created by DISTRIBUTOR or its agents shall be subject to prior review and approval by SUPPLIER for compliance with SUPPLIER's corporate identity manual, a copy of which has been provided to DISTRIBUTOR. 12. CONFIDENTIALITY 12.1 The Parties expressly agree to hold as confidential ("Confidential Information") any information which is designated in writing by the disclosing Party as confidential, provided such information is clearly marked as confidential, and the disclosing Party obtains a signed receipt or agreement from the receiving Party acknowledging that such information is confidential. In the event Confidential Information is exchanged according to these guidelines, such information will be retained by the other Party in confidence for a period of two (2) years following the termination of this Agreement; the transmittal of such information is and shall be upon the express condition that the information is to be used solely to effectuate this Agreement; and the receiving Party shall not use, publish, or disclose said information, in whole or in part, for any purpose other than that stated herein. SUPPLIER expressly acknowledges and agrees that DISTRIBUTOR's customer names, address and key contacts are and shall be the Confidential Information of DISTRIBUTOR. Notwithstanding the foregoing, the above restrictions on disclosure and use shall not apply to any information which the Party can show by written evidence, was known to it at the time of receipt, or which may be obtained from third Parties who are not bound by a confidentiality agreement, or which is in the public domain. Information disclosed to DISTRIBUTOR's counsel pursuant to Section 2.3 shall be used for purposes of monitoring the specified exceptions to the exclusivity of Section 2.1 and of demonstrating DISTRIBUTOR's abilities (as set forth in Section 2.3); and DISTRIBUTOR shall use reasonable efforts to limit the dissemination of such information on a need-to-know basis. Similarly, information on monthly amounts of Supplier Direct Sales, Supplier Indirect Sales and Distributor Product Sales exchanged pursuant to Section 5.4 shall be disclosed to employees of the recipient party on a need- to-know basis; such restrictions shall not, however, apply to the Aggregate Net In-Market Sales totals calculated from such information. 13. MISCELLANEOUS 13.1 Force Majeure: The obligations of either Party to perform under this Agreement shall be excused during each period of delay if such delay arises from any cause or causes which are reasonably beyond the control of the Party obligated to perform, including, but not limited to, the following: acts of God, acts or omissions of any government, or any rules, regulations or orders of any governmental authority or any officer, department, agency or instrumentality thereof; fire, storm, flood, earthquake, insurrection, riot, invasion or strikes. The affected Party shall use its best efforts to remedy the effects of such force majeure. Any force majeure shall not excuse perfor mance by the Party, but shall postpone performance, unless such force majeure continues for a period in excess of ninety (90) days. In such event, the Party seeking performance may cancel its obligations hereunder. 13.2. Dispute Resolution: Any and all disputes arising under, out of or in connection with this Agreement other than those relating to Section 13.3 hereof shall be mediated by the alternative dispute resolution procedures specified in this Section 13.2 ("ADR") only after such dispute has been presented to a panel composed of two members of senior management from each Party (the "Panel") and the Panel either (i) determines that such dispute cannot be resolved by the Parties or (ii) has not taken action for a period of sixty (60) days after such dispute has been presented to the Panel. Each Party agrees to pursue ADR in good faith and not to commence any suit or other proceeding or to pursue any other remedies at law or in equity prior to the conclusion of ADR. Each Party agrees to share all costs of conducting ADR. All conduct, statements, promises, offers, views and opinions, whether oral or written, and in the course of ADR by either of the Parties, are confidential, shall, in addition and where appropriate, be deemed to be work product and privileged, and shall not be discoverable or admissible for any purpose in any lawsuit arising out of this Agreement. Upon written notice from either Party invoking ADR, each Party shall designate in writing an individual who shall have authority to settle the dispute on its behalf. The authorized individuals shall be generally familiar with the industries in which the Parties operate and shall make such investigation as they deem appropriate and shall thereafter promptly commence discussions concerning resolution of the dispute. If the dispute has not been resolved within thirty (30) days thereafter, it shall be submitted to a neutral Party in Washington, DC (the "Neutral") designated by CPR Institute for Dispute Resolution to act as a neutral Party to conduct the ADR in accordance with this Section 13.2. One week prior to the first scheduled session of ADR, each Party shall deliver to the Neutral and to the other Party a concise written summary of its views on the matter in dispute. In addition to the authorized representative, each Party may bring such additional persons as reasonably needed to respond to questions, contribute information and participate in negotiations. ADR may be conducted by means of both joint meetings and separate private caucuses of each Party with Neutral. The Neutral: (i) shall provide his or her opinion to both Parties on the probable outcome should the matter be litigated, and (ii) shall make one or more recommendations as to the terms of a possible settlement. The Neutral shall base his or her opinions and recommendations on information available to both Parties, excluding such information as may be disclosed to the Neutral by the Parties in confidence. While the opinions and recommendations of the Neutral shall not be binding on the Parties, the Parties agree to give good faith consideration to the Neutral's views. After they have received the Neutral's views, the Parties agree to negotiate in good faith to resolve the dispute with the Neutral acting as a mediator. Each Party agrees to participate in ADR to its conclusion, as designated by the Neutral, and not to initiate legal proceedings seeking a resolution to the matters in dispute until the earlier of (a) six (6) months from the commencement of proceedings or (b) ten (10) days after conclusion of proceedings. In the event that the dispute relates to a matter upon which a third party has brought a claim against DISTRIBUTOR or SUPPLIER, the foregoing obligation not to initiate legal proceedings shall not preclude the filing of third party complaints, cross-claims or similar pleadings by one Party to this Agreement against the other in a civil action brought by the third party at a time reasonably determined by the Party filing such a pleading to be required to preserve its rights under the applicable procedural and substantive law. The filing Party shall make reasonable effort to notify the other Party in advance concerning the proposed pleading and the basis for its determination that timely filing of such proposed pleading is required to preserve rights. 13.3. Indemnification (a) General: In the event of a claim by an unaffiliated third party against either Party to this Agreement or its affiliates or past, present and future officers, directors, shareholders, partners, employees, lawyers, representative or agents (collectively, the "Indemnified Party"), based upon an alleged breach by the other Party (the "Indemnifying Party") of any of its warranties or obligations under this Agreement (including Exhibit D) ("Third Party Claim"), the Indemnifying Party shall indemnify, defend and hold the Indemnified Party harmless against all losses, costs, damages, and expenses (including reasonable attorneys fees, expert witness fees and expenses) incurred as a result of such Third Party Claim. (b) Notice of Claims: The Indemnified Party shall provide the Indemnifying Party with prompt notice of the assertion of any Third Party Claim, including the commencement of any suit, action or proceeding, for which indemnity hereunder is sought, specifying with reasonable particularity the basis therefor. The Indemnified Party shall also provide all information related to such Third Party Claim as the Indemnifying Party may reasonably request. (c) Assumption of Defense: Promptly after receipt of a notice of a Third Party Claim, the Party asserted to be the Indemnifying Party shall either: (i) deny it is required to provide indemnification under the terms of this Agreement, or (ii) agree that the Indemnified Party is entitled to indemnification under the terms of this Agreement and, at the discretion and expense of the Indemnifying Party, assume responsibility for the defense of the Third Party Claim. The Indemnified Party shall have the right (but not the duty) to participate in such defense, employing separate counsel retained at the Indemnified Party's expense. Whether or not it employs separate counsel, the Indemnified Party agrees that it will cooperate fully with the Indemnifying Party in the defense of the Third Party Claim. (d) Settlement or Compromise: If, after receipt of a notice of a Third Party Claim, the Party asserted to be the Indemnifying Party, agrees that the Indemnified Party is entitled to indemnification under the terms of this Agreement, the Indemnifying Party will have the sole authority, at its expense, to enter into any compromise or settlement of the Third Party Claim which shall be binding upon the Indemnified Party in the same manner as if a final judgment or decree had been entered by a court of competent jurisdiction; provided, however, that no settlement or compromise involving any restriction on the Indemnified Party's future action or continuing obligation by the Indemnified Party shall be binding upon it without its prior written consent. (e) Denial of Indemnification: If, after receipt of a notice of a Third Party Claim, the Party asserted to be the Indemnifying Party denies that it is required to provide indemnification under the terms of this Agreement, the Party providing such notice shall treat the denial as a Dispute subject to resolution under paragraph 13.2 of this Agreement. 13.4 Assignment: This Agreement shall not be transferable by either Party by assignment or by operation of law without the prior written consent of the other not to be unreasonably withheld or delayed. Any purported transfer in violation of this provision shall be void and constitute a breach of this Agreement. 13.5 Notices: Any notice required by this Agreement other than notice of price change shall be in writing and shall be deemed sufficient if given personally or sent by registered or certified mail, postage prepaid, or by any nationally recognized overnight delivery service, to the following: If to SUPPLIER: Susan Vogt, Vice President Analytical Division Millipore Corporation 80 Ashby Road Bedford, MA 01890 with a copy to: SUPPLIER's Legal Department at the same address; If to DISTRIBUTOR: J. Bradley Mahood, Vice President Marketing Fisher Scientific Company 711 Forbes Avenue Pittsburgh, PA 15219 with a copy to: DISTRIBUTOR's Legal Department at the same address Either Party may, by notice to the other, change its address for receiving such notices. 13.6 Entire Agreement: This Agreement, including exhibits, constitutes the entire agreement between the Parties relating to the subject matter hereof and cancels and supersedes all prior agreements and understandings, whether written or oral, between the Parties with respect to such subject matter. 13.7 Existing Obligations: SUPPLIER warrants that the terms of this Agreement do not violate any existing obligations or contracts of SUPPLIER. SUPPLIER shall protect, defend, indemnify, and hold harmless DISTRIBUTOR from and against any claims, demands, liabilities or actions which are hereafter made or brought against DISTRIBUTOR and which allege any such violation. 13.8 Governing Law: This Agreement and all transactions under it will be governed by the laws of the Commonwealth of Massachusetts. Neither the 1980 United Nations Convention on Contracts for the International Sale of Goods nor the United Nations Convention on the Limitation Period in the International Sale of Goods will apply to this Agreement or any transaction under it. 13.9 Relationship of the Parties: The Parties are independent contractors. This Agreement does not constitute a partnership or either Party as the franchisee, agent or legal representative of the other for any purpose, and neither Party has the authority to act for, bind or make commitment on behalf of the other. 13.10 Failure to Enforce: Either Party's failure to enforce any provision of this Agreement will not be deemed a waiver of that provision or the Party's right to enforce the provision in the future. 13.11 Amendment: Except as otherwise specifically provided in this Agreement, no amendment, modification or waiver of the terms of this Agreement will be binding on either Party unless reduced to writing and signed by an authorized officer to the Party to be bound. In ordering and delivering Products, the Parties may employ standard form or other documents, but no additional terms which may appear on the face or reverse side of any such document will apply to, or be construed to modify or amend the terms of this Agreement. 13.12 Headings: The headings in this Agreement have been included solely for reference and are to have no force and effect in interpreting the provisions of this Agreement. IN WITNESS WHEREOF, the Parties have executed this Agreement by their duly authorized representatives. MILLIPORE CORPORATION FISHER SCIENTIFIC COMPANY By: By: Title: Title: Date: Date: MILLIPORE CORPORATION By: ________________________ Susan Vogt Title: ________________________ Vice President Date: ________________________ EX-10.2 4 iv BOS-BUS:347608.7 REVOLVING CREDIT AGREEMENT dated as of January 22, 1997 by and among MILLIPORE CORPORATION (the "Borrower") and THE FIRST NATIONAL BANK OF BOSTON ("FNBB"), ABN AMRO BANK N.V. ("ABN"), and the other financial institutions which become a party to this agreement (Collectively, the "Banks") and FNBB, as the Administrative Agent (the "Administrative Agent") and ABN, as the Documentation Agent (the "Documentation Agent") (Collectively, the "Agents") 1. DEFINITIONS AND RULES OF INTERPRETATION. 1 1.1. Definitions. 1 1.2. Rules of Interpretation. 14 2. THE SYNDICATED FACILITY. 15 2.1. Commitment to Lend Syndicated Loans. 15 2.2. Facility Fee. 15 2.3. Reduction of Total Commitment; Increase of Total Commitment. 16 2.4. The Syndicated Notes. 16 2.5. Interest on Syndicated Loans. 17 2.6. Requests for Syndicated Loans. 17 2.7. Election of Eurodollar Rate; Notice of Election; Interest Periods; Minimum Amounts. 18 2.8. Funds for Syndicated Credit Loans. 19 2.9. Maturity of the Syndicated Loans and Reimbursement Obligations. 20 2.10. Optional Prepayments or Repayments of Syndicated Loans. 20 3. LETTERS OF CREDIT. 20 3.1. Letter of Credit Commitments. 20 3.2. Reimbursement Obligation of the Borrower. 21 3.3. Obligations Absolute. 22 3.4. Reliance by the Administrative Agent. 22 3.5. Letter of Credit Fee. 23 4. COMPETITIVE BID LOANS. 23 4.1. The Competitive Bid Option. 23 4.2. Competitive Bid Notes. 23 4.3. Competitive Bid Quote Request; Invitation for Competitive Bid Quotes. 24 4.4. Alternative Manner of Procedure. 25 4.5. Submission and Contents of Competitive Bid Quotes. 25 4.6. Notice to Borrower. 27 4.7. Acceptance and Notice by Borrower and Administrative Agent. 27 4.8. Allocation by Administrative Agent. 28 4.9. Funding of Competitive Bid Loans. 28 4.10. Funding Losses. 28 4.11. Repayment of Competitive Bid Loans; Interest. 29 5. Provisions Relating to All Loans and letters of credit. 29 5.1. Payments. 29 5.2. Mandatory Repayments of the Loans. 32 5.3. Computations. 32 5.4. Illegality; Inability to Determine Eurodollar Rate. 32 5.5. Additional Costs, Etc. 33 5.6. Capital Adequacy. 35 5.7. Certificate. 35 5.8. Eurodollar and Competitive Bid Indemnity. 35 5.9. Interest on Overdue Amounts. 36 5.10. Interest Limitation. 36 5.11. Reasonable Efforts to Mitigate. 36 5.12. Replacement of Banks. 37 5.13. Advances by Administrative Agent. 38 6. REPRESENTATIONS AND WARRANTIES. 38 6.1. Corporate Authority. 38 6.2. Governmental Approvals. 39 6.3. Title to Properties; Leases. 39 6.4. Financial Statements; Solvency. 40 6.5. No Material Changes, Etc. 40 6.6. Franchises, Patents, Copyrights, Etc. 41 6.7. Litigation. 41 6.8. Compliance With Other Instruments, Laws, Etc. 42 6.9. Tax Status. 42 6.10. No Event of Default. 42 6.11. Holding Company and Investment Company Acts. 42 6.12. Absence of Financing Statements, Etc. 43 6.13. Employee Benefit Plans. 43 6.14. Environmental Compliance. 44 6.15. True Copies of Charter and Other Documents. 45 6.16. Disclosure. 46 6.17. Permits and Governmental Authority. 46 6.18. Purchase of Tylan Shares. 46 7. AFFIRMATIVE COVENANTS OF THE BORROWER. 46 7.1. Punctual Payment. 46 7.2. Maintenance of Office. 47 7.3. Records and Accounts. 47 7.4. Financial Statements, Certificates and Information. 47 7.5. Corporate Existence and Conduct of Business. 48 7.6. Maintenance of Properties. 49 7.7. Insurance. 49 7.8. Taxes. 49 7.9. Inspection of Properties, Books and Contracts. 50 7.10. Compliance with Laws, Contracts, Licenses and Permits; Maintenance of Material Licenses and Permits. 50 7.11. Environmental Indemnification. 51 7.12. Further Assurances. 51 7.13. Notice of Potential Claims or Litigation. 51 7.14. Notice of Certain Events Concerning Insurance. 51 7.15. Notice of Default. 51 7.16. Use of Proceeds. 52 7.17. Certain Transactions. 52 7.18. Amendment to Note Purchase Agreement. 52 7.19. The Tylan Merger. 52 8. CERTAIN NEGATIVE COVENANTS OF THE BORROWER. 53 8.1. Restrictions on Liens. 53 8.2. Restrictions on Investments. 55 8.3. Merger, Consolidation, and Disposition of Assets. 55 8.4. Restricted Distributions and Redemptions. 56 8.5. Employee Benefit Plans. 57 9. FINANCIAL COVENANTS OF THE BORROWER. 58 9.1. Funded Debt to EBITDA Ratio. 58 9.2. Interest Coverage Ratio. 58 10. CONDITIONS TO EFFECTIVENESS. 58 10.1. Corporate Action. 58 10.2. Loan Documents, Etc. 59 10.3. Certified Copies of Charter Documents. 59 10.4. Incumbency Certificate. 59 10.5. Certificates of Insurance. 59 10.6. Opinions of Counsel. 59 10.7. Existing Debt. 59 10.8. Satisfactory Financial Condition. 59 10.9. Lien Searches. 60 10.10. Fees. 60 11. CONDITIONS TO LOANS. 60 11.1. Representations True. 60 11.2. Performance; No Event of Default. 60 11.3. No Legal Impediment. 60 11.4. Governmental Regulation. 61 11.5. Proceedings and Documents. 61 12. EVENTS OF DEFAULT; ACCELERATION; TERMINATION OF COMMITMENT. 61 12.1. Events of Default and Acceleration. 61 12.2. Termination of Commitments. 64 12.3. Remedies. 64 13. SETOFF. 65 14. EXPENSES. 65 15. THE AGENTS. 66 15.1. Appointment, Powers and Immunities. 66 15.2. Actions By Administrative Agent. 67 15.3. Indemnification. 67 15.4. Reimbursement. 67 15.5. Documents. 68 15.6. Non-Reliance on Agents and Other Banks. 68 15.7. Resignation of Administrative Agent. 69 15.8. Action by the Banks, Consents, Amendments, Waivers, Etc. 69 15.9. Holders of Notes. 70 15.10. Administrative Agent's Fee. 70 16. INDEMNIFICATION. 70 17. SURVIVAL OF COVENANTS, ETC. 71 18. ASSIGNMENT AND PARTICIPATION. 71 19. PARTIES IN INTEREST. 73 20. NOTICES, ETC. 73 21. MISCELLANEOUS. 73 22. CONSENTS, ETC. 74 23. PARI PASSU TREATMENT. 74 24. CONFIDENTIALITY. 74 25. WAIVER OF JURY TRIAL. 75 26. GOVERNING LAW. 75 27. SEVERABILITY. 76 28. FINAL AGREEMENT. 76 Exhibits Exhibit A Form of Syndicated Note Exhibit B Form of Competitive Bid Note Exhibit C-1 Form of Syndicated Loan Request Exhibit C-2 Form of Letter of Credit Request Exhibit D Form of Compliance Certificate Exhibit E Form of Assignment and Acceptance Exhibit F Form of Competitive Bid Quote Request Exhibit G Form of Invitation for Competitive Bid Quotes Exhibit H Form of Competitive Bid Quote Exhibit I Form of Notice of Acceptance of Competitive Bid Quote(s) Schedules Schedule 1 Banks; Commitment Percentages Schedule 6.7 Litigation Schedule 6.13(c) Guaranteed Pension Plans Schedule 6.14 Environmental Compliance Schedule 8.1(a) Existing Liens Schedule 8.2(d) Existing Investments REVOLVING CREDIT AGREEMENT This REVOLVING CREDIT AGREEMENT is made as of the 22nd day of January, 1997, by and among (a) MILLIPORE CORPORATION, a Massachusetts corporation having its principal place of business at 80 Ashby Road, Bedford, MA 01730-2271 (the "Borrower"), (b) THE FIRST NATIONAL BANK OF BOSTON, a national banking association with its head office at 100 Federal Street, Boston, Massachusetts 02110 ("FNBB"), ABN AMRO BANK N.V., with its Boston branch at One Post Office Square, Boston, Massachusetts 02109 ("ABN"), and the other lending institutions which become parties hereto (collectively with FNBB and ABN, the "Banks") and (c) THE FIRST NATIONAL BANK OF BOSTON, as administrative agent for the Banks (the "Administrative Agent") and ABN AMRO BANK N.V., as documentation agent for the Banks (the "Documentation Agent," and collectively with the Administrative Agent, the "Agents"). DEFINITIONS AND RULES OF INTERPRETATION. Definitions. The following terms shall have the meanings set forth in this 1 or elsewhere in the provisions of this Agreement referred to below: Absolute Competitive Bid Loan(s). See 4.3(a). Accountants. See 7.4(a). Administrative Agent. See Preamble. Affected Bank. See 5.12. Agents. See Preamble. Agreement. This Revolving Credit Agreement, including the Schedules and Exhibits hereto, as from time to time amended and supplemented in accordance with the terms hereof. Amicon. Amicon, a recently acquired business of the Borrower. Amicon Acquisition. The acquisition of the Amicon business from W.R. Grace & Co. - Conn. pursuant to the Purchase and Sale Agreement dated November 18, 1996 Applicable Eurodollar Rate. The applicable rate per annum of interest on the Eurodollar Loans shall be the Eurodollar Rate plus the Applicable Margin as set forth in the Pricing Table. Applicable Facility Rate. The applicable rate per annum with respect to the Facility Fee shall be as set forth in the Pricing Table. Applicable L/C Rate. The applicable rate per annum on the Maximum Drawing Amount shall be as set forth in the Pricing Table. Applicable Margin. The Applicable Margin on Eurodollar Loans shall be as set forth in the Pricing Table. Applicable Requirements. See 7.10. Assignment and Acceptance. See 18. Balance Sheet Date. December 31, 1995. Banks. See Preamble. Base Rate. The higher of (a) the annual rate of interest announced from time to time by the Administrative Agent at its Head Office as its "base rate" (it being understood that such rate is a reference rate and not necessarily the lowest rate of interest charged by the Administrative Agent) or (b) one-half percent (0.50%) above the Overnight Federal Funds Effective Rate. Base Rate Loans. Syndicated Loans bearing interest calculated by reference to the Base Rate. Borrower. See Preamble. Bridge Loan. The Bridge Loan Agreement dated as of December 31, 1996, by and between the Borrower and FNBB. Business Day. Any day, other than a Saturday, Sunday or any day on which banking institutions in either Boston, Massachusetts or New York, New York are authorized by law to close, and, when used in connection with a Eurodollar Loan, a Eurodollar Business Day. Capital Assets. Fixed assets, both tangible (such as land, buildings, fixtures, machinery and equipment) and intangible (such as patents, copyrights, trademarks, franchises and good will); provided that Capital Assets shall not include any item customarily charged directly to expense or depreciated over a useful life of twelve (12) months or less in accordance with generally accepted accounting principles. Capital Expenditures. Amounts paid or indebtedness incurred by the Borrower or any of its Subsidiaries in connection with the purchase or lease by the Borrower or any of its Subsidiaries of Capital Assets that would be required to be capitalized and shown on the balance sheet of such Person in accordance with generally accepted accounting principles. Capitalized Leases. Leases under which the Borrower or any of its Subsidiaries (including Tylan and its Subsidiaries) is the lessee or obligor, the discounted future rental payment obligations under which are required to be capitalized on the balance sheet of the lessee or obligor in accordance with GAAP. CERCLA. See 6.14(a). Certified or certified. With respect to the financial statements of any Person, such statements as audited by a firm of independent auditors, whose report expresses the opinion, without qualification, that such financial statements present fairly the financial position of such Person. CFO or the CAO. See 7.4(b). Closing Date. The date on which the conditions precedent set forth in 10 hereof are satisfied. Code. The Internal Revenue Code of 1986, as amended and in effect from time to time. Commitment. With respect to each Bank, the amount determined by multiplying such Bank's Commitment Percentage by the aggregate amount of the Total Commitment specified in 2.1 hereof, as the same may be reduced from time to time. Commitment Percentage. With respect to each Bank, the percentage set forth on Schedule 1. Competitive Bid Loan(s). A borrowing hereunder consisting of one or more loans made by any of the participating Banks whose offer to make a Competitive Bid Loan as part of such borrowing has been accepted by the Borrower under the auction bidding procedure described in 4 hereof. Competitive Bid Margin. See 4.5(b)(iv). Competitive Bid Notes. See 4.2(a). Competitive Bid Quote. An offer by a Bank to make a Competitive Bid Loan in accordance with 4.5 hereof. Competitive Bid Quote Request. See 4.3. Competitive Bid Rate. See 4.5(b)(v). Compliance Certificate. See 7.4(c). Consolidated or consolidated. With reference to any term defined herein, shall mean that term as applied to the accounts of the Borrower and its Subsidiaries consolidated in accordance with GAAP. Consolidated Earnings Before Interest, Taxes, Depreciation and Amortization or EBITDA. For any period, Consolidated Net Income (or Deficit) plus (a) Consolidated Total Interest Expense, (b) income taxes, (c) depreciation expense, (d) amortization expense, (e) non-cash expenses, not to exceed $70,000,000, in connection with the Amicon Acquisition taken as a special charge in the quarter ending December 31, 1996, (f) non-cash expenses, not to exceed $120,000,000, in connection with the Tylan Tender Offer or Tylan Merger which will be taken as a special charge in the quarter ending March 31, 1997, and (g) other non-recurring charges in connection with the Amicon Acquisition and the Tylan Merger, not to exceed $25,000,000 in the aggregate, which will be taken as a special charge in the quarter ending March 31, 1997, to the extent that each was deducted in determining Consolidated Net Income (or Deficit), provided that, for purposes of calculating the financial covenants pursuant to 9, the portion of EBITDA derived from Subsidiaries acquired since the date of the most recent financial statements delivered to the Banks pursuant to 7.4 hereof shall be included in the calculation of EBITDA if (i) the financial statements of such acquired Subsidiaries have been audited for the period sought to be included by an independent accounting firm satisfactory to the Administrative Agent or (ii) the Administrative Agent consents to such inclusion, such consent not to be unreasonably withheld. Consolidated Net Income (or Deficit). The consolidated net income (or deficit) of the Borrower and its Subsidiaries on a consolidated basis, after deduction of all expenses, taxes, and other proper charges, determined in accordance with GAAP. Consolidated Net Worth. The excess of Consolidated Total Assets over Consolidated Total Liabilities, less, to the extent otherwise includable in the computations of Consolidated Net Worth, any subscriptions receivable. Consolidated Tangible Assets. All assets of the Borrower and its Subsidiaries determined on a consolidated basis in accordance with GAAP, less the sum of: (a) the total book value of all assets of the Borrower and its Subsidiaries properly classified as intangible assets under generally accepted accounting principles, including such items as goodwill, the purchase price of acquired assets in excess of the fair market value thereof, trademarks, trade names, service marks, customer lists, brand names, copyrights, patents and licenses, and rights with respect to the foregoing; plus (b) all amounts representing any write-up in the book value of any assets of the Borrower or its Subsidiaries resulting from a revaluation thereof subsequent to the Balance Sheet Date. Consolidated Total Assets. All assets of the Borrower and its Subsidiaries determined on a consolidated basis in accordance with generally accepted accounting principles. Consolidated Total Interest Expense. For any period, the aggregate amount of interest expense required by GAAP to be paid or accrued during such period on all Indebtedness of the Borrower and its Subsidiaries outstanding during all or any part of such period, including capitalized interest expense for such period. Consolidated Total Liabilities. All liabilities of the Borrower and its Subsidiaries determined on a consolidated basis in accordance with generally accepted accounting principles and all Indebtedness of the Borrower and its Subsidiaries, whether or not so classified. Default. See 12. Defaulting Bank. See 5.12. Disposal. See "Release." Distribution. The declaration or payment of any dividend or distribution on or in respect of any shares of any class of capital stock, any partnership interests or any membership interests of any Person, other than dividends or other distributions payable solely in shares of common stock, partnership interests or membership units of such Person, as the case may be; the purchase, redemption, or other retirement of any shares of any class of capital stock, partnership interests or membership units of such Person, directly or indirectly through a Subsidiary or otherwise; the return of equity capital by any Person to its shareholders, partners or members as such; or any other distribution on or in respect of any shares of any class of capital stock, partnership interest or membership unit of such Person. Documentation Agent. See Preamble. Dollars or $. Dollars in lawful currency of the United States of America. Drawdown Date. The date on which any Loan is made or is to be made. EBITDA. See definition for Consolidated Earnings Before Interest, Taxes, Depreciation and Amortization. Eligible Foreign Bank. (a) Any commercial bank organized under the laws of any other country which is a member of the Organization for Economic Cooperation and Development (the "OECD"), or a political subdivision of any such country, provided that such bank is acting through a branch or agency located in the country in which it is organized or another country which is also a member of the OECD; or (b) the central bank of any country which is a member of the OECD. Employee Benefit Plan. Any employee benefit plan within the meaning of 3(3) of ERISA maintained or contributed to by the Borrower, any of its Subsidiaries, or any ERISA Affiliate, other than a Multiemployer Plan. Environmental Laws. See 6.14(a). EPA. See 6.14(b). ERISA. The Employee Retirement Income Security Act of 1974, as amended and in effect from time to time. ERISA Affiliate. Any Person which is treated as a single employer with the Borrower or any of its Subsidiaries under 414 of the Code. ERISA Reportable Event. A reportable event with respect to a Guaranteed Pension Plan within the meaning of 4043 of ERISA and the regulations promulgated thereunder as to which the requirement of notice has not been waived. Eurocurrency Reserve Rate. For any day with respect to a Eurodollar Loan, the maximum rate (expressed as a decimal) at which the Administrative Agent would be required to maintain reserves under Regulation D of the Board of Governors of the Federal Reserve System (or any successor or similar regulations relating to such reserve requirements) against "Eurocurrency Liabilities" (as that term is used in Regulation D), if such liabilities were outstanding. The Eurocurrency Reserve Rate shall be adjusted automatically on and as of the effective date of any change in the Eurocurrency Reserve Rate. Eurodollar Business Day. Any day on which commercial banks are open for international business (including dealings in Dollar deposits) in London or such other eurodollar interbank market as may be selected by the Administrative Agent in its sole discretion acting in good faith. Eurodollar Interest Determination Date. For any Interest Period, the date two (2) Eurodollar Business Days prior to the first day of such Interest Period. Eurodollar Loans. Syndicated Loans bearing interest calculated by reference to the Eurodollar Rate. Eurodollar Offered Rate. The rate per annum at which deposits of Dollars are offered to the Administrative Agent by prime banks in whatever Eurodollar interbank market may be selected by the Administrative Agent, in its sole discretion, acting in good faith, at or about 11:00 a.m. local time in such interbank market, on the Eurodollar Interest Determination Date for a period equal to the period of such Interest Period in an amount substantially equal to the principal amount requested to be loaned at or converted to a rate based on the Eurodollar Rate. Eurodollar Rate. With respect to Syndicated Loans, the rate per annum, rounded upwards to the nearest 1/16 of 1%, determined by the Administrative Agent with respect to an Interest Period, in accordance with the following formula: Eurodollar Rate = Eurodollar Offered Rate 1-Reserve Rate Event of Default. See 12. Facility Fee. See 2.2. Funded Debt. Consolidated Indebtedness of the Borrower and its Subsidiaries for borrowed money and purchase money Indebtedness, and guarantees of such debt, recorded on the Consolidated balance sheet, including the amount of any Indebtedness for Capitalized Leases which corresponds to principal and for Permitted Receivables Transactions determined on a consolidated basis in accordance with GAAP. generally accepted accounting principles, or GAAP. (i) When used in 9, whether directly or indirectly through reference to a capitalized term used therein, means (A) principles that are consistent with the principles promulgated or adopted by the Financial Accounting Standards Board and its predecessors in effect for the fiscal year ended on the Balance Sheet Date and (B) to the extent consistent with such principles, the accounting practice of the Borrower reflected in its financial statements for the year ended on the Balance Sheet Date, and (ii) when used in general, other than as provided above, means principles that are (A) consistent with the principles promulgated or adopted by the Financial Accounting Standards Board and its predecessors, as in effect from time to time, and (B) consistently applied with past financial statements of the Borrower adopting the same principles, provided that in each case referred to in this definition of "generally accepted accounting principles" a certified public accountant would, insofar as the use of such accounting principles is pertinent, be in a position to deliver an unqualified opinion with respect to the use of such principles (other than a qualification regarding changes in generally accepted accounting principles) as to financial statements in which such principles have been properly applied. Guaranteed Pension Plan. Any employee pension benefit plan within the meaning of 3(2) of ERISA maintained or contributed to by the Borrower, its Subsidiaries or any ERISA Affiliate, the benefits of which are guaranteed on termination in full or in part by the PBGC pursuant to Title IV of ERISA, other than a Multiemployer Plan. Hazardous Substances. See 6.14(b). Head Office. The Administrative Agent's head office located at 100 Federal Street, Boston, MA 02110 or at such other location as the Administrative Agent may designate from time to time. Income Taxes. See 5.5(a). Indebtedness. All obligations, contingent and otherwise, that in accordance with generally accepted accounting principles should be classified upon the obligor's balance sheet as liabilities, or to which reference should be made by footnotes thereto, including in any event and whether or not so classified: (i) all debt and similar monetary obligations, whether direct or indirect; (ii) all liabilities secured by any mortgage, pledge, security interest, lien, charge, or other encumbrance existing on property owned or acquired subject thereto, whether or not the liability secured thereby shall have been assumed; and (iii) all guarantees, endorsements and other contingent obligations whether direct or indirect in respect of indebtedness of others, including any obligation to supply funds to or in any manner to invest in, directly or indirectly, the debtor, to purchase indebtedness, or to assure the owner of indebtedness against loss, through an agreement to purchase goods, supplies, or services for the purpose of enabling the debtor to make payment of the indebtedness held by such owner or otherwise, and the obligations to reimburse the issuer in respect of any letters of credit. Interest Period. With respect to each Loan (a) initially, the period commencing on the Drawdown Date of such Loan and ending on the last day of one of the periods set forth below, as selected by the Borrower in accordance with this Agreement (i) for any Base Rate Loan, the last day of the quarter (or shorter specified time); (ii) for any Eurodollar Loan, 1, 2, 3, or 6 months; (iii) for any Absolute Competitive Bid Loan, from 7 through 180 days; and (iv) for any LIBOR Competitive Bid Loan, 1, 2, 3, 4, 5, or 6 months; and (b) thereafter, each period commencing on the last day of the next preceding Interest Period applicable to such Loan and ending on the last day of one of the periods set forth above, as selected by the Borrower in accordance with this Agreement; provided that any Interest Period which would otherwise end on a day which is not a Business Day shall be deemed to end on the next succeeding Business Day; provided further that for any Interest Period for any Eurodollar Loan or LIBOR Competitive Bid Loan if such next succeeding Business Day falls in the next succeeding calendar month, it shall be deemed to end on the next preceding Business Day; and provided further that no Interest Period shall extend beyond the Maturity Date. Investments. All expenditures made and all liabilities incurred (contingently or otherwise) for the acquisition of stock or Indebtedness of, or for loans, advances, capital contributions or transfers of property to, or in respect of any guaranties (or other commitments as described under Indebtedness), or obligations of, any Person. In determining the aggregate amount of Investments outstanding at any particular time: (i) the amount of any Investment represented by a guaranty shall be taken at not less than the principal amount of the obligations guaranteed and still outstanding; (ii) there shall be included as an Investment all interest accrued with respect to Indebtedness constituting an Investment unless and until such interest is paid; (iii) there shall be deducted in respect of each such Investment any amount received as a return of capital (but only by repurchase, redemption, retirement, repayment, liquidating dividend or liquidating distribution); (iv) there shall not be deducted in respect of any Investment any amounts received as earnings on such Investment, whether as dividends, interest or otherwise, except that accrued interest included as provided in the foregoing clause (ii) may be deducted when paid; and (v) there shall not be deducted from the aggregate amount of Investments any decrease in the value thereof. Invitation for Competitive Bid Quotes. See 4.3(b). Issuance Fee. See 3.5. Letter of Credit Applications. Letter of Credit Applications in such form as may be agreed upon by the Borrower and the Administrative Agent from time to time which are entered into pursuant to 3 hereof as such Letter of Credit Applications are amended, varied or supplemented from time to time; provided, however, in the event of any conflict or inconsistency between the terms of any Letter of Credit Application and this Agreement, the terms of this Agreement shall control. Letter of Credit Fee. See 3.5. Letter of Credit Participation. See 3.1(b). Letter of Credit Request. See 3.1(a). Letters of Credit. Standby Letters of Credit issued or to be issued by the Administrative Agent under 3 hereof for the account of the Borrower. LIBOR Competitive Bid Loan(s). See 4.3(a). LIBOR Rate. For any Interest Period with respect to a LIBOR Competitive Bid Loan, (a) the rate of interest equal to the rate determined by the Administrative Agent at which Dollar deposits for such Interest Period are offered based on information presented on Telerate Page 3750 as of 11:00 a.m. (London time) two (2) Eurodollar Business Days prior to the first day of such Interest Period, or (b) if such rate is not shown at such place, the rate of interest equal to (i) the arithmetic average of the rates per annum for each Agent at which such Agent's Eurodollar Lending Office is offered Dollar deposits two (2) Eurodollar Business Days prior to the beginning of such Interest Period in the interbank eurodollar market where the eurodollar operations of such Eurodollar Lending Office are customarily conducted, for delivery on the first day of such Interest Period for the number of days comprised therein and in an amount comparable to the amount of the Eurodollar Rate Loan of such Agent to which such Interest Period applies, divided by (ii) a number equal to 1.00 minus the Eurocurrency Reserve Rate, if applicable (rounded upwards to the nearest 1/16 of one percent). Loan Documents. This Agreement, the Notes, the Letter of Credit Applications, the Letters of Credit, and any documents, instruments or agreements executed in connection with any of the foregoing, each as amended, modified, supplemented, or replaced from time to time. Loans. Collectively, the Syndicated Loans to be made by the Banks to the Borrower pursuant to 2 and the Competitive Bid Loans made by Banks selected pursuant to 4. Majority Banks. The Banks holding fifty-one percent (51%) of the Total Commitment; provided that in the event that the Total Commitment has been terminated, the Majority Banks shall be the Banks holding fifty-one percent (51%) of the outstanding principal amount of the Loans on such date. Maturity Date. January 22, 2002. Maximum Drawing Amount. The maximum aggregate amount from time to time that the beneficiaries may draw under outstanding Letters of Credit. MCTG. MCTG Acquisition Corp., a Delaware corporation and a wholly owned Subsidiary of the Borrower. Moody's. Moody's Investors Service, Inc. Multiemployer Plan. Any multiemployer plan within the meaning of 3(37) of ERISA maintained or contributed to by the Borrower, any Subsidiary, or any ERISA Affiliate. New Lending Office. See 5.1(d). Non-U.S. Bank. See 5.1(c). Note Purchase Agreement. That certain note purchase and exchange agreement, dated March 3, 1994, as amended and in effect from time to time, between the Borrower and Metropolitan Life Insurance Company. Notes. The Competitive Bid Notes and the Syndicated Notes. Notice of Acceptance of Competitive Bid Quote(s). See 4.7. Obligations. All indebtedness, obligations and liabilities of the Borrower to any of the Banks and the Administrative Agent arising or incurred under this Agreement or any of the other Loan Documents or in respect of any of the Loans made or Reimbursement Obligations incurred or the Letters of Credit, the Notes, or any other instrument at any time evidencing any thereof, individually or collectively, existing on the date of this Agreement or arising thereafter, direct or indirect, joint or several, absolute or contingent, matured or unmatured, liquidated or unliquidated, secured or unsecured, arising by contract, operation of law or otherwise. Overnight Federal Funds Effective Rate. The overnight federal funds effective rate as published by the Board of Governors of the Federal Reserve System, as in effect from time to time. PBGC. The Pension Benefit Guaranty Corporation created by 4002 of ERISA and any successor entity or entities having similar responsibilities. Permitted Investments. See 8.2. Permitted Liens. See 8.1. Permitted Receivables Transaction. Any sale or sales of, and/or securitization of, any accounts receivable of the Borrower and/or any of its Subsidiaries (the "Receivables") pursuant to which the Borrower and its Subsidiaries realize aggregate net proceeds of not more than $100,000,000 at any one time outstanding, including, without limitation, any revolving purchase(s) of Receivables where the maximum aggregate uncollected purchase price (exclusive of any deferred purchase price) for such Receivables at any time outstanding does not exceed $100,000,000. Person. Any individual, corporation, partnership, limited liability company, trust, unincorporated association, business, or other legal entity, and any government or any governmental agency or political subdivision thereof. Pricing Table: Applicabl Applicabl Applicabl e e e Level Senior Public Debt Facility L/C Rate Margin Rating Rate (per (per (per annum) annum) annum) 1 BBB+/Baa1 0.1000% 0.1800% 0.1800% 2 BBB/Baa2 0.1250% 0.2250% 0.2250% 3 BBB-/Baa3 0.1500% 0.3000% 0.3000% 4 BB+/Ba1 0.2250% 0.4250% 0.4250% 5 BB/Ba2 or unrated 0.2500% 0.6500% 0.6500% The applicable rates or margin charged on any day shall be determined by the Senior Public Debt Rating in effect as of that day. RCRA. See 6.14(a). Real Property. All real property heretofore, now, or hereafter owned, operated, or leased by the Borrower or any of its Subsidiaries. Reference Period. The period of four consecutive fiscal quarters (or such shorter period of one, two, or three consecutive fiscal quarters as has elapsed since December 31, 1996). Reimbursement Obligation. The Borrower's obligation to reimburse the Administrative Agent and the Banks on account of any drawing under any Letter of Credit as provided in 3.2. Release. Shall have the meaning specified in the Comprehensive Environmental Response, Compensation and Liability Act of 1980, 42 U.S.C. 9601 et seq. ("CERCLA") and the term "Disposal" (or "Disposed") shall have the meaning specified in the Resource Conservation and Recovery Act of 1976, 42 U.S.C. 6901 et seq. ("RCRA") and regulations promulgated thereunder; provided that, in the event either CERCLA or RCRA is amended so as to broaden the meaning of any term defined thereby, such broader meaning shall apply as of the effective date of such amendment and provided further, to the extent that the laws of a state wherein the property lies establish a meaning for "Release" or "Disposal" which is broader than specified in either CERCLA or RCRA, such broader meaning shall apply. Replacement Bank. See 5.12. Replacement Notice. See 5.12. Reserve Rate. The highest rate, expressed as a decimal, at which the Administrative Agent would be required to maintain reserves under Regulation D of the Board of Governors of the Federal Reserve System (or any subsequent or similar regulation relating to such reserve requirements) against "Eurocurrency Liabilities" (as such term is defined in Regulation D), or against any other category of liabilities which might be incurred by the Administrative Agent to fund Loans bearing interest based on the Eurodollar Rate, if such liabilities were outstanding. Senior Public Debt Rating. The rating of the Borrower's public unsecured long-term senior debt, without third party credit enhancement, issued by Moody's and/or Standard & Poor's provided that in the event that both Moody's and Standard & Poor's have issued such ratings, the Senior Public Debt Rating will be the lower of the two ratings. Standard & Poor's. Standard & Poor's Ratings Group, a division of McGraw Hill, Inc. Subsidiary. Any corporation, association, trust, or other business entity of which the designated parent shall at any time own directly or indirectly through a Subsidiary or Subsidiaries at least a majority of the outstanding capital stock or other interest entitled to vote generally. Syndicated Loan Request. See 2.6. Syndicated Loans. Loans advanced pursuant to 2.1. Syndicated Notes. See 2.4. Total Commitment. See 2.1. Tylan. Tylan General, Inc., a Delaware corporation. Tylan Merger. The merger of MCTG with and into Tylan pursuant to the Tylan Merger Agreement, with Tylan being the surviving corporation and a Subsidiary of the Borrower. Tylan Merger Agreement. The Agreement and Plan of Merger dated as of December 16, 1996 among Tylan, the Borrower and MCTG. Tylan Merger Date. The date as of which the transactions contemplated by the Tylan Merger Agreement are consummated. Tylan Revolving Credit Agreement. The revolving credit agreement between Tylan and Comerica. Tylan Shares. See definition of Tylan Tender Offer. Tylan Tender Offer. The Offer to Purchase, dated December 20, 1996, made by MCTG, to purchase all of the outstanding shares of common stock, together with all associated Series A Junior Participating Preferred Stock Purchase Rights of Tylan (collectively, the "Tylan Shares"). Rules of Interpretation. (a) A reference to any document or agreement (including this Agreement) shall include such document or agreement as amended, modified or supplemented from time to time in accordance with its terms and the terms of this Agreement. (b) The singular includes the plural and the plural includes the singular. (c) A reference to any law includes any amendment or modification to such law. (d) A reference to any Person includes its permitted successors and permitted assigns. (e) Accounting terms capitalized but not otherwise defined herein have the meanings assigned to them by generally accepted accounting principles applied on a consistent basis by the accounting entity to which they refer. (f) The words "include", "includes" and "including" are not limiting. (g) All terms not specifically defined herein or by generally accepted accounting principles, which terms are defined in the Uniform Commercial Code as in effect in the Commonwealth of Massachusetts, have the meanings assigned to them therein. (h) Reference to a particular "" refers to that section of this Agreement unless otherwise indicated. (i) The words "herein", "hereof", "hereunder" and words of like import shall refer to this Agreement as a whole and not to any particular section or subdivision of this Agreement. THE SYNDICATED FACILITY. Commitment to Lend Syndicated Loans. Subject to the terms and conditions set forth in this Agreement, each of the Banks severally agrees to lend to the Borrower and the Borrower may borrow, repay, and reborrow from time to time between the Closing Date and the Maturity Date, upon notice by the Borrower to the Administrative Agent given in accordance with this 2, such Bank's Commitment Percentage of the Syndicated Loans as are requested by the Borrower; provided that the sum of the outstanding principal amount of the Syndicated Loans and the Maximum Drawing Amount of outstanding Letters of Credit shall not exceed a maximum aggregate amount outstanding of (i) $450,000,000, as such amount may be reduced pursuant to 2.3 hereof (the "Total Commitment") minus (ii) the aggregate amount of Competitive Bid Loans outstanding at such time. Each request for a Syndicated Loan or Letter of Credit hereunder shall constitute a representation and warranty by the Borrower that the conditions set forth in 10 and 11, as the case may be, have been satisfied on the date of such request. Any unpaid Reimbursement Obligation with respect to any Letter of Credit shall be a Base Rate Loan hereunder. Facility Fee. The Borrower agrees to pay to the Administrative Agent for the account of the Banks a fee (the "Facility Fee") equal to the Applicable Facility Rate multiplied by the Total Commitment for the number of days the facility is outstanding. The Facility Fee shall be payable quarterly in arrears on the first day of each calendar quarter for the immediately preceding calendar quarter commencing on April 1, 1997 with a final payment on the Maturity Date (or on the date of termination in full of the Total Commitment, if earlier). The Facility Fee shall be distributed pro rata among the Banks in accordance with each Bank's Commitment Percentage. Reduction of Total Commitment; Increase of Total Commitment. (a) The Borrower shall have the right at any time and from time to time upon seven (7) Business Days' prior written notice to the Administrative Agent to reduce by $10,000,000 or larger multiples of $5,000,000 or terminate entirely the Total Commitment, whereupon the Commitment of each Bank shall be reduced pro rata in accordance with such Bank's Commitment Percentage of the amount specified in such notice or, as the case may be, terminated. The Administrative Agent will notify the Banks promptly after receiving any notice delivered by the Borrower pursuant to this 2.3. Notwithstanding the foregoing, at no time may the Total Commitment be reduced to an amount less than the sum of (i) the Maximum Drawing Amount of all Letters of Credit and (ii) all Loans then outstanding. (b) No reduction or termination of the Total Commitment once made may be revoked; the portion of the Total Commitment reduced or terminated may not be reinstated; and amounts in respect of such reduced or terminated portion may not be reborrowed. (c) In the event that the Note Purchase Agreement is not amended on or before February 20, 1997, the Borrower may request that the Total Commitment be increased by $50,000,000 hereunder, which increase is subject to the approval of the Administrative Agent; provided, however, that in the event that such an increase is approved, (i) any Bank which is a party to this Agreement prior to such increase shall not be required to increase its Commitment hereunder and (ii) such Bank's Commitment Percentage shall be correspondingly decreased to reflect such increase in the Total Commitment. The Syndicated Notes. The Syndicated Loans shall be evidenced by separate promissory notes of the Borrower in substantially the form of Exhibit A hereto (each, a "Syndicated Note"), dated as of the Closing Date (or syndication date, if later) and completed with appropriate insertions. One Syndicated Note shall be payable to the order of each Bank in an amount equal to such Bank's Commitment, and shall represent the obligation of the Borrower to pay such Bank such principal amounts or, if less, the outstanding principal amount of all Syndicated Loans made by such Bank, plus interest accrued thereon, as set forth below. The Borrower irrevocably authorizes each Bank to make or cause to be made, in connection with a Drawdown Date of any Syndicated Loan or at the time of receipt of any payment of principal on such Bank's Syndicated Note, an appropriate notation on such Bank's records or on the schedule attached to such Bank's Syndicated Note or a continuation of such schedule attached thereto reflecting the making of the Syndicated Loan or the receipt of such payment (as the case may be) and may, prior to any transfer of its Syndicated Note, endorse on the reverse side thereof the outstanding principal amount of Syndicated Loans evidenced thereby. The outstanding amount of the Syndicated Loans set forth on such Bank's records shall be prima facie evidence of the principal amount thereof owing and unpaid to such Bank, but the failure to record, or any error in so recording, any such amount shall not limit or otherwise affect the obligations of the Borrower hereunder or under the Syndicated Notes to make payments of principal of or interest on any Syndicated Note when due. Interest on Syndicated Loans. The outstanding principal amount of the Syndicated Loans shall bear interest at the rate per annum equal to the Base Rate on Base Rate Loans or the Applicable Eurodollar Rate on Eurodollar Loans. Interest shall be payable (a) quarterly in arrears on the first Business Day of the next succeeding quarter, commencing April 1, 1997, on Base Rate Loans, (b) on the last day of the applicable Interest Period, and if such Interest Period is longer than three (3) months, also on the last day of the third month following the commencement of such Interest Period, on Eurodollar Loans, and (c) on the Maturity Date for all Loans. Requests for Syndicated Loans. The Borrower shall give to the Administrative Agent written notice in the form of Exhibit C-1 hereto (or telephonic notice confirmed in writing or a facsimile in the form of Exhibit C-1 hereto) of each Syndicated Loan requested hereunder (a "Syndicated Loan Request") not later than (a) 11:00 a.m. (Boston time) on the proposed Drawdown Date of any Base Rate Loan, or (b) 11:00 a.m. (Boston time) three (3) Eurodollar Business Days prior to the proposed Drawdown Date of any Eurodollar Loan. Each such notice shall specify (A) the principal amount of the Syndicated Loan requested, (B) the proposed Drawdown Date of such Syndicated Loan, (C) whether such Syndicated Loan requested is to be a Base Rate Loan or a Eurodollar Loan and (D) the Interest Period for such Syndicated Loan, if a Eurodollar Loan. Each Syndicated Loan requested shall be in a minimum amount of $10,000,000. Each such request shall specify the principal amount of the Syndicated Loan requested and shall reflect the Maximum Drawing Amount of all Letters of Credit outstanding and the amount of Loans outstanding (including Competitive Bid Loans). Syndicated Loan requests made hereunder shall be irrevocable and binding on the Borrower, and shall obligate the Borrower to accept the Syndicated Loan requested from the Banks on the proposed Drawdown Date. Each of the representations and warranties made by the Borrower to the Banks or the Administrative Agent in this Agreement or any other Loan Document shall be true and correct in all material respects when made and shall, for all purposes of this Agreement, be deemed to be repeated on and as of the date of the submission of a Syndicated Loan Request or Letter of Credit Request and on and as of the Drawdown Date of such Syndicated Loan or the date of issuance of such Letter of Credit (except to the extent (i) of changes resulting from transactions contemplated or permitted by this Agreement and the other Loan Documents, (ii) of changes occurring in the ordinary course of business that singly or in the aggregate are not materially adverse to the business, assets or financial condition of the Borrower and its Subsidiaries as a whole, or (iii) that such representations and warranties expressly relate only to an earlier date). The Administrative Agent shall promptly notify each Bank of each Syndicated Loan Request received by the Administrative Agent. Election of Eurodollar Rate; Notice of Election; Interest Periods; Minimum Amounts. (a) At the Borrower's option, so long as no Default or Event of Default has occurred and is then continuing, the Borrower may (i) elect to convert any Base Rate Loan or a portion thereof to a Eurodollar Loan, (ii) at the time of any Syndicated Loan Request, specify that such requested Syndicated Loan shall be a Eurodollar Loan, or (iii) upon expiration of the applicable Interest Period, elect to maintain an existing Eurodollar Loan as such, provided that the Borrower gives notice to the Administrative Agent pursuant to 2.7(b) hereof. Upon determining any Eurodollar Rate, the Administrative Agent shall forthwith provide notice thereof to the Borrower and each Bank, and each such notice to the Borrower shall be considered prima facie correct and binding, absent manifest error. (b) Three (3) Eurodollar Business Days prior to the making of any Eurodollar Loan or the conversion of any Base Rate Loan to a Eurodollar Loan, or, in the case of an outstanding Eurodollar Loan, the expiration date of the applicable Interest Period, the Borrower shall give written, telex or facsimile notice received by the Administrative Agent not later than 11:00 a.m. (Boston time) of its election pursuant to 2.7(a). Each such notice delivered to the Administrative Agent shall specify the aggregate principal amount of the Syndicated Loans to be borrowed or maintained as or converted to Eurodollar Loans and the requested duration of the Interest Period that will be applicable to such Eurodollar Loan, and shall be irrevocable and binding upon the Borrower. If the Borrower shall fail to give the Administrative Agent notice of its election hereunder together with all of the other information required by this 2.7(b) with respect to any Syndicated Loan, whether at the end of an Interest Period or otherwise, such Syndicated Loan shall be deemed a Base Rate Loan. The Administrative Agent shall promptly notify each Bank in writing (or by telephone confirmed in writing or by facsimile) of such election. (c) Notwithstanding anything herein to the contrary, the Borrower may not specify an Interest Period that would extend beyond the Maturity Date. (d) No conversion of Syndicated Loans pursuant to this 2.7 may result in Eurodollar Loans that are less than $10,000,000. In no event shall the Borrower have more than ten (10) different maturities of borrowings of Eurodollar Loans outstanding at any time. (e) Subject to the terms and conditions of 5.8 hereof, if any affected Bank demands compensation under 5.5(c) or (d) with respect to any Eurodollar Loan, the Borrower may at any time, upon at least three (3) Business Days' prior written notice to the Administrative Agent elect to convert such Eurodollar Loan into a Base Rate Loan (on which interest and principal shall be payable contemporaneously with the related Eurodollar Loans of the other Banks). Thereafter, and until such time as the affected Bank notifies the Borrower that the circumstances giving rise to the demand for compensation under 5.5(c) or (d) no longer exist, all requests for Eurodollar Loans from such affected Bank shall be deemed to be requests for Base Rate Loans, regardless of whether the Borrower has requested a Eurodollar Loan from the other Banks. Once the affected Bank notifies the Borrower that such circumstances no longer exist, the Borrower may elect that the principal amount of each such Bank's Loans again bear interest as Eurodollar Loans beginning on the first day of the next succeeding Interest Period applicable to the related Eurodollar Loans of the other Banks. Funds for Syndicated Credit Loans. Not later than 1:00 p.m. (Boston time) on the proposed Drawdown Date of any Syndicated Loan, each of the Banks will make available to the Administrative Agent, at its Head Office, in immediately available funds, the amount of such Bank's Commitment Percentage of the amount of the requested Syndicated Loan. Upon receipt from each Bank of such amount, and upon receipt of the documents required by 10 or 11, as the case may be, and the satisfaction of the other conditions set forth therein, to the extent applicable, the Administrative Agent will make available to the Borrower the aggregate amount of such Syndicated Loans made available to the Administrative Agent by the Banks. The failure or refusal of any Bank to make available to the Administrative Agent at the aforesaid time and place on any Drawdown Date the amount of its Commitment Percentage of the requested Syndicated Loan shall not relieve any other Bank from its several obligations hereunder to make available to the Administrative Agent the amount of such Bank's Commitment Percentage of any requested Syndicated Loan. Maturity of the Syndicated Loans and Reimbursement Obligations. The Syndicated Loans shall be due and payable on the Maturity Date. The Borrower promises to pay on the Maturity Date all Syndicated Loans and all unpaid Reimbursement Obligations outstanding on such date, together with any and all accrued and unpaid interest thereon and any fees and other amounts owing hereunder. Optional Prepayments or Repayments of Syndicated Loans. Subject to the terms and conditions of 5.8, the Borrower shall have the right, at its election, to repay or prepay the outstanding amount of the Syndicated Loans, as a whole or in part, at any time without penalty or premium. The Borrower shall give the Administrative Agent, no later than 11:00 a.m. (Boston time) one (1) Business Day prior to the proposed date of prepayment or repayment, written notice (or telephonic notice confirmed in writing or by facsimile) of any proposed prepayment or repayment pursuant to this 2.10, specifying the proposed date of prepayment or repayment of Loans and the principal amount to be paid. The Administrative Agent shall promptly notify each Bank by written notice (or telephonic notice confirmed in writing or by facsimile) of such payment. LETTERS OF CREDIT. Letter of Credit Commitments. (a) Subject to the terms and conditions hereof and the receipt of a letter of credit request in substantially the form of Exhibit C-2 hereto (a "Letter of Credit Request") by the Administrative Agent reflecting the Maximum Drawing Amount of all Letters of Credit (including the requested Letter of Credit) and a Letter of Credit Application, the Administrative Agent, on behalf of the Banks and in reliance upon the representations and warranties of the Borrower contained herein and the agreement of the Banks contained in 3.1(b) hereof, agrees to issue letters of credit, in such form as may be requested from time to time by the Borrower and agreed to by the Administrative Agent; provided, however, that, (i) after giving effect to such request, the aggregate Maximum Drawing Amount of all letters of credit issued at any time under this 3.1(a) (the "Letters of Credit") shall not exceed the lesser of (A) $50,000,000, or (B) the Total Commitment minus the outstanding amount of the Loans, and (ii) no Letter of Credit shall have an expiration date later than the earlier of (x) twelve (12) months after the date of issuance (which may incorporate automatic renewals for periods of up to twelve (12) months), or (y) fourteen (14) Business Days prior to the Maturity Date. (b) Each Bank severally agrees that it shall be absolutely liable, without regard to the occurrence of any Default or Event of Default, the termination of the Total Commitment pursuant to 12.2, or any other condition precedent whatsoever, to the extent of such Bank's Commitment Percentage thereof, to reimburse the Administrative Agent on demand for the amount of each draft paid by the Administrative Agent under each Letter of Credit to the extent that such amount is not reimbursed by the Borrower pursuant to 3.2 (such agreement for a Bank being called herein the "Letter of Credit Participation" of such Bank). Each Bank agrees that its obligation to reimburse the Administrative Agent pursuant to this 3.1(b) shall not be affected in any way by any circumstance other than the gross negligence or willful misconduct of the Administrative Agent. (c) Each such reimbursement payment made by a Bank to the Administrative Agent shall be treated as the purchase by such Bank of a participating interest in the Borrower's Reimbursement Obligation under 3.2 in an amount equal to such payment. Each Bank shall share in accordance with its participating interest in any interest which accrues pursuant to 3.2. Reimbursement Obligation of the Borrower. In order to induce the Administrative Agent to issue, extend and renew each Letter of Credit, the Borrower hereby agrees to reimburse or pay to the Administrative Agent, with respect to each Letter of Credit issued, extended or renewed by the Administrative Agent hereunder, as follows: (a) if any draft presented under any Letter of Credit is honored by the Administrative Agent or the Administrative Agent otherwise makes payment with respect thereto, the sum of (i) the amount paid by the Administrative Agent under or with respect to such Letter of Credit, and (ii) the amount of any taxes, fees, charges or other costs and expenses whatsoever incurred by the Administrative Agent in connection with any payment made by the Administrative Agent under, or with respect to, such Letter of Credit, provided however, if the Borrower does not reimburse the Administrative Agent on the Drawdown Date, such amount shall become automatically a Syndicated Loan which is a Base Rate Loan advanced hereunder in an amount equal to such sum; and (b) upon the Maturity Date or the acceleration of the Reimbursement Obligations with respect to all Letters of Credit in accordance with 12, an amount equal to the then Maximum Drawing Amount of all outstanding Letters of Credit shall be paid by the Borrower to the Administrative Agent to be held as cash collateral for all Reimbursement Obligations. Obligations Absolute. The Borrower's obligations under this 3 shall be absolute and unconditional under any and all circumstances and irrespective of the occurrence of any Default or Event of Default or any condition precedent whatsoever or any setoff, counterclaim or defense to payment which the Borrower may have or have had against the Administrative Agent, any Bank or any beneficiary of a Letter of Credit. The Borrower further agrees with the Administrative Agent and the Banks that the Administrative Agent and the Banks (i) shall not be responsible for, and the Borrower's Reimbursement Obligations under 3.2 shall not be affected by, among other things, the validity or genuineness of documents or of any endorsements thereon, even if such documents should appear on their face to conform to the requirements of the Letter of Credit but in fact prove to be in any or all respects invalid, fraudulent or forged (unless due to the willful misconduct of the Administrative Agent or any other Banks), or any dispute between or among the Borrower and the beneficiary of any Letter of Credit or any financing institution or other party to which any Letter of Credit may be transferred or any claims or defenses whatsoever of the Borrower against the beneficiary of any Letter of Credit or any such transferee, and (ii) shall not be liable for any error, omission, interruption or delay in transmission, dispatch or delivery of any message or advice, however transmitted, in connection with any Letter of Credit except to the extent of their own willful misconduct. The Borrower agrees that any action taken or omitted by the Administrative Agent or any Bank in good faith under or in connection with each Letter of Credit and the related drafts and documents shall be binding upon the Borrower and shall not result in any liability on the part of the Administrative Agent or any Bank (or their respective affiliates) to the Borrower. Nothing herein shall constitute a waiver by the Borrower of any of its rights against any beneficiary of a Letter of Credit. Reliance by the Administrative Agent. To the extent not inconsistent with 3.3, the Administrative Agent shall be entitled to rely, and shall be fully protected in relying upon, any Letter of Credit, draft, writing, resolution, notice, consent, certificate, affidavit, letter, cablegram, telegram, facsimile, telex or teletype message, statement, order or other document believed by it in good faith to be genuine and correct and to have been signed, sent or made by the proper Person or Persons and upon advice and statements of legal counsel, independent accountants and other experts selected by the Administrative Agent. Letter of Credit Fee. The Borrower shall pay a fee (the "Letter of Credit Fee") equal to the Applicable L/C Rate for the number of days outstanding on the Maximum Drawing Amount of Letters of Credit issued hereunder to the Administrative Agent for the account of the Banks, to be shared pro-rata by each of the Banks in accordance with their respective Commitment Percentages. The Letter of Credit Fee shall be payable quarterly in arrears on the first day of each calendar quarter for the quarter just ended, commencing April 1, 1997, and on the Maturity Date. In addition, the Borrower shall pay an issuing fee (the "Issuance Fee") equal to 0.125% per annum on the Maximum Drawing Amount of Letters of Credit issued hereunder to the Administrative Agent for its account, plus its customary issuance fee, payable in accordance with customary practice. The Issuance Fee shall be payable quarterly in arrears on the first day of each calendar quarter for the quarter just ended, commencing April 1, 1997, and on the Maturity Date. COMPETITIVE BID LOANS. The Competitive Bid Option. In addition to the Syndicated Loans made pursuant to 2 hereof, the Borrower may request Competitive Bid Loans pursuant to the terms of this 4. The Banks may, but shall have no obligation to, make such offers and the Borrower may, but shall have no obligation to, accept such offers in the manner set forth in this 4. Notwithstanding any other provision herein to the contrary, at no time shall the aggregate outstanding principal amount of Competitive Bid Loans outstanding at any time exceed the sum of the Total Commitment minus the aggregate outstanding principal amount of Syndicated Loans minus the Maximum Drawing Amount of Letters of Credit outstanding at such time. No Bank's funding of Competitive Bid Loans shall reduce such Bank's obligation to lend its Commitment Percentage of the available Total Commitment. Competitive Bid Notes. (a) The obligation of the Borrower to repay the outstanding principal amount of any and all Competitive Bid Loans, plus interest at the applicable Competitive Bid Rate accrued thereon, shall be evidenced by the promissory notes of the Borrower in substantially the form of Exhibit B hereto (each, a "Competitive Bid Note"), dated as of the Closing Date (or the syndication date, if later) and completed with appropriate insertions. One Competitive Bid Note shall be payable to the order of each Bank in an amount equal to $450,000,000, and representing the obligation of the Borrower to pay such Bank such principal amounts or, if less, the outstanding principal amount of any and all Competitive Bid Loans made by such Bank, plus interest at the applicable Competitive Bid Rate or Competitive Bid Margin accrued thereon, as set forth herein. (b) The Borrower irrevocably authorizes (i) each Bank to make or cause to be made, in connection with a Drawdown Date of any Competitive Bid Loan or at the time of receipt of any payment of principal on such Bank's Competitive Bid Note in the case of a Competitive Bid Note, an appropriate notation on such Bank's records or on the schedule attached to such Bank's Competitive Bid Note or a continuation of such schedule attached thereto, reflecting the making of the Competitive Bid Loan or the receipt of such payment (as the case may be) and may, prior to any transfer of a Competitive Bid Note, endorse on the reverse side thereof the outstanding principal amount of Competitive Bid Loans evidenced thereby. The outstanding amount of the Competitive Bid Loans set forth on such Bank's records shall be prima facie evidence of the principal amount thereof owing and unpaid to such Bank, but the failure to record, or any error in so recording, any such amount shall not limit or otherwise affect the obligations of the Borrower hereunder to make payments of principal of or interest on any Competitive Bid Loan when due. Competitive Bid Quote Request; Invitation for Competitive Bid Quotes. (a) When the Borrower wishes to request offers to make Competitive Bid Loans under this 4, it shall transmit to the Administrative Agent by telex or facsimile a Competitive Bid Quote Request substantially in the form of Exhibit F hereto (a "Competitive Bid Quote Request") so as to be received no later than 1:00 p.m. (Boston time) (x) five (5) Eurodollar Business Days prior to the requested Drawdown Date in the case of a LIBOR Competitive Bid Loan (a "LIBOR Competitive Bid Loan") or (y) one (1) Business Day prior to the requested Drawdown Date in the case of an Absolute Competitive Bid Loan (an "Absolute Competitive Bid Loan"), specifying: (i) the requested Drawdown Date (which must be a Eurodollar Business Day in the case of a LIBOR Competitive Bid Loan or a Business Day in the case of an Absolute Competitive Bid Loan); (ii) the aggregate amount of such Competitive Bid Loans, which shall be $10,000,000 or larger multiples of $1,000,000; (iii) the duration of the Interest Period(s) applicable thereto, subject to the provisions of the definition of Interest Period; and (iv) whether the Competitive Bid Quotes requested are LIBOR Competitive Bid Loans or Absolute Competitive Bid Loans. The Borrower may request offers to make Competitive Bid Loans for more than one Interest Period in a single Competitive Bid Quote Request. No new Competitive Bid Quote Request shall be given until the Borrower has notified the Administrative Agent of its acceptance or non-acceptance of the Competitive Bid Quotes relating to any outstanding Competitive Bid Quote Request. (b) Promptly upon receipt of a Competitive Bid Quote Request and payment by the Borrower of a $2,000 auction fee to the Administrative Agent for its own account, the Administrative Agent shall send to the Banks by telecopy or facsimile transmission an Invitation for Competitive Bid Quotes substantially in the form of Exhibit G hereto ("Invitation for Competitive Bid Quotes"), which shall constitute an invitation by the Borrower to each Bank to submit Competitive Bid Quotes in accordance with this 4. Alternative Manner of Procedure. If, after receipt by the Administrative Agent and each of the Banks of a Competitive Bid Quote Request from the Borrower in accordance with 4.3, the Administrative Agent or any Bank shall be unable to complete any procedure of the auction process described in 4.5 through 4.6 (inclusive) due to the inability of such Person to transmit or receive communications through the means specified therein, such Person may rely on telephonic notice for the transmission or receipt of such communications. In any case where such Person shall rely on telephone transmission or receipt, any communication made by telephone shall, as soon as possible thereafter, be followed by written confirmation thereof. Submission and Contents of Competitive Bid Quotes. (a) Each Bank may, but shall be under no obligation to, submit a Competitive Bid Quote containing an offer or offers to make Competitive Bid Loans in response to any Competitive Bid Quote Request. Each Competitive Bid Quote must comply with the requirements of this 4.5 and must be submitted to the Administrative Agent by telex or facsimile transmission at its offices as specified in or pursuant to 20 not later than (x) 2:00 p.m. (Boston time) on the fourth Eurodollar Business Day prior to the proposed Drawdown Date, in the case of a LIBOR Competitive Bid Loan or (y) 10:00 a.m. (Boston time) on the proposed Drawdown Date, in the case of an Absolute Competitive Bid Loan, provided that Competitive Bid Quotes may be submitted by the Administrative Agent in its capacity as a Bank only if it submits its Competitive Bid Quote to the Borrower not later than (x) one hour prior to the deadline for the other Banks, in the case of a LIBOR Competitive Bid Loan or (y) 15 minutes prior to the deadline for the other Banks, in the case of an Absolute Competitive Bid Loan. Subject to the provisions of 10 and 11 hereof, any Competitive Bid Quote so made shall be irrevocable except with the written consent of the Administrative Agent given on the instructions of the Borrower. (b) Each Competitive Bid Quote shall be in substantially the form of Exhibit H hereto and shall in any case specify: (i) the proposed Drawdown Date; (ii) the principal amount of the Competitive Bid Loan for which each proposal is being made, which principal amount (w) may be greater than or less than the Commitment of the quoting Bank, (x) must be $5,000,000 or larger multiples of $1,000,000, (y) may not exceed the aggregate principal amount of Competitive Bid Loans for which offers were requested and (z) may be subject to an aggregate limitation as to the principal amount of Competitive Bid Loans for which offers being made by such quoting Bank may be accepted; (iii) the Interest Period(s) for which Competitive Bid Quotes are being submitted; (iv) in the case of a LIBOR Competitive Bid Loan, the margin above or below the applicable LIBOR Rate (the "Competitive Bid Margin") offered for each such Competitive Bid Loan, expressed as a percentage (specified to the nearest 1/10,000th of 1%) to be added to or subtracted from such LIBOR Rate; (v) in the case of an Absolute Competitive Bid Loan, the rate of interest per annum (specified to the nearest 1/10,000th of 1%) (the "Competitive Bid Rate") offered for each such Absolute Competitive Bid Loan; and (vi) the identity of the quoting Bank. A Competitive Bid Quote may include up to five (5) separate offers by the quoting Bank with respect to each Interest Period specified in the related Invitation for Competitive Bid Quotes. (c) Any Competitive Bid Quote shall be disregarded if it: (i) is not substantially in the form of Exhibit H hereto; (ii) contains qualifying, conditional or similar language; (iii) proposes terms other than or in addition to those set forth in the applicable Invitation for Competitive Bid Quotes; or (iv) arrives after the time set forth in 4.5(a) hereof. Notice to Borrower. The Administrative Agent shall promptly notify the Borrower of the terms (x) of any Competitive Bid Quote submitted by a Bank that is in accordance with 4.5 and (y) of any Competitive Bid Quote that amends, modifies or is otherwise inconsistent with a previous Competitive Bid Quote submitted by such Bank with respect to the same Competitive Bid Quote Request. Any such subsequent Competitive Bid Quote shall be disregarded by the Administrative Agent unless such subsequent Competitive Bid Quote is submitted solely to correct a manifest error in such former Competitive Bid Quote. The Administrative Agent's notice to the Borrower shall specify (A) the aggregate principal amount of Competitive Bid Loans for which offers have been received for each Interest Period specified in the related Competitive Bid Quote Request, (B) the respective principal amounts and Competitive Bid Margins or Competitive Bid Rates, as the case may be, so offered, and the identity of the respective Banks submitting such offers, and (C) if applicable, limitations on the aggregate principal amount of Competitive Bid Loans for which offers in any single Competitive Bid Quote may be accepted. Acceptance and Notice by Borrower and Administrative Agent. Not later than 11:00 a.m. (Boston time) on (x) the third Eurodollar Business Day prior to the proposed Drawdown Date, in the case of a LIBOR Competitive Bid Loan or (y) the proposed Drawdown Date, in the case of an Absolute Competitive Bid Loan, the Borrower shall notify the Administrative Agent of its acceptance or non-acceptance of each Competitive Bid Quote in substantially the form of Exhibit I hereto ("Notice of Acceptance of Competitive Bid Quote(s)"). The Borrower may accept any Competitive Bid Quote in whole or in part; provided that: (i) the aggregate principal amount of each Competitive Bid Loan may not exceed the applicable amount set forth in the related Competitive Bid Quote Request; (ii) acceptance of offers may only be made on the basis of ascending Competitive Bid Margins or Competitive Bid Rates, as the case may be, and (iii) the Borrower may not accept any offer that is described in subsection 4.5(c) or that otherwise fails to comply with the requirements of this Agreement. The Administrative Agent shall promptly notify each Bank which submitted a Competitive Bid Quote of the Borrower's acceptance or non-acceptance thereof. At the request of any Bank which submitted a Competitive Bid Quote and with the consent of the Borrower, the Administrative Agent will promptly notify all Banks which submitted Competitive Bid Quotes of (a) the aggregate principal amount of, and (b) the range of Competitive Bid Rates or Competitive Bid Margins of, the accepted Competitive Bid Loans for each requested Interest Period. Allocation by Administrative Agent. If offers are made by two or more Banks with the same Competitive Bid Margin or Competitive Bid Rate, as the case may be, for a greater aggregate principal amount than the amount in respect of which offers are accepted for the related Interest Period, the principal amount of Competitive Bid Loans in respect of which such offers are accepted shall be allocated by the Administrative Agent among such Banks as nearly as possible (in such multiples of $1,000,000, as the Administrative Agent may deem appropriate) in proportion to the aggregate principal amounts of such offers. Determination by the Administrative Agent of the amounts of Competitive Bid Loans shall be conclusive in the absence of manifest error. Funding of Competitive Bid Loans. If, on or prior to the Drawdown Date of any Competitive Bid Loan, the Total Commitment has not terminated in full and if, on such Drawdown Date, the applicable conditions of 10 and 11 hereof are satisfied, the Bank or Banks whose offers the Borrower has accepted will fund each Competitive Bid Loan so accepted. Such Bank or Banks will make such Competitive Bid Loans, by crediting the Administrative Agent for further credit to the Borrower's specified account with the Administrative Agent, in immediately available funds not later than 2:00 p.m. (Boston time) on such Drawdown Date. Funding Losses. If, after acceptance of any Competitive Bid Quote pursuant to 4, the Borrower (i) fails to borrow any Competitive Bid Loan so accepted on the date specified therefor, or (ii) repays or prepays the outstanding amount of the Competitive Bid Loan prior to the last day of the Interest Period relating thereto, the Borrower shall indemnify the Bank making such Competitive Bid Quote or funding such Competitive Bid Loan against any loss or expense incurred by reason of the liquidation or reemployment of deposits or other funds acquired by such Bank to fund or maintain such unborrowed Loans, including, without limitation compensation as provided in 5.8. Repayment of Competitive Bid Loans; Interest. The principal of each Competitive Bid Loan shall become absolutely due and payable by the Borrower on the last day of the Interest Period relating thereto, and the Borrower hereby absolutely and unconditionally promises to pay to the Administrative Agent for the account of the relevant Banks at or before 1:00 p.m. (Boston time) on the last day of the Interest Periods relating thereto the principal amount of all such Competitive Bid Loans, plus interest thereon at the applicable Competitive Bid Rates or Competitive Bid Margins, as the case may be. The Competitive Bid Loans shall bear interest at the rate per annum specified in the applicable Competitive Bid Quotes. Interest on the Competitive Bid Loans shall be payable (a) on the last day of the applicable Interest Periods, and if any such Interest Period is longer than three (3) months, also on the last day of the third month following the commencement of such Interest Period, and (b) on the Maturity Date for all Loans. Subject to the terms of this Agreement, the Borrower may make Competitive Bid Quote Requests with respect to new borrowings of any amounts so repaid prior to the Maturity Date. PROVISIONS RELATING TO ALL LOANS AND LETTERS OF CREDIT. Payments. (a) All payments of principal, interest, Reimbursement Obligations, fees (other than the Issuance Fee) and any other amounts due hereunder or under any of the other Loan Documents shall be made to the Administrative Agent, received at its Head Office in immediately available funds by 11:00 a.m. (Boston time) on any due date. If a payment is received by the Administrative Agent from the Borrower at or before 1:00 p.m. (Boston time) on any Business Day, the Administrative Agent shall on the same Business Day transfer in immediately available funds to (1) each of the Banks, their pro-rata portion of such payment in accordance with their respective Commitment Percentages, in the case of payments with respect to Syndicated Loans, and (2) the appropriate Bank(s), in the case of payments with respect to Competitive Bid Loans. If such payment is received by the Administrative Agent after 1:00 p.m. (Boston time) on any Business Day, such transfer shall be made by the Administrative Agent to the Banks on the next Business Day. In the event that the Administrative Agent fails to make such transfer to any Bank as set forth above, the Administrative Agent shall pay to such Bank on demand an amount equal to the product of (i) the average, computed for the period referred to in clause (iii) below, of the weighted average interest rate paid by such Bank for federal funds acquired by such Bank during each day included in such period, times (ii) the amount (A) equal to such Bank's Commitment Percentage of such payment in the case of payments with respect to Syndicated Loans, or (B) of such payment to which such Bank is entitled in the case of payments with respect to Competitive Bid Loans, times (iii) a fraction, the numerator of which is the number of days that elapse from and including the date of payment to and including the date on which the amount due to such Bank shall become immediately available to such Bank, and the denominator of which is 365. (b) All payments by the Borrower hereunder and under any of the other Loan Documents shall be made without setoff or counterclaim (and the Borrower hereby expressly waives any such rights) and free and clear of and without deduction for any taxes, levies, imposts, duties, charges, fees, deductions, withholdings, compulsory loans, restrictions or conditions of any nature now or hereafter imposed or levied by any jurisdiction or any political subdivision thereof or taxing or other authority therein unless the Borrower is compelled by law to make such deduction or withholding. If any such obligation is imposed upon the Borrower with respect to any amount payable by it hereunder or under any of the other Loan Documents, the Borrower will pay to the Administrative Agent for the account of the Banks (or as the case may be, the Administrative Agent) on the date on which such amount is due and payable hereunder or under such other Loan Document, such additional amount in Dollars as shall be necessary to enable the Banks or the Administrative Agent to receive the same net amount which the Banks or the Administrative Agent would have received on such due date had no such obligation been imposed upon the Borrower. The Borrower will deliver promptly to the Administrative Agent certificates or other valid vouchers for all taxes or other charges deducted from or paid with respect to payments made by the Borrower hereunder or under such other Loan Document. (c) Each Bank that is not incorporated or organized under the laws of the United States of America or a state thereof or the District of Columbia (a "Non-U.S. Bank") agrees that, prior to the first date on which any payment is due to it hereunder, it will deliver to the Borrower and the Administrative Agent two duly completed copies of United States Internal Revenue Service Form 1001 or 4224 or successor applicable form, as the case may be, certifying in each case that such Non-U.S. Bank is entitled to receive payments under this Agreement and the Notes payable to it, without deduction or withholding of any United States federal income taxes. Each Non-U.S. Bank that so delivers a Form 1001 or 4224 pursuant to the preceding sentence further undertakes to deliver to each of the Borrower and the Administrative Agent two further copies of Form 1001 or 4224 or successor applicable form, or other manner of certification, as the case may be, on or before the date that any such letter or form expires or becomes obsolete or after the occurrence of any event requiring a change in the most recent form previously delivered by it to the Borrower, and such extensions or renewals thereof as may reasonably be requested by the Borrower, certifying in the case of a Form 1001 or 4224 that such Non-U.S. Bank is entitled to receive payments under this Agreement and the Notes without deduction or withholding of any United States federal income taxes, unless in any such case an event (including, without limitation, any change in treaty, law or regulation) has occurred prior to the date on which any such delivery would otherwise be required which renders all such forms inapplicable or which would prevent such Non-U.S. Bank from duly completing and delivering any such form with respect to it and such Non-U.S. Bank advises the Borrower that it is not capable of receiving payments without any deduction or withholding of United States federal income tax. (d) The Borrower shall not be required to pay any additional amounts to any Non-U.S. Bank in respect of United States Federal withholding tax pursuant to paragraph (b) above to the extent that (i) the obligation to withhold amounts with respect to United States Federal withholding tax existed on the date such Non-U.S. Bank became a party to this Credit Agreement or, with respect to payments to a different lending office designated by the Non-U.S. Bank as its applicable lending office (a "New Lending Office"), the date such Non-U.S. Bank designated such New Lending Office with respect to a Loan; provided, however, that this clause (i) shall not apply to any transferee or New Lending Office as a result of an assignment, transfer or designation made at the request of the Borrower; and provided further, however, that this clause (i) shall not apply to the extent the indemnity payment or additional amounts any transferee, or Bank through a New Lending Office, would be entitled to receive without regard to this clause (i) do not exceed the indemnity payment or additional amounts that the Person making the assignment or transfer to such transferee, or Bank making the designation of such New Lending Office, would have been entitled to receive in the absence of such assignment, transfer or designation; or (ii) the obligation to pay such additional amounts would not have arisen but for a failure by such Non-U.S. Bank to comply with the provisions of paragraph (c) above. (e) Notwithstanding the foregoing, each Bank agrees to use reasonable efforts (consistent with legal and regulatory restrictions) to change its lending office to avoid or to minimize any amounts otherwise payable under paragraph (b) in each case solely if such change can be made in a manner so that such Bank, in its sole determination, suffers no legal, economic or regulatory disadvantage. Mandatory Repayments of the Loans. If at any time the outstanding amount of the Loans plus the Maximum Drawing Amount of all outstanding Letters of Credit exceeds the Total Commitment whether by reduction of the Total Commitment or otherwise, then the Borrower shall immediately pay the amount of such excess to the Administrative Agent (a) for application to the Loans (for application first to Syndicated Loans, then to Competitive Bid Loans, and subject to 5.8), or (b) if no Loans shall be outstanding, to be held by the Administrative Agent for the benefit of the Banks as collateral security for such excess Maximum Drawing Amount; provided, however, that if the amount of cash collateral held by the Administrative Agent pursuant to this 5.2 exceeds the Maximum Drawing Amount required to be collateralized from time to time, the Administrative Agent shall return such excess to the Borrower. Computations. All computations of interest, Letter of Credit Fees or other fees shall be based on a 360-day year and paid for the actual number of days elapsed, except that computations of the Base Rate shall be based on a 365 day year and paid for the actual number of days elapsed. Whenever a payment hereunder or under any of the other Loan Documents becomes due on a day that is not a Business Day, the due date for such payment shall be extended to the next succeeding Business Day, and interest shall accrue during such extension; provided that for any Interest Period for any Eurodollar Loan if such next succeeding Business Day falls in the next succeeding calendar month or after the Maturity Date, it shall be deemed to end on the next preceding Business Day. Illegality; Inability to Determine Eurodollar Rate. (a) Notwithstanding any other provision of this Agreement, if the introduction of, any change in, or any change in the interpretation of, any law or regulation applicable to any Bank shall make it unlawful for any Bank to make or maintain Eurodollar Loans, such Bank shall forthwith give notice of such circumstances to the Borrower and the Administrative Agent and thereupon (i) the commitment of such Bank to make Eurodollar Loans or convert Base Rate Loans to Eurodollar Loans shall forthwith be suspended and (ii) such Bank's outstanding Eurodollar Loans, if any, shall be converted automatically to Base Rate Loans on the last day of each Interest Period applicable to such Eurodollar Loans or such earlier date as may be required by law. The Borrower hereby agrees promptly to pay the Administrative Agent for the account of such Bank, upon demand by such Bank, any additional amounts necessary to compensate such Bank for any costs incurred by such Bank in making any conversion in accordance with this 5.4, including any interest or fees payable by such Bank to lenders of funds obtained by it in order to make or maintain its Eurodollar Loans hereunder. (b) In the event, prior to the commencement of any Interest Period relating to any Eurodollar Loan, the Administrative Agent shall determine or shall be notified by the Majority Banks that adequate and reasonable methods do not exist for ascertaining the Eurodollar Rate that would otherwise be applicable to any Eurodollar Loan during such Interest Period, the Administrative Agent shall forthwith give notice of such determination (which shall be conclusive and binding on the Borrower and the Banks) to the Borrower and the Banks. In such event (i) any request for Eurodollar Loans hereunder or request to convert a Base Rate Loan to a Eurodollar Loan shall be automatically withdrawn and shall be deemed a request for a Base Rate Loan, (ii) each Eurodollar Loan will automatically, on the last day of the then current Interest Period thereof, become a Base Rate Loan, and (iii) the obligations of the Banks to make Eurodollar Loans shall be suspended until the Administrative Agent or the Majority Banks (as applicable) determine that the circumstances giving rise to such suspension no longer exist, whereupon the Administrative Agent, or the Administrative Agent upon the instruction of the Majority Banks, as the case may be, shall so notify the Borrower and the Banks. Additional Costs, Etc. If any change in present applicable law or adoption of any applicable law after the date hereof (including, in either case, without limitation, statutes, rules and regulations thereunder and interpretations thereof by any competent court or by any governmental or other regulatory body or official charged with the administration or the interpretation thereof and requests, directives, instructions and notices at any time or from time to time hereafter made upon or otherwise issued to any Bank by any central bank or other fiscal, monetary or other authority, whether or not having the force of law) shall: (a) subject such Bank to any tax, levy, impost, duty, charge, fee, deduction or withholding of any nature with respect to this Agreement, the other Loan Documents, such Bank's Commitment, or the Loans (other than taxes based upon or measured by the income or profits of such Bank imposed by the jurisdiction of its incorporation or organization, or the location of its lending office, hereinafter referred to as "Income Taxes"); or (b) materially change the basis of taxation (except for changes in Income Taxes) of payments to such Bank of the principal or of the interest on any Loans or any other amounts payable to such Bank under this Agreement or the other Loan Documents; or (c) except as provided in 5.6 or as otherwise reflected in the Base Rate, the Eurodollar Rate, or the Competitive Bid Rate, impose or increase or render applicable (other than to the extent specifically provided for elsewhere in this Agreement) any special deposit, reserve, assessment, liquidity, capital adequacy or other similar requirements (whether or not having the force of law) against assets held by, or deposits in or for the account of, or loans by, or commitments of, an office of any Bank with respect to this Agreement, the other Loan Documents, the Commitment, or the Loans; or (d) impose on such Bank any other conditions or requirements with respect to this Agreement, the other Loan Documents, the Loans, such Bank's Commitment, or any class of loans or commitments of which any of the Loans or such Bank's Commitment forms a part, and the result of any of the foregoing is (i) to increase the cost to such Bank of making, funding, issuing, renewing, extending or maintaining the Loans or such Bank's Commitment, or issuing or participating in Letters of Credit; (ii) to reduce the amount of principal, interest or other amount payable to such Bank hereunder on account of such Bank's Commitment or the Loans; (iii) to require such Bank to make any payment or to forego any interest or other sum payable hereunder, the amount of which payment or foregone interest or other sum is calculated by reference to the gross amount of any sum receivable or deemed received by such Bank from the Borrower hereunder, then, and in each such case, the Borrower will, upon demand made by such Bank at any time and from time to time as often as the occasion therefore may arise (which demand shall be accompanied by a statement setting forth the basis of such demand which shall be conclusive absent manifest error), pay such reasonable additional amounts as will be sufficient to compensate such Bank for such additional costs, reduction, payment or foregone interest or other sum. Capital Adequacy. If any Bank shall have determined that, after the date hereof, the adoption of any applicable law, rule or regulation regarding capital adequacy, or any change in any such law, rule, or regulation, or any change in the interpretation or administration thereof by any governmental authority, central bank or comparable agency charged with the interpretation or administration thereof, or any request or directive regarding capital adequacy (whether or not having the force of law) of any such authority, central bank or comparable agency, has or would have the effect of reducing the rate of return on capital of such Bank (or any corporation controlling such Bank) as a consequence of such Bank's obligations hereunder to a level below that which such Bank (or any corporation controlling such Bank) could have achieved but for such adoption, change, request or directive (taking into consideration its policies with respect to capital adequacy) by an amount deemed by such Bank to be material, then from time to time, within 15 days after demand by such Bank, the Borrower shall pay to such Bank such additional amount or amounts as will, in such Bank's reasonable determination, fairly compensate such Bank (or any corporation controlling such Bank) for such reduction. Each Bank shall allocate such cost increases among its customers in good faith and on an equitable basis. Certificate. A certificate setting forth the additional amounts payable pursuant to 5.4, 5.5 or 5.6 and a reasonable explanation of such amounts which are due, submitted by any Bank to the Borrower, shall be conclusive, absent manifest error, that such amounts are due and owing. Eurodollar and Competitive Bid Indemnity. The Borrower agrees to indemnify each Bank and the Administrative Agent and to hold them harmless from and against any reasonable loss, cost or expense that any Bank and the Administrative Agent may sustain or incur as a consequence of (a) the default by the Borrower in payment of the principal amount of or any interest on any Eurodollar Loans or Competitive Bid Loans as and when due and payable, including any such loss or expense arising from interest or fees payable by any Bank or the Administrative Agent to lenders of funds obtained by it in order to maintain its Eurodollar Loans or Competitive Bid Loans, (b) the default by the Borrower in making a borrowing of a Eurodollar Loan or Competitive Bid Loan or conversion of a Eurodollar Loan or a prepayment of a Eurodollar or Competitive Bid Loan other than on an Interest Payment Date after the Borrower has given (or is deemed to have given) a Syndicated Loan Request, a notice pursuant to 2.7, a Notice of Acceptance of Competitive Bid Quote(s), or a notice pursuant to 2.10, as the case may be, and (c) the making of any payment of a Eurodollar Loan or Competitive Bid Loan, or the making of any conversion of any Eurodollar Loan to a Base Rate Loan on a day that is not the last day of the applicable Interest Period with respect thereto. Such loss or reasonable expense shall include an amount equal to the excess, if any, as reasonably determined by each Bank of (i) its cost of obtaining the funds for (A) the Eurodollar Loan being paid, prepaid, converted, not converted, or not borrowed, as the case may be (based on the Eurodollar Rate), or (B) the Competitive Bid Loan being paid, prepaid, or not borrowed, as the case may be (based on the Competitive Bid Rate) for the period from the date of such payment, prepayment, conversion, or failure to borrow or convert, as the case may be, to the last day of the Interest Period for such Loan (or, in the case of a failure to borrow, the Interest Period for the Loan which would have commenced on the date of such failure to borrow) over (ii) the amount of interest (as reasonably determined by such Bank) that would be realized by such Bank in reemploying the funds so paid, prepaid, converted, or not borrowed, converted, or prepaid for such period or Interest Period, as the case may be, which determinations shall be conclusive absent manifest error. Interest on Overdue Amounts. Overdue principal and (to the extent permitted by applicable law) interest on the Loans and all other overdue amounts payable hereunder or under any of the other Loan Documents shall bear interest compounded monthly and payable on demand at a rate per annum equal to the Base Rate plus 2% until such amount shall be paid in full (after as well as before judgment). Interest Limitation. Notwithstanding any other term of this Agreement or the Notes, any other Loan Document or any other document referred to herein or therein, the maximum amount of interest which may be charged to or collected from any person liable hereunder or under the Notes by any Bank shall be absolutely limited to, and shall in no event exceed, the maximum amount of interest which could lawfully be charged or collected by such Bank under applicable laws (including, to the extent applicable, the provisions of 5197 of the Revised Statutes of the United States of America, as amended, 12 U.S.C. 85, as amended). Reasonable Efforts to Mitigate. Each Bank agrees that as promptly as practicable after it becomes aware of the occurrence of an event or the existence of a condition that would cause it to be affected under 5.4, 5.5 or 5.6, such Bank will give notice thereof to the Borrower, with a copy to the Administrative Agent, and, to the extent so requested by the Borrower and not inconsistent with such Bank's internal policies, such Bank shall use reasonable efforts and take such actions as are reasonably appropriate if as a result thereof the additional moneys which would otherwise be required to be paid to such Bank pursuant to such subsections would be materially reduced, or the illegality or other adverse circumstances which would otherwise require a conversion of such Loans or result in the inability to make such Loans pursuant to such sections would cease to exist, and in each case if, as determined by such Bank in its sole discretion, the taking such actions would not adversely affect such Loans or such Bank or otherwise be disadvantageous to such Bank. Replacement of Banks. If any Bank (an "Affected Bank") (i) makes demand upon the Borrower for (or if Borrower is otherwise required to pay) amounts pursuant to 5.5 or 5.6, (ii) is unable to make or maintain Eurodollar Loans as a result of a condition described in 5.4 or (iii) defaults in its obligation to make Loans in accordance with the terms of this Agreement (such Bank being referred to as a "Defaulting Bank"), the Borrower may, within 90 days of receipt of such demand, notice (or the occurrence of such other event causing the Borrower to be required to pay such compensation or causing 5.4 to be applicable), or default, as the case may be, by notice (a "Replacement Notice") in writing to the Administrative Agent and such Affected Bank (A) request the Affected Bank to cooperate with the Borrower in obtaining a replacement bank satisfactory to the Administrative Agent and the Borrower (the "Replacement Bank"); (B) request the non-Affected Banks to acquire and assume all of the Affected Bank's Loans and Commitment, as provided herein, but none of such Banks shall be under an obligation to do so; or (C) designate a Replacement Bank reasonably satisfactory to the Administrative Agent. If any satisfactory Replacement Bank shall be obtained, and/or any of the non-Affected Banks shall agree to acquire and assume all of the Affected Bank's Loans and Commitment, then such Affected Bank shall, so long as no Event of Default shall have occurred and be continuing, assign, in accordance with 18, all of its Commitment, Loans, Notes and other rights and obligations under this Agreement and all other Loan Documents to such Replacement Bank or non-Affected Banks, as the case may be, in exchange for payment of the principal amount so assigned and all interest and fees accrued on the amount so assigned, plus all other Obligations then due and payable to the Affected Bank; provided, however, that (i) such assignment shall be without recourse, representation or warranty and shall be on terms and conditions reasonably satisfactory to such Affected Bank and such Replacement Bank and/or non- Affected Banks, as the case may be, and (ii) prior to any such assignment, the Borrower shall have paid to such Affected Bank all amounts properly demanded and unreimbursed under 5.4, 5.5, 5.6 and 5.8. Upon the effective date of such assignment, the Borrower shall issue replacement Notes to such Replacement Bank and/or non-Affected Banks, as the case may be, and such institution shall become a "Bank" for all purposes under this Agreement and the other Loan Documents. Advances by Administrative Agent. The Administrative Agent may (unless earlier notified to the contrary by any Bank by 12:00 noon (Boston time) one (1) Business Day prior to any Drawdown Date) assume that each Bank has made available (or will before the end of such Business Day make available) to the Administrative Agent the amount of such Bank's Commitment Percentage with respect to the Syndicated Loan (or, in the case of Competitive Bid Loans, the amount of such Bank's accepted offers of Competitive Bid Loans, if any) to be made on such Drawdown Date, and the Administrative Agent may (but shall not be required to), in reliance upon such assumption, make available to the Borrower a corresponding amount. If any Bank makes such amount available to the Administrative Agent on a date after such Drawdown Date, such Bank shall pay the Administrative Agent on demand an amount equal to the product of (i) the average, computed for the period referred to in clause (iii) below, of the weighted average annual interest rate paid by the Administrative Agent for federal funds acquired by the Administrative Agent during each day included in such period times (ii) the amount equal to such Bank's Commitment Percentage of such Syndicated Loan (or, in the case of a Competitive Bid Loan, the amount of such Bank's accepted offer of such Competitive Bid Loan, if any), times (iii) a fraction, the numerator of which is the number of days that elapse from and including such Drawdown Date to but not including the date on which the amount equal to such Bank's Commitment Percentage of such Syndicated Loan, or the amount of such Bank's accepted offers of such Competitive Bid Loan, shall become immediately available to the Administrative Agent, and the denominator of which is 365. A statement of the Administrative Agent submitted to such Bank with respect to any amounts owing under this paragraph shall be prima facie evidence of the amount due and owing to the Administrative Agent by such Bank. If such amount is not in fact made available to the Administrative Agent by such Bank within three (3) Business Days of such Drawdown Date, the Administrative Agent shall be entitled to debit the Borrower's accounts to recover such amount from the Borrower, with interest thereon at the applicable rate per annum. REPRESENTATIONS AND WARRANTIES. The Borrower represents and warrants to the Banks that: Corporate Authority. (a) Incorporation; Good Standing. The Borrower and each of its Subsidiaries (i) is a corporation duly organized, validly existing and in good standing under the laws of its respective jurisdiction of incorporation, (ii) has all requisite corporate power to own its property and conduct its business as now conducted and as presently contemplated, and (iii) is in good standing as a foreign corporation and is duly authorized to do business in each jurisdiction in which its property or business as presently conducted or contemplated makes such qualification necessary, except where a failure to be so qualified would not have a material adverse effect on the business, assets or financial condition of the Borrower and its Subsidiaries as a whole. (b) Authorization. The execution, delivery and performance of the Loan Documents and the transactions contemplated hereby and thereby (i) are within the corporate authority of the Borrower, (ii) have been duly authorized by all necessary corporate proceedings on the part of the Borrower, (iii) do not conflict with or result in any breach or contravention of any provision of law, statute, rule or regulation to which the Borrower or any Subsidiary is subject or any judgment, order, writ, injunction, license or permit applicable to the Borrower or any Subsidiary so as to materially adversely affect the assets, business or any activity of the Borrower and its Subsidiaries as a whole, and (iv) do not conflict with any provision of the corporate charter or bylaws of the Borrower or any Subsidiary or any agreement or other instrument binding upon the Borrower or any of its Subsidiaries. (c) Enforceability. The execution, delivery and performance of the Loan Documents by the Borrower will result in valid and legally binding obligations of the Borrower enforceable against it in accordance with the respective terms and provisions hereof and thereof, except as enforceability is limited by bankruptcy, insolvency, reorganization, moratorium or other laws relating to or affecting generally the enforcement of creditors rights and except to the extent that availability of the remedy of specific performance or injunctive relief is subject to the discretion of the court before which any proceeding therefor may be brought. Governmental Approvals. The execution, delivery and performance of the Loan Documents by the Borrower and the consummation by the Borrower of the transactions contemplated hereby and thereby do not require any approval or consent of, or filing with, any governmental agency or authority other than those already obtained and those required after the date hereof in connection with the Borrower's and its Subsidiaries' performance of their covenants contained in 7, 8 and 9 hereof. Title to Properties; Leases. The Borrower and its Subsidiaries own all of the assets reflected in the consolidated balance sheet as at the Balance Sheet Date or acquired since that date (except property and assets operated under capital leases or sold or otherwise disposed of in the ordinary course of business since that date), subject to no mortgages, capitalized leases, conditional sales agreements, title retention agreements, liens or other encumbrances except Permitted Liens. Financial Statements; Solvency. (a) There has been furnished to the Banks (i) audited consolidated financial statements of the Borrower and its Subsidiaries dated the Balance Sheet Date, (ii) estimated pro forma financial statements of the Borrower and its Subsidiaries, and Amicon, dated January 11, 1997 and (iii) forecasted consolidated financial statements taking into account the Tylan Merger dated January 11, 1997. All said balance sheets and statements of operations have been prepared in accordance with GAAP (but, in the case of any of such financial statements which are unaudited, only to the extent GAAP is applicable to interim unaudited reports), fairly present the financial condition of the Borrower and its Subsidiaries or, to the best knowledge of the Borrower after due inquiry, Tylan and its Subsidiaries, as the case may be, on a consolidated basis, as at the close of business on the dates thereof and the results of operations for the periods then ended, subject, in the case of unaudited interim financial statements, to changes resulting from audit and normal year-end adjustments and to the absence of complete footnotes. There are no contingent liabilities of the Borrower and its Subsidiaries, or of Tylan and its Subsidiaries involving material amounts, known to the officers of the Borrower, which have not been disclosed in said balance sheets and the related notes thereto or otherwise in writing to the Banks. (b) The Borrower and its Subsidiaries on a consolidated basis (both before and after giving effect to the transactions contemplated by this Agreement including the Tylan Tender Offer and the Tylan Merger) are and will be solvent (i.e., they have assets having a fair value in excess of the amount required to pay their probable liabilities on their existing debts as they become absolute and matured) and have, and expect to have, the ability to pay their debts from time to time incurred in connection therewith as such debts mature. No Material Changes, Etc. Since the Balance Sheet Date, in the case of the Borrower and its Subsidiaries, and since December 31, 1995, in the case of Amicon, and, to the best knowledge of the Borrower after due inquiry, since October 31, 1996, in the case of Tylan and its Subsidiaries, there have occurred no material adverse changes in the consolidated financial condition, business or assets of the Borrower and its Subsidiaries, or Tylan and its Subsidiaries, taken together, as shown on or reflected in the consolidated balance sheets of the Borrower and its Subsidiaries, or Tylan and its Subsidiaries, as at the respective Balance Sheet Date or October 31, 1996, as applicable, or the consolidated statements of income for the period then ended other than changes in the ordinary course of business which have not had any material adverse effect either individually or in the aggregate on the financial condition, business or assets of the Borrower and its Subsidiaries, or Tylan and its Subsidiaries, taken together. Since the Balance Sheet Date, in the case of the Borrower and its Subsidiaries and, to the best knowledge of the Borrower after due inquiry, since October 31, 1996 in the case of Tylan and its Subsidiaries, there have not been any Distributions (including Distributions made by Tylan) other than as permitted by 8.4 hereof. The parties agree that any charges identified in sections (e), (f), and (g) in the definition of EBITDA related to the Amicon Acquisition and the Tylan Merger shall not be deemed to be material adverse changes. Franchises, Patents, Copyrights, Etc. The Borrower and each of its Subsidiaries possesses all franchises, patents, copyrights, trademarks, trade names, licenses and permits, and rights in respect of the foregoing, adequate for the conduct of its business substantially as now conducted (other than those the absence of which would not have a material adverse effect on the business, operations or financial condition of the Borrower and its Subsidiaries as a whole) without known conflict with any rights of others other than a conflict which would not have a material adverse effect on the financial condition, business or assets of the Borrower and its Subsidiaries as a whole. Litigation. (a) Except as set forth on Schedule 6.7, there are no actions, suits, proceedings or investigations of any kind pending or, to the knowledge of the Borrower or any of its Subsidiaries, threatened against the Borrower or any of its Subsidiaries before any court, tribunal or administrative agency or board which, either in any case or in the aggregate, could reasonably be expected to have a material adverse effect on the financial condition, business, or assets of the Borrower and its Subsidiaries, considered as a whole, or materially impair the right of the Borrower and its Subsidiaries, considered as a whole, to carry on business substantially as now conducted, or result in any substantial liability not adequately covered by insurance, or for which adequate reserves are not maintained on the consolidated balance sheet or which question the validity of any of the Loan Documents to which the Borrower or any of its Subsidiaries is a party, or any action taken or to be taken pursuant hereto or thereto. (b) Except as set forth in Schedule 6.7 hereto, there are no actions, suits, proceedings or investigations of any kind pending or, to the knowledge of the Borrower or any of its Subsidiaries, threatened, before any court, tribunal or administrative agency or board which contest the validity of the Tylan Tender Offer or the Tylan Merger. Compliance With Other Instruments, Laws, Etc. Neither the Borrower nor any of its Subsidiaries is (a) violating any provision of its charter documents or by-laws or (b) any agreement or instrument by which any of them may be subject or by which any of them or any of their properties may be bound or any decree, order, judgment, or any statute, license, rule or regulation, in a manner which could (in the case of such agreements or such instruments) reasonably be expected to result in the imposition of substantial penalties or materially and adversely affect the financial condition, business or assets of any of the Borrower and its Subsidiaries, considered as a whole. Tax Status. The Borrower and its Subsidiaries have filed all federal and state income and all other tax returns, reports and declarations (or obtained extensions with respect thereto) required by applicable law to be filed by them (unless and only to the extent that the Borrower or such Subsidiary has set aside on its books provisions reasonably adequate for the payment of all unpaid and unreported taxes as required by GAAP); and have paid all taxes and other governmental assessments and charges (other than taxes, assessments and other governmental charges imposed by foreign jurisdictions which in the aggregate are not material to the financial condition, business or assets of the Borrower or such Subsidiary on an individual basis or of the Borrower and Subsidiary on a consolidated basis) that are material in amount, shown or determined to be due on such returns, reports and declarations, except those being contested in good faith; and, as required by GAAP, have set aside on their books provisions reasonably adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply. Except to the extent contested in the manner permitted in the preceding sentence, there are no unpaid taxes in any material amount claimed by the taxing authority of any jurisdiction to be due and owing by the Borrower or any Subsidiary, nor do the officers of the Borrower or any of its Subsidiaries know of any basis for any such claim. No Event of Default. No Default or Event of Default has occurred and is continuing. Holding Company and Investment Company Acts. Neither the Borrower nor any of its Subsidiaries is a "holding company", or a "subsidiary company" of a "holding company", or an "affiliate" of a "holding company", as such terms are defined in the Public Utility Holding Company Act of 1935; nor is any of them a "registered investment company", or an "affiliated company" or a "principal underwriter" of a "registered investment company", as such terms are defined in the Investment Company Act of 1940, as amended. Absence of Financing Statements, Etc. Except as permitted by 8.1 of this Agreement, there is no effective financing statement, security agreement, chattel mortgage, real estate mortgage or other documents filed or recorded with any filing records, registry, or other public office, which purports to cover, affect or give notice of any present or possible future lien on, or security interests in, any assets or property of the Borrower or any of its Subsidiaries or right thereunder. Employee Benefit Plans. (a) In General. Each Employee Benefit Plan has been maintained and operated in compliance in all material respects with the provisions of ERISA and, to the extent applicable, the Code, including but not limited to the provisions thereunder respecting prohibited transactions. (b) Terminability of Welfare Plans. Under each Employee Benefit Plan which is an employee welfare benefit plan within the meaning of 3(1) or 3(2)(B) of ERISA, no benefits are due unless the event giving rise to the benefit entitlement occurs prior to plan termination (except as required by Title I, part 6 of ERISA.) The Borrower, each of its Subsidiaries, or ERISA Affiliate, as appropriate, may terminate each such plan at any time (or at any time subsequent to the expiration of any applicable bargaining agreement) in the discretion of such Borrower, Subsidiary, or ERISA Affiliate without material liability to any Person. (c) Guaranteed Pension Plans. Except as disclosed in Schedule 6.13(c), neither the Borrower nor any of its Subsidiaries is a sponsor of, or contributor to, a Guaranteed Pension Plan. (d) Multiemployer Plans. None of the Borrower, any of its Subsidiaries, nor any ERISA Affiliate has incurred any material liability (including secondary liability) to any Multiemployer Plan as a result of a complete or partial withdrawal from such Multiemployer Plan under 4201 of ERISA or as a result of a sale of assets described in 4204 of ERISA. None of the Borrower, any of its Subsidiaries, or any ERISA Affiliate has been notified that any Multiemployer Plan is in reorganization or is insolvent under and within the meaning of 4241 or 4245 of ERISA or that any Multiemployer Plan intends to terminate or has been terminated under 4041A of ERISA. Environmental Compliance. Except as set forth on Schedule 6.14: (a) None of the Borrower, its Subsidiaries, or any operator of their properties, is in violation, or alleged violation, of any judgment, decree, order, law, permit, license, rule or regulation pertaining to environmental matters, including without limitation, those arising under the Resource Conservation and Recovery Act ("RCRA"), the Comprehensive Environmental Response, Compensation and Liability Act of 1980 as amended ("CERCLA"), the Superfund Amendments and Reauthorization Act of 1986 ("SARA"), the Federal Clean Water Act, the Federal Clean Air Act, the Toxic Substances Control Act, or any state or local statute, regulation, ordinance, order or decree relating to health, safety, waste transportation or disposal, or the environment (the "Environmental Laws"), which violation would have a material adverse effect on the business, assets or financial condition of the Borrower and its Subsidiaries on a consolidated basis. (b) Except as described on Schedule 6.14, neither the Borrower nor any of its Subsidiaries has received notice from any third party including, without limitation: any federal, state or local governmental authority, (i) that any one of them has been identified by the United States Environmental Protection Agency ("EPA") as a potentially responsible party under CERCLA with respect to a site listed on the National Priorities List, 40 C.F.R. Part 300 Appendix B; (ii) that any hazardous waste, as defined by 42 U.S.C. 6903(5), any hazardous substances as defined by 42 U.S.C. 9601(14), any pollutant or contaminant as defined by 42 U.S.C. 9601(33) and any toxic substance, oil or hazardous materials or other chemicals or substances regulated by any Environmental Laws, excluding household hazardous waste ("Hazardous Substances") which any one of them has generated, transported or disposed of, has been found at any site at which a federal, state or local agency or other third party has conducted or has ordered that the Borrower or any of its Subsidiaries conduct a remedial investigation, removal or other response action pursuant to any Environmental Law; or (iii) that it is or shall be a named party to any claim, action, cause of action, complaint, legal or administrative proceeding arising out of any third party's incurrence of costs, expenses, losses or damages of any kind whatsoever in connection with the release of Hazardous Substances. (c) (i) No portion of the Real Property or other assets of the Borrower or its Subsidiaries has been used for the handling, processing, storage or disposal of Hazardous Substances except in accordance with applicable Environmental Laws, except as would not reasonably be expected to have a material adverse effect on the business, assets or financial conditions of the Borrower and the Subsidiaries on a consolidated basis; and no underground tank or other underground storage receptacle for Hazardous Substances is located on such properties; (ii) in the course of any activities conducted by the Borrower, its Subsidiaries, or operators of the Real Property or other assets of the Borrower and its Subsidiaries, no Hazardous Substances have been generated or are being used on such properties except in accordance with applicable Environmental Laws, except for occurrences that would not have a material adverse effect on the business, assets or financial condition of the Borrower and Subsidiaries on a consolidated basis; (iii) there have been no unpermitted Releases or threatened Releases of Hazardous Substances on, upon, into or from the Real Property or other assets of the Borrower or its Subsidiaries, which Releases would have a material adverse effect on the value of such properties; (iv) to the best of the Borrower's and its Subsidiaries' knowledge, there have been no Releases on, upon, from or into any real property in the vicinity of the Real Property or other assets of the Borrower or its Subsidiaries which, through soil or groundwater contamination, may have come to be located on, and which would reasonably be expected to have a material adverse effect on the value of, such properties; and (v) in addition, any Hazardous Substances that have been generated on the Real Property or other assets of the Borrower or its Subsidiaries have been transported offsite only by carriers having an identification number issued by the EPA, treated or disposed of only by treatment or disposal facilities maintaining valid permits as required under applicable Environmental Laws, which transporters and facilities have been and are, to the best of the Borrower's and its Subsidiaries' knowledge, operating in compliance with such permits and applicable Environmental Laws. (d) None of the Real Property or other assets of the Borrower or its Subsidiaries or any of the stock (or assets) being acquired with proceeds of Loans is or shall be subject to any applicable environmental clean- up responsibility law or environmental restrictive transfer law or regulation, by virtue of the transactions set forth herein and contemplated hereby. True Copies of Charter and Other Documents. The Borrower has furnished the Administrative Agent copies, in each case true and complete as of the Closing Date, of (a) all charter and other incorporation documents (together with any amendments thereto) and (b) by-laws (together with any amendments thereto). Disclosure. No representation or warranty made by the Borrower in this Agreement or in any agreement, instrument, document, certificate, statement or letter furnished to the Banks or the Administrative Agent by or on behalf of or at the request of the Borrower in connection with any of the transactions contemplated by the Loan Documents contains any untrue statement of a material fact or omits to state a material fact necessary in order to make the statements contained therein not misleading in light of the circumstances in which they are made. Permits and Governmental Authority. All permits (other than those the absence of which would not have a material adverse effect on the business, operations or financial condition of the Borrower and its Subsidiaries as a whole) required for current operations of the Borrower or any of its Subsidiaries have been obtained and remain in full force and effect and are not subject to any appeals or further proceedings or to any unsatisfied conditions that may allow material modification or revocation. Neither the Borrower nor any of its Subsidiaries is in violation of any such permits, except for any violation which would not have a material adverse effect on the business, operations or financial condition of the Borrower and its Subsidiaries as a whole. Purchase of Tylan Shares. As of the Closing Date, MCTG shall have received tenders of at least 50% of the Tylan Shares in accordance with the terms of the Tylan Tender Offer, which Tylan Shares are to be purchased with the proceeds of the initial Loan advanced hereunder. AFFIRMATIVE COVENANTS OF THE BORROWER. The Borrower agrees that, so long as any Obligation or any Letter of Credit is outstanding or the Banks have any obligation to make Loans or the Administrative Agent has any obligation to issue, extend or renew any Letters of Credit hereunder or the Banks have any obligations to reimburse the Administrative Agent for advances made under any Letter of Credit, it shall, and shall cause its Subsidiaries to comply with the following covenants: Punctual Payment. The Borrower will duly and punctually pay or cause to be paid the principal and interest on the Loans, all Reimbursement Obligations, fees and other amounts provided for in this Agreement and the other Loan Documents, all in accordance with the terms of this Agreement and such other Loan Documents. Maintenance of Office. The Borrower will maintain its chief executive office at Bedford, Massachusetts, or at such other place in the United States of America as the Borrower shall designate upon 30 days' prior written notice to the Administrative Agent. Records and Accounts. The Borrower will, and will cause each of its Subsidiaries to, keep true and accurate records and books of account in which full, true and correct entries will be made in accordance with GAAP and with the requirements of all regulatory authorities and maintain adequate accounts and reserves for all taxes (including income taxes), depreciation, depletion, obsolescence and amortization of its properties, all other contingencies, and all other proper reserves. Financial Statements, Certificates and Information. The Borrower will deliver to the Banks: (a) as soon as practicable, but, in any event not later than 90 days after the end of each fiscal year of the Borrower, the consolidated balance sheet of the Borrower and its Subsidiaries as at the end of such year, consolidated statements of cash flows, and the related consolidated statements of operations, each setting forth in comparative form the figures for the previous fiscal year, all such consolidated financial statements to be in reasonable detail, prepared, in accordance with GAAP and, with respect to the consolidated financial statements, certified by Coopers & Lybrand LLP or by other independent auditors selected by the Borrower and reasonably satisfactory to the Banks (the "Accountants"); (b) as soon as practicable, but in any event not later than 45 days after the end of each of the first three (3) fiscal quarters of each fiscal year of the Borrower, copies of the consolidated balance sheet and statement of operations of the Borrower and its Subsidiaries as at the end of such quarter, subject to year end adjustments, and the related consolidated statement of cash flows, all in reasonable detail and prepared in accordance with GAAP (to the extent GAAP is applicable to interim unaudited financial statements) with a certification by the principal financial or accounting officer of the Borrower (the "CFO or the CAO") that the consolidated financial statements are prepared in accordance with GAAP (to the extent GAAP is applicable to interim unaudited financial statements) and fairly present the consolidated financial condition of the Borrower and its Subsidiaries on a consolidated basis as at the close of business on the date thereof and the results of operations for the period then ended, it being understood that no such statement need be accompanied by complete footnotes; (c) simultaneously with the delivery of the financial statements referred to in (a) and (b) above, a certificate in the form of Exhibit D hereto (the "Compliance Certificate") signed by the CFO or the CAO or corporate treasurer, stating that the Borrower and its Subsidiaries are in compliance with the covenants contained in 7, 8 and 9 hereof as of the end of the applicable period setting forth in reasonable detail computations evidencing such compliance with respect to the covenants contained in 9 hereof and that no Default or Event of Default exists, provided that if the Borrower shall at the time of issuance of such Compliance Certificate or at any other time obtain knowledge of any Default or Event of Default, the Borrower shall include in such certificate or otherwise deliver forthwith to the Banks a certificate specifying the nature and period of existence thereof and what action the Borrower proposes to take with respect thereto; (d) contemporaneously with, or promptly following, the filing or mailing thereof, copies of all material of a financial nature filed with the Securities and Exchange Commission or sent to the Borrower's stockholders generally; (e) from time to time such other financial data and other information as the Banks may reasonably request; and (f) on or prior to the effective date, notice of any change in the Senior Public Debt Rating and the time at which such rating shall become effective. The Borrower hereby authorizes each Agent and Bank to disclose any information obtained pursuant to this Agreement to all appropriate governmental regulatory authorities where required by law; provided, however that such Agent or such Bank shall, to the extent allowable under law, notify the Borrower at the time any such disclosure is made (except in the case of disclosures made in the course of bank regulatory reviews); and provided further that this authorization shall not be deemed to be a waiver of any rights to object to the disclosure by the Banks of any such information which any Borrower has or may have under the federal Right to Financial Privacy Act of 1978, as in effect from time to time, except as to matters specifically permitted therein. Corporate Existence and Conduct of Business. The Borrower will, and will cause each Subsidiary to do or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence, corporate rights and franchises; and effect and maintain its foreign qualifications (except where the failure of the Borrower or any Subsidiary to remain so qualified would not materially adversely impair the financial condition, business or assets of the Borrower and its Subsidiaries on a consolidated basis), licensing, domestication or authorization except as terminated by its Board of Directors in the exercise of its reasonable judgment; provided that such termination would not have a material adverse effect on the financial condition, business or assets of the Borrower and its Subsidiaries on a consolidated basis. The Borrower will, and will cause each Subsidiary to, continue to engage primarily in the businesses now conducted by it and in related businesses. Maintenance of Properties. The Borrower will and will cause its Subsidiaries to, cause all material properties used or useful in the conduct of their businesses to be maintained and kept in good condition, repair and working order (ordinary wear and tear excepted) and supplied with all necessary equipment and will cause to be made all necessary repairs, renewals, replacements, betterments and improvements thereof, all as in the judgment of the Borrower and its Subsidiaries may be necessary so that the businesses carried on in connection therewith may be properly and advantageously conducted at all times; provided, however, that nothing in this section shall prevent the Borrower or any of its Subsidiaries from discontinuing the operation and maintenance of any of its properties if such discontinuance is, in the judgment of such Borrower or Subsidiary, desirable in the conduct of its or their business and which does not in the aggregate materially adversely affect the financial condition, business or assets of the Borrower and its Subsidiaries on a consolidated basis. Insurance. The Borrower will, and will cause its Subsidiaries to, maintain with financially sound and reputable insurance companies funds or underwriters' insurance of the kinds, covering the risks (other than risks arising out of or in any way connected with personal liability of any officers and directors thereof) and in the relative proportionate amounts usually carried by reasonable and prudent companies conducting businesses similar to that of the Borrower and its Subsidiaries, in amounts substantially similar to the existing coverage policies maintained by the Borrower and its Subsidiaries, copies of which have been provided to the Administrative Agent. In addition, the Borrower will furnish from time to time, upon the Banks' request, a summary of the insurance coverage of the Borrower and its Subsidiaries, which summary shall be in form and substance satisfactory to the Banks and, if requested by any of the Banks, will furnish to the Administrative Agent and such Bank copies of the applicable policies. Taxes. The Borrower will, and will cause its Subsidiaries to, duly pay and discharge, or cause to be paid and discharged, before the same shall become overdue, all taxes, assessments and other governmental charges (other than taxes, assessments and other governmental charges imposed by foreign jurisdictions which in the aggregate are not material to the business, financial conditions, or assets of the Borrower and its Subsidiaries on a consolidated basis) imposed upon it and its real properties, sales and activities, or any part thereof, or upon the income or profits therefrom, as well as all claims for labor, materials, or supplies, which if unpaid might by law become a lien or charge upon any of its property; provided, however, that any such tax, assessment, charge, levy or claim need not be paid if the validity or amount thereof shall currently be contested in good faith by appropriate proceedings and if such Borrower or Subsidiary shall have set aside on its books adequate reserves with respect thereto as required by GAAP; and provided, further, that such Borrower or Subsidiary will pay all such taxes, assessments, charges, levies or claims forthwith upon the commencement of proceedings to foreclose any lien which may have attached as security therefor. Inspection of Properties, Books and Contracts. The Borrower will, and will cause its Subsidiaries to, permit the Agents or any Bank or any of their designated representatives, upon reasonable notice, to visit and inspect any of the properties of the Borrower and its Subsidiaries, to examine the books of account of the Borrower and its Subsidiaries, or contracts (and to make copies thereof and extracts therefrom), and to discuss the affairs, finances and accounts of the Borrower and its Subsidiaries with, and to be advised as to the same by, their officers, all at such times and intervals as may be reasonably requested. Compliance with Laws, Contracts, Licenses and Permits; Maintenance of Material Licenses and Permits. The Borrower will, and will cause each Subsidiary to, (i) comply with the provisions of its charter documents and by-laws; (ii) comply in all material respects with all agreements and instruments by which it or any of its properties may be bound; and (iii) comply with all applicable laws and regulations, decrees, orders, judgments, licenses and permits ("Applicable Requirements"), except where noncompliance with such Applicable Requirements would not reasonably be expected to have a material adverse effect in the aggregate on the consolidated financial condition, properties or businesses of the Borrower and its Subsidiaries. If at any time any authorization, consent, approval, permit or license from any officer, agency or instrumentality of any government shall become necessary or required in order that the Borrower or any Subsidiary may fulfill any of its obligations hereunder, the Borrower will immediately take or cause to be taken all reasonable steps within the power of such Borrower or Subsidiary to obtain such authorization, consent, approval, permit or license and furnish the Banks with evidence thereof. Environmental Indemnification. The Borrower covenants and agrees that it will indemnify and hold the Banks and the Agents and their respective affiliates, and each of the representatives, agents and officers of each of the foregoing, harmless from and against any and all claims, expense, damage, loss or liability incurred by the Banks or the Agents (including all costs of legal representation incurred by the Banks or the Agents) relating to (a) any Release or threatened Release of Hazardous Substances on the Real Property; (b) any violation of any Environmental Laws or Applicable Requirements with respect to conditions at the Real Property or other assets of the Borrower or its Subsidiaries, or the operations conducted thereon; or (c) the investigation or remediation of offsite locations at which the Borrower, any of its Subsidiaries, or their predecessors are alleged to have directly or indirectly Disposed of Hazardous Substances. It is expressly acknowledged by the Borrower that this covenant of indemnification shall survive the payment of the Loans and Reimbursement Obligations and shall inure to the benefit of the Banks, the Agents and their affiliates, successors and assigns. Further Assurances. The Borrower will cooperate with the Administrative Agent and execute such further instruments and documents as the Administrative Agent shall reasonably request to carry out to the Banks' satisfaction the transactions contemplated by this Agreement. Notice of Potential Claims or Litigation. The Borrower shall deliver to the Banks, within 30 days of receipt thereof, written notice of the initiation of any action, claim, complaint, or any other notice of dispute or potential litigation wherein the potential liability would be material under the regulations of the United States Securities and Exchange Commission, together with a copy of each such notice received by the Borrower or any of its Subsidiaries. Notice of Certain Events Concerning Insurance. The Borrower will provide the Banks with written notice as to any material cancellation or material adverse change in any insurance of the Borrower or any of its Subsidiaries within ten (10) Business Days after the Borrower's and any of its Subsidiary's receipt of any notice (whether formal or informal) of such material cancellation or material change by any of its insurers. Notice of Default. The Borrower will promptly notify the Banks in writing of the occurrence of any Default or Event of Default. If any Person shall give any notice or take any other action in respect of a claimed default (whether or not constituting an Event of Default) under this Agreement or any other note, evidence of indebtedness, indenture or other obligation evidencing indebtedness in excess of $5,000,000 as to which the Borrower or any of its Subsidiaries is a party or obligor, whether as principal or surety, the Borrower shall forthwith upon obtaining actual knowledge thereof give written notice thereof to the Banks, describing the notice of action and the nature of the claimed default. Use of Proceeds. The proceeds of the Loans shall be used for general corporate and working capital purposes and in connection with the Tylan Tender Offer, and to refinance existing debt and letters of credit, including the Bridge Loan and the Tylan Revolving Credit Agreement. No proceeds of the Loans shall be used in any way that will violate Regulations G, T, U or X of the Board of Governors of the Federal Reserve System. Certain Transactions. Except as was disclosed in filings made by the Borrower, Amicon, or Tylan under the Securities Exchange Act of 1934 prior to Closing, and except for arm's length transactions pursuant to which the Borrower or any Subsidiary makes payments in the ordinary course of business upon terms no less favorable than the Borrower or such Subsidiary could obtain from third parties, none of the officers, directors, or employees of the Borrower or any Subsidiary are presently or shall be a party to any material transaction with the Borrower or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Borrower or any Subsidiary, any corporation, partnership, trust or other entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee or partner. Amendment to Note Purchase Agreement. On or before February 20, 1997, the Note Purchase Agreement will be amended, in form and substance satisfactory to the Administrative Agent, such that the incurrence of the Obligations hereunder shall not result in a default or an event of default thereunder. Until such amendment is effective or the Note Purchase Agreement is terminated, the Borrower shall ensure that $50,000,000 of the Total Commitment remains available. The Tylan Merger. As soon as practicable, but in no event later than March 31, 1997, the Tylan Merger shall have been successfully completed on terms no less favorable to the Borrower than the terms set forth in the Tylan Merger Agreement, and evidence thereof satisfactory to the Administrative Agent, including, without limitation, an opinion of general counsel to the Borrower as to the completion of the Tylan Merger, shall have been furnished to the Administrative Agent. CERTAIN NEGATIVE COVENANTS OF THE BORROWER. The Borrower agrees that, so long as any Obligation or Letter of Credit is outstanding or the Banks have any obligation to make Loans or the Administrative Agent has any obligation to issue, extend or renew any Letters of Credit hereunder or the Banks have any obligation to reimburse the Administrative Agent for advances made under any Letter of Credit, it shall, and shall cause its Subsidiaries to, comply with the following covenants: Restrictions on Liens. The Borrower will not, and will cause its Subsidiaries not to, create or incur or suffer to be created or incurred or to exist any lien, encumbrance, mortgage, pledge, charge, restriction or other security interest of any kind upon any property or assets of any character, whether now owned or hereafter acquired, or upon the income or profits therefrom; or transfer any of such property or assets or the income or profits therefrom for the purpose of subjecting the same to the payment of Indebtedness or performance of any other obligation in priority to payment of its general creditors; or acquire, or agree or have an option to acquire, any property or assets upon conditional sale or other title retention or purchase money security agreement, device or arrangement; or suffer to exist for a period of more than 30 days after the same shall have been incurred any Indebtedness or claim or demand against it which if unpaid might by law or upon bankruptcy or insolvency, or otherwise, be given any priority whatsoever over its general creditors; or sell, assign, pledge or otherwise transfer any accounts, contract rights, general intangibles or chattel paper, with or without recourse, except as follows (the "Permitted Liens"): (a) Liens existing on the Closing Date and listed on Schedule 8.1(a) hereto; (b) Liens to secure taxes, assessments and other government charges in respect of obligations not overdue; (c) Deposits or pledges made in connection with, or to secure payment of, workmen's compensation, unemployment insurance, old age pensions or other social security obligations; (d) Liens of carriers, warehousemen, mechanics and materialmen, and other like liens, in existence less than 120 days from the date of creation thereof in respect of obligations not overdue, provided that such liens may continue to exist for a period of more than 120 days if the validity or amount thereof shall currently be contested by the Borrower in good faith by appropriate proceedings and if the Borrower shall have set aside on its books adequate reserves with respect thereto as required by GAAP and provided further that the Borrower will pay any such claim forthwith upon commencement of proceedings to foreclose any such lien; (e) Encumbrances consisting of easements, rights of way, zoning restrictions, restrictions on the use of real property and defects and irregularities in the title thereto, landlord's or lessor's liens under leases to which the Borrower or any Subsidiary is a party, and other minor liens or encumbrances none of which in the opinion of the Borrower interferes materially with the use of the property affected in the ordinary conduct of the business of the Borrower or any of its Subsidiaries, which defects do not individually or in the aggregate have a material adverse effect on the business of the Borrower or any Subsidiary individually or of the Borrower and its Subsidiaries on a consolidated basis; (f) Liens in respect of judgments or awards which have been in force for less than the applicable period for taking an appeal so long as execution is not levied thereunder or in respect of which the Borrower shall at the time in good faith be prosecuting an appeal or proceedings for review and in respect of which a stay of execution shall have been obtained pending such appeal or review and in respect of which the Borrower has maintained adequate reserves; (g) the rights of lessors under Capitalized Leases, not to exceed $15,000,000 in the aggregate at any time; (h) Liens with respect to receivables transferred pursuant to Permitted Receivables Transactions, which Liens are only on the receivables so transferred and secure only the obligations with respect thereto; (i) previously existing Liens granted by acquired Subsidiaries or businesses on the terms and conditions in effect as of the date of such acquisition, provided that such Liens shall not have been incurred in contemplation of such acquisition; (j) existing Liens in connection with the Tylan Revolving Credit Agreement, provided that the proceeds of the Loans advanced hereunder shall be used to discharge the Indebtedness under the Tylan Revolving Credit Agreement on or before March 31, 1997; and (k) other Liens securing Indebtedness of the Borrower and its Subsidiaries not to exceed $25,000,000 in the aggregate at any time outstanding. Restrictions on Investments. The Borrower will not, and will not permit any of its Subsidiaries to, make or permit to exist or to remain outstanding any Investment except Investments in the following ("Permitted Investments"): (a) marketable direct or guaranteed obligations of the United States of America or Eligible Foreign Banks that mature within one (1) year from the date of purchase by the Borrower; (b) demand deposits, certificates of deposit, bankers acceptances and time deposits of United States banks or Eligible Foreign Banks having total assets in excess of $1,000,000,000; (c) securities commonly known as "commercial paper" issued by a corporation organized and existing under the laws of the United States of America or any state thereof that at the time of purchase have been rated and the ratings for which are not less than "P 1" if rated by Moody's Investors Services, Inc., and not less than "A 1" if rated by Standard and Poor's; (d) Investments existing on the date hereof and listed on Schedule 8.2(d) hereto; (e) Investments by the Borrower in Subsidiaries existing on the Closing Date or as permitted by 8.3 hereof; (f) Investments consisting of loans and advances to employees for moving, entertainment, travel and other similar expenses in the ordinary course of business not to exceed $1,000,000 in the aggregate at any time outstanding; and (g) Other Investments not to exceed $20,000,000 in the aggregate. Merger, Consolidation, and Disposition of Assets. Neither the Borrower nor any Subsidiary shall be a party to any merger, consolidation or exchange of stock unless the Borrower shall be the surviving entity with respect to any such transactions to which the Borrower is a party or a Subsidiary shall be the surviving entity (and continue to be a Subsidiary) with respect to any such transactions to which one or more Subsidiaries is a party (and the conditions set forth below are satisfied), or purchase or otherwise acquire all or substantially all of the assets or stock of any class of, or any partnership or joint venture interest in, any other Person except as otherwise provided in this 8.3, or sell, transfer, convey or lease any assets or group of assets including the sale or transfer of any property owned by the Borrower or any Subsidiary in order then or thereafter to lease such property or lease other property which the Borrower or such Subsidiary intends to use for substantially the same purpose as the property being sold or transferred (except (1) transfers of personal property among Subsidiaries of the Borrower which are wholly owned by the Borrower and (2) so long as no Default or Event of Default has occurred and is continuing, or would result therefrom, sales of assets between the date hereof and the Maturity Date with an aggregate value not greater than ten percent (10%) of Consolidated Tangible Assets, as set forth in the most recent financial statements delivered to the Banks pursuant to 7.4 hereof) or sell or assign, with or without recourse, any receivables (except accounts receivable more than sixty (60) days past due sold or assigned in the ordinary course of collecting past due accounts, or pursuant to a Permitted Receivables Transaction). Notwithstanding the foregoing, the Borrower and its Subsidiaries may purchase or otherwise acquire any or all of the assets or stock of any class of, or joint venture interest in, any Person if the following conditions have been met: (a) the proposed transaction will not otherwise create a Default or an Event of Default hereunder; (b) such entity is in substantially the same lines, related lines, or supporting lines of business as the Borrower or its Subsidiaries, provided that the cash consideration (including liabilities assumed) to be paid by the Borrower or its Subsidiaries in connection with any such acquisition (or series of related acquisitions) shall not exceed ten percent (10%) of Consolidated Tangible Assets and provided, further, that if the cash consideration (including liabilities assumed) to be paid by the Borrower or its Subsidiaries in connection with any such acquisition exceeds $5,000,000, the Borrower will provide calculations showing compliance with the covenants set forth in 9 hereof on a pro forma historical combined basis as if the transaction occurred on the first day of the period of measurement; and (c) the board of directors and (if required by applicable law) the shareholders, or the equivalent thereof, of the business to be acquired (or the owner thereof) has approved such acquisition. Restricted Distributions and Redemptions. Neither the Borrower nor any of its Subsidiaries will (a) declare or pay any Distributions, or (b) redeem, convert, retire or otherwise acquire shares of any class of its capital stock (other than in connection with a merger permitted by 8.3 hereof or conversion into another form of equity of any preferred shares of the Borrower existing as of the Closing Date pursuant to the terms thereof); provided that the Borrower and its Subsidiaries, so long as no Default or Event of Default shall have occurred and be continuing, or would be created as a result of such Distribution, may pay cash dividends and redeem, convert, retire, or otherwise acquire stock in an aggregate amount not to exceed (i) $50,000,000 plus (ii) for the years ending December 31, 1997 and December 31, 1998, 50% of positive Consolidated Net Income, plus (iii) for the years ending December 31, 1999, December 31, 2000 and December 31, 2001, 75% of positive Consolidated Net Income, provided that no Distribution would be permitted for the years ending December 31, 1999, December 31, 2000 and December 31, 2001 if such Distribution would result in a ratio of pro forma (x) Funded Debt to (y) Consolidated Net Worth plus Funded Debt in excess of 55% based on the amounts of Funded Debt and Consolidated Net Worth reported in the most recent Compliance Certificate, adjusted to give pro forma effect to such Distribution. Notwithstanding the above, any Subsidiary may make Distributions to the Borrower and the Borrower agrees that neither the Borrower nor any Subsidiary will enter into any agreement restricting Distributions from such Subsidiary to the Borrower, and warrants that no such restriction is in effect as of the Closing Date. Employee Benefit Plans. None of the Borrower, any of its Subsidiaries, or any ERISA Affiliate will: (a) engage in any "prohibited transaction" within the meaning of 9406 of ERISA or 4975 of the Code which could result in a material liability for the Borrower on a consolidated basis; or (b) permit any Guaranteed Pension Plan to incur an "accumulated funding deficiency," as such term is defined in 302 of ERISA, whether or not such deficiency is or may be waived; or (c) fail to contribute to any Guaranteed Pension Plan to an extent which, or terminate any Guaranteed Pension Plan in a manner which, could result in the imposition of a lien or encumbrance on the assets of the Borrower or any guarantor pursuant to 302(f) or 4068 of ERISA; or (d) permit or take any action which would result in the aggregate benefit liabilities (within the meaning of 4001 of ERISA) of all Guaranteed Pension Plans exceeding the value of the aggregate assets of such Plans, disregarding for this purpose the benefit liabilities and assets of any such Plan with assets in excess of benefit liabilities. The Borrower and its Subsidiaries will (i) promptly upon filing the same with the Department of Labor or Internal Revenue Service, furnish to the Banks a copy of the most recent actuarial statement required to be submitted under 103(d) of ERISA and Annual Report, Form 5500, with all required attachments, in respect of each Guaranteed Pension Plan and (ii) promptly upon receipt or dispatch, furnish to the Banks any notice, report or demand sent or received in respect of a Guaranteed Pension Plan under 302, 4041, 4042, 4043, 4063, 4065, 4066 and 4068 of ERISA, or in respect of a Multiemployer Plan, under 4041A, 4202, 4219, or 4245 of ERISA. FINANCIAL COVENANTS OF THE BORROWER. The Borrower agrees that, so long as any Obligation or Letter of Credit is outstanding or the Banks have any obligation to make Loans or any Administrative Agent has any obligation to issue, extend or renew any Letters of Credit hereunder or the Banks have any obligation to reimburse the Administrative Agent for advances made under any Letter of Credit, it shall, and shall cause its Subsidiaries to, comply with the following covenants: Funded Debt to EBITDA Ratio. As of the end of any fiscal quarter of the Borrower, the ratio of (a) Funded Debt as at the end of such quarter to (b) EBITDA for the period of four (4) consecutive fiscal quarters ending on such date shall not exceed the stated ratio for the periods set forth below: For the Quarters Ending: Ratio On or before 12/31/97 3.25:1.00 3/31/98 through 12/31/98 2.75:1.00 Thereafter 2.50:1.00 Interest Coverage Ratio. As of the end of any fiscal quarter, the ratio of (a) EBITDA minus Capital Expenditures for the Reference Period ending on such date to (b) Consolidated Total Interest Expense for the Reference Period ending on such date shall not be less than the stated ratio for the periods set forth below: For the Quarters Ending: Ratio 3/31/97 and 6/30/97 3.00:1.00 9/30/97 through 12/31/98 3.50:1.00 Thereafter 4.00:1.00 CONDITIONS TO EFFECTIVENESS. The effectiveness of the Agreement and the obligations of the Banks to make any Loans and of any Administrative Agent to issue Letters of Credit on the Closing Date and otherwise be bound by the terms of this Agreement shall be subject to the satisfaction of each of the following conditions precedent which shall occur no later than January 22, 1997: Corporate Action. All corporate action necessary for the valid execution, delivery and performance by the Borrower of the Loan Documents shall have been duly and effectively taken, and evidence thereof certified by an authorized officer of the Borrower and satisfactory to the Administrative Agent shall have been provided to the Administrative Agent. Loan Documents, Etc. Each of the Loan Documents and other documents listed on the closing agenda shall have been duly and properly authorized, executed and delivered by the respective parties thereto and shall be in full force and effect in a form satisfactory to the Administrative Agent. Certified Copies of Charter Documents. The Administrative Agent shall have received from the Borrower a copy, certified by a duly authorized officer of such Person to be true and complete on the Closing Date, of (a) its charter or other incorporation documents as in effect on such date of certification, and (b) its by-laws as in effect on such date. Incumbency Certificate. The Administrative Agent shall have received an incumbency certificate, dated as of the Closing Date, signed by duly authorized officers giving the name and bearing a specimen signature of each individual who shall be authorized: (a) to sign the Loan Documents on behalf of the Borrower (b) to make Syndicated Loan and Letter of Credit Requests; (d) to make Competitive Bid Quote Requests; and (d) to give notices and to take other action on the Borrower's behalf under the Loan Documents. Certificates of Insurance. The Administrative Agent shall have received (i) a certificate of insurance from an independent insurance broker dated as of the Closing Date, or within 15 days prior thereto, identifying insurers, types of insurance, insurance limits, and policy terms, and otherwise describing the insurance obtained in accordance with the provisions of the Loan Documents and (ii) copies of all policies evidencing such insurance (or certificates therefor signed by the insurer or an agent authorized to bind the insurer). Opinions of Counsel. The Administrative Agent shall have received favorable legal opinions from outside counsel to the Borrower, addressed to the Administrative Agent, dated the Closing Date, in form and substance satisfactory to the Administrative Agent. Existing Debt. The Administrative Agent shall have received a payoff letter with respect to the Bridge Loan indicating the amount of the loan obligations of the Borrower to be discharged on or about January 24, 1997. Satisfactory Financial Condition. No material adverse change, in the judgment of the Administrative Agent, shall have occurred in the financial condition, results of operations, business, properties or prospects of the Borrower and its Subsidiaries, or Amicon, or Tylan and its Subsidiaries, taken as a whole, since the most recent financial statements and projections provided to the Administrative Agent. Lien Searches. The Administrative Agent shall have received the results of lien searches demonstrating that there are no liens on the assets of the Borrower or Tylan, other than Permitted Liens. Fees. The Borrower shall have paid to the Administrative Agent all fees, including legal fees, required to be paid as of the Closing Date. CONDITIONS TO LOANS. The obligations of the Banks to make any Loan and the obligation of the Administrative Agent to issue, extend, or renew any Letter of Credit at the time of and subsequent to the Closing Date is subject to the following conditions precedent: Representations True. Each of the representations and warranties of the Borrower contained in this Agreement or in any document or instrument delivered pursuant to or in connection with this Agreement shall be true as of the date as of which they were made and shall also be true at and as of the time of the making of such Loan or the issuance, extension, or renewal of such Letter of Credit, as applicable, with the same effect as if made at and as of that time (except to the extent of changes resulting from transactions contemplated or permitted by this Agreement and changes occurring in the ordinary course of business which singly or in the aggregate are not materially adverse to the business, assets or financial condition of the Borrower and its Subsidiaries as a whole, and to the extent that such representations and warranties relate expressly and solely to an earlier date). Performance; No Event of Default. The Borrower and its Subsidiaries shall have performed and complied with all terms and conditions herein required to be performed or complied with by them prior to or at the time of the making of any Loan or the issuance, extension or renewal of any Letter of Credit, and at the time of the making of any Loan, there shall exist no Default or Event of Default or condition which would result in a Default or an Event of Default upon consummation of such Loan or the issuance, extension, or renewal of such Letter of Credit, as applicable. Each request by the Borrower for a Loan and each request for issuance, extension or renewal of a Letter of Credit shall constitute certification by the Borrower that the conditions specified in 11.1 and 11.2 will be duly satisfied on the date of such Loan or Letter of Credit issuance, extension or renewal. No Legal Impediment. No change shall have occurred in any law or regulations thereunder or interpretations thereof which in the reasonable opinion of the Banks would make it illegal for the Banks to make Loans or for the Administrative Agent to issue, extend or renew Letters of Credit hereunder. Governmental Regulation. The Banks shall have received from the Borrower and its Subsidiaries such statements in substance and form reasonably satisfactory to the Banks as they shall require for the purpose of compliance with any applicable regulations of the Comptroller of the Currency or the Board of Governors of the Federal Reserve System. Proceedings and Documents. All proceedings in connection with the transactions contemplated by this Agreement and all documents incident thereto shall have been delivered to the Banks as of the date of the making of such Loan in substance and in form satisfactory to the Banks, including without limitation a Syndicated Loan Request in the form attached hereto as Exhibit C-1 and a Letter of Credit Request in the form of Exhibit C-2, and the Banks shall have received all information and such counterpart originals or certified or other copies of such documents as the Banks may reasonably request. EVENTS OF DEFAULT; ACCELERATION; TERMINATION OF COMMITMENT. Events of Default and Acceleration. If any of the following events ("Events of Default" or, if the giving of notice or the lapse of time or both is required, then, prior to such notice and/or lapse of time, "Defaults") shall occur: (a) the Borrower shall fail to pay any principal of the Loans when the same shall become due and payable, whether at the stated date of maturity or any accelerated date of maturity or at any other date fixed for payment; (b) the Borrower shall fail to pay any interest or fees or other amounts owing hereunder within three (3) Business Days after the same shall become due and payable whether at the Maturity Date or any accelerated date of maturity or at any other date fixed for payment; (c) the Borrower shall fail to comply with the covenants contained in 7, 8 or 9 hereof; (d) the Borrower shall fail to perform any term, covenant or agreement contained herein or in any of the other Loan Documents (other than those specified in subsections (a), (b), and (c) above) and such failure shall not be remedied within 30 days after written notice of such failure shall have been given to the Borrower by the Administrative Agent or any of the Banks; (e) any representation or warranty contained in this Agreement or in any document or instrument delivered pursuant to or in connection with this Agreement shall prove to have been false in any material respect upon the date when made or repeated; (f) the Borrower or any of its Subsidiaries shall fail to pay when due, or within any applicable period of grace, any Indebtedness in an aggregate amount greater than $5,000,000, or fail to observe or perform any material term, covenant or agreement contained in any one or more agreements by which it is bound, evidencing or securing any Indebtedness in an aggregate amount greater than $5,000,000 for such period of time as would, or would have permitted (assuming the giving of appropriate notice if required) the holder or holders thereof or of any obligations issued thereunder to accelerate the maturity thereof or terminate its commitment with respect thereto; (g) the Borrower or any Subsidiary makes an assignment for the benefit of creditors, or admits in writing its inability to pay or generally fails to pay its debts as they mature or become due, or petitions or applies for the appointment of a trustee or other custodian, liquidator or receiver of the Borrower or any Subsidiary or of any substantial part of the assets of the Borrower or commences any case or other proceeding relating to the Borrower or any Subsidiary under any bankruptcy, reorganization, arrangement, insolvency, readjustment of debt, dissolution or liquidation or similar law of any jurisdiction, now or hereafter in effect, or takes any action to authorize or in furtherance of any of the foregoing, or if any such petition or application is filed or any such case or other proceeding is commenced against the Borrower or any Subsidiary or the Borrower or any Subsidiary indicates its approval thereof, consent thereto or acquiescence therein; (h) a decree or order is entered appointing any such trustee, custodian, liquidator or receiver or adjudicating the Borrower or any Subsidiary bankrupt or insolvent, or approving a petition in any such case or other proceeding, or a decree or order for relief is entered in respect of the Borrower or any Subsidiary in an involuntary case under federal bankruptcy laws as now or hereafter constituted, and such decree or order remains in effect for more than 30 days, whether or not consecutive; (i) there shall remain in force, undischarged, unsatisfied and unstayed, for more than thirty days, whether or not consecutive, any final judgment against the Borrower or any Subsidiary which, with other outstanding final judgments against the Borrower and its Subsidiaries exceeds in the aggregate $5,000,000 after taking into account any undisputed insurance coverage; (j) with respect to any Guaranteed Pension Plan, an ERISA Reportable Event shall have occurred and the Banks shall have determined in their reasonable discretion that such event reasonably could be expected to result in liability of the Borrower or any Subsidiary or any Subsidiary to the PBGC or the Plan in an aggregate amount exceeding $5,000,000 and such event in the circumstances occurring reasonably could constitute grounds for the termination of such Plan by the PBGC or for the appointment by the appropriate United States District Court of a trustee to administer such Plan; or a trustee shall have been appointed by the United States District Court to administer such Plan; or the PBGC shall have instituted proceedings to terminate such Plan; (k) any of the Loan Documents shall be canceled, terminated, revoked or rescinded otherwise than in accordance with the terms thereof or with the express prior written agreement, consent or approval of the Banks, or any action at law, suit or in equity or other legal proceeding to cancel, revoke or rescind any of the Loan Documents shall be commenced by or on behalf of the Borrower or any of its respective stockholders, or any court or any other governmental or regulatory authority or agency of competent jurisdiction shall make a determination that, or issue a judgment, order, decree or ruling to the effect that, any one or more of the Loan Documents is illegal, invalid or unenforceable in accordance with the terms thereof; or (l) any person or group of persons (within the meaning of Section 13 or 14 of the Securities Exchange Act of 1934, as amended) shall have acquired beneficial ownership (within the meaning of Rule 13d-3 promulgated by the Securities and Exchange Commission under said Act) of 20% or more of the outstanding shares of common voting stock of the Borrower or, during any period of twelve consecutive calendar months, individuals who were directors of the Borrower on the first day of such period shall cease to constitute a majority of the board of directors of the Borrower; then, and in any such event, so long as the same may be continuing, the Administrative Agent may, and upon the request of the Majority Banks shall, by notice in writing to the Borrower, declare all amounts owing with respect to this Agreement, the Notes and the other Loan Documents and all Reimbursement Obligations to be, and they shall thereupon forthwith become, immediately due and payable without presentment, demand, protest, notice of intent to accelerate, notice of acceleration to the extent permitted by law or other notice of any kind, all of which are hereby expressly waived by the Borrower; provided that in the event of any Event of Default specified in 12.1(g) or 12.1(h), all such amounts shall become immediately due and payable automatically and without any requirement of notice from the Administrative Agent or any Bank. Upon demand by the Majority Banks after the occurrence of any Event of Default, the Borrower shall immediately provide to the Administrative Agent cash in an amount equal to the aggregate Maximum Drawing Amount to be held by the Administrative Agent as collateral security for the Reimbursement Obligations. Termination of Commitments. If any Event of Default pursuant to 12.1(g) or 12.1(h) hereof shall occur, any unused portion of the Total Commitment hereunder shall forthwith terminate and the Banks and the Administrative Agent shall be relieved of all obligations to make Loans to or to issue, extend or renew Letters of Credit for the account of the Borrower; or if any other Event of Default shall occur, the Majority Banks may and, upon the request of the Majority Banks, shall, by notice to the Borrower, terminate the unused portion of the Total Commitment hereunder, and, upon such notice being given, such unused portion of the Total Commitment hereunder shall terminate immediately and the Banks and the Administrative Agent shall be relieved of all further obligations to make Loans to or to issue, extend or renew Letters of Credit for the account of the Borrower hereunder. No termination of any portion of the Commitment Percentage hereunder shall relieve the Borrower of any of its existing Obligations to the Banks or the Administrative Agent hereunder or elsewhere. Remedies. In case any one or more of the Events of Default shall have occurred and be continuing, and whether or not the Banks shall have accelerated the maturity of the Loans pursuant to 12.1, each Bank, if owed any amount with respect to the Loans or the Reimbursement Obligations, with the consent of the Majority Banks but not otherwise, may proceed to protect and enforce its rights by suit in equity, action at law or other appropriate proceeding, whether for the specific performance of any covenant or agreement contained in this Agreement and the other Loan Documents or any instrument pursuant to which the Obligations to such Bank are evidenced, including, without limitation, as permitted by applicable law the obtaining of the ex parte appointment of a receiver, and, if such amount shall have become due, by declaration or otherwise, proceed to enforce the payment thereof or any legal or equitable right of such Bank. No remedy herein conferred upon any Bank or the Administrative Agent or the holder of any Note is intended to be exclusive of any other remedy and each and every remedy shall be cumulative and shall be in addition to every other remedy given hereunder or now or hereafter existing at law or in equity or by statute or any other provision of law. SETOFF. Regardless of the adequacy of any collateral, during the continuance of any Event of Default, any deposits or other sums credited by or due from any of the Banks to the Borrower and any securities or other property of the Borrower in the possession of such Bank may be applied to or set off by such Bank against the payment of Obligations and any and all other liabilities, direct, or indirect, absolute or contingent, due or to become due, now existing or hereafter arising, of the Borrower to such Bank. Each of the Banks agrees with each other Bank that (i) if an amount to be set off is to be applied to Indebtedness of the Borrower to such Bank, other than Indebtedness evidenced by the Notes held by such Bank, such amount shall be applied ratably to such other Indebtedness and to the Indebtedness evidenced by all such Notes held by such Bank, and (ii) if such Bank shall receive from the Borrower, whether by voluntary payment, exercise of the right of setoff, counterclaim, cross action, enforcement of the claim evidenced by the Notes held by such Bank by proceedings against the Borrower at law or in equity or by proof thereof in bankruptcy, reorganization, liquidation, receivership or similar proceedings, or otherwise, and shall retain and apply to the payment of the Note or Notes held by such Bank any amount in excess of its ratable portion of the payments received by all of the Banks with respect to the Notes held by all of the Banks, such Bank will make such disposition and arrangements with the other Banks with respect to such excess, either by way of distribution, pro tanto assignment of claims, subrogation or otherwise as shall result in each Bank receiving in respect of the Notes held by its proportionate payment as contemplated by this Agreement; provided that if all or any part of such excess payment is thereafter recovered from such Bank, such disposition and arrangements shall be rescinded and the amount restored to the extent of such recovery, but without interest. EXPENSES. Whether or not the transactions contemplated herein shall be consummated, the Borrower hereby promises to reimburse the Administrative Agent for all reasonable out-of- pocket fees and disbursements (including all reasonable attorneys' fees) incurred or expended in connection with the preparation, filing or recording, or interpretation of this Agreement, the other Loan Documents, or any amendment, modification, approval, consent or waiver hereof or thereof. The Borrower further promises to reimburse the Administrative Agent and the Banks for all reasonable out-of- pocket fees and disbursements (including all reasonable legal fees and the allocable cost of in-house attorneys' fees) incurred or expended in connection with the enforcement of any Obligations or the satisfaction of any indebtedness of the Borrower hereunder or thereunder, or in connection with any litigation, proceeding or dispute hereunder in any way related to the credit hereunder. The Borrower also promises to pay the Administrative Agent all reasonable out-of-pocket fees and disbursements incurred or expended in connection with the Competitive Bid Loan procedure under 4 hereof, or in connection with the syndication of the Syndicated Loans hereunder. The Borrower will pay any taxes (including any interest and penalties in respect thereof) other than any Bank's or the Administrative Agent's Income Taxes payable on or with respect to the transactions contemplated by this Agreement (the Borrower hereby agreeing to indemnify each Bank and the Administrative Agent with respect thereto). THE AGENTS. Appointment, Powers and Immunities. Each Bank hereby irrevocably appoints and authorizes FNBB to act as Administrative Agent hereunder and under the other Loan Documents, and to exercise such powers as are reasonably incidental thereto and as are set forth in this Agreement and the other Loan Documents. The Administrative Agent hereby acknowledges that it does not have the authority to negotiate any agreement which would bind the Banks or agree to any amendment, waiver or modification of any of the Loan Documents or bind the Banks except as set forth in this Agreement or the Loan Documents. Except as provided in this Agreement and in the other Loan Documents, the Administrative Agent shall take action or refrain from acting only upon instructions of the Banks. It is agreed that the duties, rights, privileges and immunities of the Administrative Agent, in its capacity as issuer of Letters of Credit hereunder, shall be identical to the duties, rights, privileges and immunities of the Administrative Agent as provided in this 15. The Administrative Agent shall not have any duties or responsibilities or any fiduciary relationship with any Bank except those expressly set forth in this Agreement. Neither the Administrative Agent nor any of its affiliates shall be responsible to the Banks for any recitals, statements, representations or warranties made by the Borrower or any other Person whether contained herein or otherwise or for the value, validity, effectiveness, genuineness, enforceability or sufficiency of this Agreement, the other Loan Documents or any other document referred to or provided for herein or therein or for any failure by the Borrower or any other Person to perform its obligations hereunder or thereunder or in respect of the Notes. The Administrative Agent may employ agents and attorneys-in-fact and shall not be responsible for the negligence or misconduct of any such agents or attorneys-in-fact selected by it with reasonable care. Neither the Administrative Agent nor any of its directors, officers, employees or agents shall be responsible for any action taken or omitted to be taken by it or them hereunder or in connection herewith, except for its or their own gross negligence or willful misconduct. The Administrative Agent in its separate capacity as a Bank shall have the same rights and powers hereunder as any other Bank. Actions By Administrative Agent. The Administrative Agent shall be fully justified in failing or refusing to take any action under this Agreement as reasonably deemed appropriate unless it shall first have received the consent of the Banks and shall be indemnified to its reasonable satisfaction by the Banks against any and all liability and expense which may be incurred by it by reason of taking or continuing to take any such action. The Administrative Agent shall in all cases be fully protected in acting, or in refraining from acting, under this Agreement or any of the Loan Documents in accordance with the instruction of the Banks, and such instruction and any action taken or failure to act pursuant thereto shall be binding upon the Banks and all future holders of the Notes or any Letter of Credit Participation. Indemnification. Without limiting the obligations of the Borrower and its Subsidiaries hereunder or under any other Loan Document, the Banks agree to indemnify the Agents, ratably in accordance with their respective Commitment Percentages, for any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind or nature whatsoever which may at any time be imposed on, incurred by or asserted against the Agents in any way relating to or arising out of this Agreement or any other Loan Document or any documents contemplated by or referred to herein or therein or the transactions contemplated hereby or thereby or the enforcement of any of the terms hereof or thereof or of any such other documents; provided, that no Bank shall be liable for any of the foregoing to the extent they arise from the gross negligence or willful misconduct of the Agents (or any agent thereof), IT BEING THE INTENT OF THE PARTIES HERETO THAT THE AGENTS SHALL BE INDEMNIFIED FOR THEIR ORDINARY SOLE OR CONTRIBUTORY NEGLIGENCE. Reimbursement. Without limiting the provisions of 5.1(a), 5.13, and 13, the Administrative Agent shall not be obliged to make available to any Person any sum which the Administrative Agent is expecting to receive for the account of that Person until the Administrative Agent has determined that it has received that sum. The Administrative Agent may, however, disburse funds prior to determining that the sums which the Administrative Agent expects to receive have been finally and unconditionally paid to the Administrative Agent, if the Administrative Agent wishes to do so. If and to the extent that the Administrative Agent does disburse funds and it later becomes apparent that the Administrative Agent did not then receive a payment in an amount equal to the sum paid out, then any Person to whom the Administrative Agent made the funds available shall, on demand from the Administrative Agent, refund to the Administrative Agent the sum paid to that Person. If, in the opinion of the Administrative Agent, the distribution of any amount received by it in such capacity hereunder or under the Loan Documents might involve it in liability, it may refrain from making such distribution until its right to make such distribution shall have been adjudicated by a court of competent jurisdiction. If a court of competent jurisdiction shall adjudge that any amount received and distributed by the Administrative Agent is to be repaid, each Person to whom any such distribution shall have been made shall either repay to the Administrative Agent its proportionate share of the amount so adjudged to be repaid or shall pay over the same in such manner and to such Persons as shall be determined by such court. Documents. The Administrative Agent will forward to each Bank, promptly after receipt thereof, a copy of each notice or other document furnished to the Administrative Agent for such Bank hereunder; provided, however, that, notwithstanding the foregoing, the Administrative Agent may furnish to the Banks a monthly summary with respect to Letters of Credit issued hereunder in lieu of copies of the related Letter of Credit Applications. The Documentation Agent shall have no responsibility to the Banks with respect to the documents hereunder. Non-Reliance on Agents and Other Banks. Each Bank represents that it has, independently and without reliance on the Agents or any other Bank, and based on such documents and information as it has deemed appropriate, made its own appraisal of the financial condition and affairs of the Borrower and the decision to enter into this Agreement and the other Loan Documents and agrees that it will, independently and without reliance upon the Agents or any other Bank, and based on such documents and information as it shall deem appropriate at the time, continue to make its own appraisals and decisions in taking or not taking action under this Agreement or any other Loan Document. Except as herein expressly provided to the contrary, the Agents shall not be required to keep informed as to the performance or observance by the Borrower of this Agreement, the other Loan Documents or any other document referred to or provided for herein or therein or by any other Person of any other agreement or to make inquiry of, or to inspect the properties or books of, any Person. Except for notices, reports and other documents and information expressly required to be furnished to the Banks by the Administrative Agent hereunder, the Agents shall not have any duty or responsibility to provide any Bank with any credit or other information concerning any Person which may come into the possession of the Agents or any of their affiliates. Each Bank shall have access to all documents relating to the Administrative Agent's performance of its duties hereunder at such Bank's request. Unless any Bank shall promptly object to any action taken by the Administrative Agent hereunder of which such Bank has actual knowledge (other than actions which require the prior consent of such Bank in accordance with the terms hereof or to which the provisions of 15.8 are applicable and other than actions which constitute gross negligence or willful misconduct by the Agents), such Bank shall be presumed to have approved the same. Resignation of Administrative Agent. The Administrative Agent may resign at any time by giving 60 days' prior written notice thereof to the Banks and the Borrower. Upon any such resignation, the Banks (other than the resigning Administrative Agent) shall have the right to appoint a successor Administrative Agent from among the Banks. If no successor to such Administrative Agent shall have been so appointed by the Banks and shall have accepted such appointment within 30 days after the retiring Administrative Agent's giving of notice of resignation, then the retiring Administrative Agent may, on behalf of the Banks, appoint a successor Administrative Agent from among the remaining Banks, which shall be a financial institution having a combined capital and surplus in excess of $1,000,000,000. Upon the acceptance of any appointment as Administrative Agent hereunder by a successor Administrative Agent, such successor Administrative Agent shall thereupon succeed to and become vested with all the rights, powers, privileges and duties of the retiring Administrative Agent, and the retiring Administrative Agent shall be discharged from its duties and obligations hereunder. After any retiring Administrative Agent's resignation, the provisions of this Agreement shall continue in effect for its benefit in respect of any actions taken or omitted to be taken by it while it was acting as Administrative Agent. Any new Administrative Agent appointed pursuant to this 15.7 shall immediately issue new Letters of Credit in place of Letters of Credit previously issued, or if acceptable to the resigning Administrative Agent, issue letters of credit in favor of the resigning Administrative Agent as security for the outstanding Letters of Credit and shall in due course replace all Letters of Credit previously issued by the resigning Administrative Agent. Action by the Banks, Consents, Amendments, Waivers, Etc. Any action to be taken (including the giving of notice) may be taken, any consent or approval required or permitted by the Agreement or any other Loan Document to be given by the Banks may be given, any term of this Agreement, any other Loan Document or any other instrument, document or agreement related to this Agreement or the other Loan Documents or mentioned herein or therein may be amended, and the performance or observance by the Borrower or any other Person of any of the terms hereof or thereof and any Default or Event of Default (as defined in any of the above- referenced documents or instruments) may be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Majority Banks; provided, however, that no such consent or amendment which affects the rights, duties or liabilities of either Agent shall be effective without the written consent of such Agent. Notwithstanding the foregoing, no amendment, waiver or consent shall do any of the following unless in writing and signed by ALL of the Banks: (a) increase the principal amount of the Total Commitment (or subject the Banks to any additional obligations); (b) reduce the principal of or interest on the Notes (including, without limitation, interest on overdue amounts) or any fees payable hereunder; (c) postpone any date fixed for any payment in respect of principal or interest (including, without limitation, interest on overdue amounts) on the Notes, or any fee hereunder; (d) change the definition of "Majority Banks" or the number of Banks which shall be required for the Banks or any of them to take any action under the Loan Documents; (e) amend this 15.8; or (f) change the Commitment Percentage of any Bank, except as permitted under 18 hereof. Holders of Notes. The Administrative Agent may deem and treat the payee of any Note or the purchaser of any Letter of Credit Participation as the absolute owner or purchaser thereof for all purposes hereof until it shall have been furnished in writing with a different name by such payee or by a subsequent holder, assignee or transferee. Administrative Agent's Fee. The Borrower shall pay to the Administrative Agent, for the Administrative Agent's own account, on the Closing Date and on each anniversary thereof, an annual Administrative Agent's fee in an amount previously agreed to in that certain letter agreement, dated December 20, 1996, between the Borrower and the Administrative Agent. INDEMNIFICATION. The Borrower agrees to indemnify and hold harmless the Banks and the Agents and their affiliates, as well as the Banks' and the Agents' and their affiliates' shareholders, directors, agents, officers, subsidiaries and affiliates, from and against all damages, losses, settlement payments, obligations, liabilities, claims, suits, penalties, assessments, citations, directives, demands, judgments, actions or causes of action, whether created by statute or under the common law, and reasonable costs and expenses incurred, suffered, sustained or required to be paid by an indemnified party by reason of or resulting from the transactions contemplated hereby, except any of the foregoing which result from the gross negligence or willful misconduct of any indemnified party. In any investigation, enforcement matter, proceeding or litigation, or the preparation therefor, the Banks and the Agents shall be entitled to select their own counsel and, in addition to the foregoing indemnity, the Borrower agrees to pay promptly the reasonable fees and expenses of such counsel. In the event of the commencement of any such proceeding or litigation against the Banks by third parties, the Borrower shall be entitled to participate in such proceeding or litigation with counsel of its choice at its expense, provided that such counsel shall be reasonably satisfactory to the Banks. The covenants of this 16 shall survive payment or satisfaction of payment of amounts owing with respect to any Note or any other Loan Document, IT BEING THE INTENT OF THE PARTIES HERETO THAT ALL SUCH INDEMNIFIED PARTIES SHALL BE INDEMNIFIED FOR THEIR ORDINARY SOLE OR CONTRIBUTORY NEGLIGENCE. SURVIVAL OF COVENANTS, ETC. Unless otherwise stated herein, all covenants, agreements, representations and warranties made herein, in the other Loan Documents or in any documents or other papers delivered by or on behalf of the Borrower pursuant hereto shall be deemed to have been relied upon by the Banks and the Agents, notwithstanding any investigation heretofore or hereafter made by it, and shall survive the making by the Banks of the Loans and the issuance, extension or renewal of any Letters of Credit by the Administrative Agent, as herein contemplated, and shall continue in full force and effect so long as any amount due under this Agreement, any Obligation, any Letter of Credit or any Note remains outstanding and unpaid or any Bank has any obligation to make any Loans or the Administrative Agent has any obligation to issue, extend, or renew any Letters of Credit hereunder. All statements contained in any certificate or other paper delivered by or on behalf of the Borrower pursuant hereto or in connection with the transactions contemplated hereby shall constitute representations and warranties by the Borrower hereunder. ASSIGNMENT AND PARTICIPATION. It is understood and agreed that each Bank shall have the right to assign at any time all or a portion of its Commitment Percentage and interests in the risk relating to the Loans, outstanding Letters of Credit and its Commitment hereunder in an amount equal to or greater than $10,000,000 (which assignment shall be of an equal percentage of the Commitment, the Loans and outstanding Letters of Credit unless otherwise agreed to by the Administrative Agent) to additional banks or other financial institutions with the prior written approval of the Administrative Agent and, unless an Event of Default shall have occurred and be continuing, the Borrower, which approvals shall not be unreasonably withheld. Any Bank may at any time, and from time to time, assign to any branch, lending office, or affiliate or such Bank all or any part of its rights and obligations under the Loan Documents by notice to the Administrative Agent and the Borrower. It is further agreed that each bank or other financial institution which executes and delivers to the Administrative Agent and the Borrower hereunder an Assignment and Acceptance substantially in the form of Exhibit E hereto (an "Assignment and Acceptance") together with an assignment fee in the amount of $2,500 payable by the assigning Bank to the Administrative Agent, shall, on the date specified in such Assignment and Acceptance, become a party to this Agreement and the other Loan Documents for all purposes of this Agreement and the other Loan Documents, and its portion of the Commitment, the Loans and Letters of Credit shall be as set forth in such Assignment and Acceptance. The Bank assignor thereunder shall, to the extent that rights and obligations hereunder have been assigned by it pursuant to such Assignment and Acceptance, relinquish its rights and be released from its obligations under this Agreement. Upon the execution and delivery of such Assignment and Acceptance, (a) the Borrower shall issue to the bank or other financial institution a Syndicated Note in the amount of such bank's or other financial institution's Commitment dated the date of the assignment or such other date as may be specified by the Administrative Agent, and otherwise completed in substantially the form of Exhibit A and, to the extent any assigning Bank has retained a portion of its obligations hereunder, a replacement Syndicated Note to the assigning Bank reflecting its assignment; (b) to the extent applicable, the Borrower shall issue a Competitive Bid Note in substantially the form of Exhibit B (and a replacement Competitive Bid Note); (c) the Administrative Agent shall distribute to the Borrower, the Banks and such assignee bank or financial institution a schedule reflecting such changes; and (d) this Agreement shall be appropriately amended to reflect (i) the status of the assignee bank or financial institution as a party hereto and (ii) the status and rights of the Banks hereunder. Each Bank shall also have the right to grant participations to one or more banks or other financial institutions in its Commitment, the Loans and outstanding Letters of Credit. The documents evidencing any such participation shall limit such participating bank's or financial institution's voting rights with respect to the matters set forth in 15.8 of this Agreement which require the vote of all Banks. Notwithstanding the foregoing, no assignment or participation shall operate to increase the Commitment hereunder or otherwise alter the substantive terms of this Agreement, and no Bank which retains a Commitment hereunder shall have a Commitment of less than $10,000,000 (as such amount may be reduced upon reductions in the Total Commitment pursuant to 2.3 hereof) unless the Administrative Agent and the Borrower shall have consented to such lesser amount. Anything contained in this 18 to the contrary notwithstanding, any Bank may at any time pledge all or any portion of its interest and rights under this Agreement (including all or any portion of its Notes) to any of the twelve Federal Reserve Banks organized under 4 of the Federal Reserve Act, 12 U.S.C. 341. No such pledge or the enforcement thereof shall release the pledgor Bank from its obligations hereunder or under any of the other Loan Documents. PARTIES IN INTEREST. All the terms of this Agreement and the other Loan Documents shall be binding upon and inure to the benefit of and be enforceable by the respective successors and assigns of the parties hereto and thereto; provided that the Borrower shall not assign or transfer its rights hereunder without the prior written consent of each of the Banks. NOTICES, ETC. Except as otherwise expressly provided in this Agreement, all notices and other communications made or required to be given pursuant to this Agreement or the other Loan Documents shall be in writing and shall be delivered in hand, mailed by United States first class mail, postage prepaid, or sent by telegraph, telex or facsimile and confirmed by letter, addressed as follows: (a) if to the Borrower, at 80 Ashby Road, Bedford, MA 01730-2271, Attention: President, facsimile number (617) 533-3162, with a copy to the General Counsel of the Borrower at the same address; or (b) if to FNBB or the Administrative Agent, at The First National Bank of Boston, 100 Federal Street, Boston, MA 02110, Attention: Elizabeth C. Everett, Director, facsimile number: (617) 434-0819; or such other address for notice as shall have last been furnished in writing to the Person giving the notice. Any such notice or demand shall be deemed to have been duly given or made and to have become effective (a) if delivered by hand to a responsible officer of the party to which it is directed, at the time of the receipt thereof by such officer, (b) if sent by registered or certified first- class mail, postage prepaid, five (5) Business Days after the posting thereof, and (c) if sent by telex, facsimile, or cable, at the time of the dispatch thereof, if in normal business hours in the country of receipt, or otherwise at the opening of business on the following Business Day. MISCELLANEOUS. The rights and remedies herein expressed are cumulative and not exclusive of any other rights which the Banks would otherwise have. The captions in this Agreement are for convenience of reference only and shall not define or limit the provisions hereof. This Agreement and any amendment hereof may be executed in several counterparts and by each party on a separate counterpart, each of which when so executed and delivered shall be an original, but all of which together shall constitute one instrument. In proving this Agreement it shall not be necessary to produce or account for more than one such counterpart signed by the party against whom enforcement is sought. CONSENTS, ETC. Neither this Agreement nor any term hereof may be changed, waived, discharged or terminated, except as provided in this 22, subject to the provisions of 15.8. No waiver shall extend to or affect any obligation not expressly waived or impair any right consequent thereon. Except as otherwise expressly provided in this Agreement, any consent or approval required or permitted by this Agreement to be given by the Banks may be given, and any term of this Agreement or of any other instrument related hereto or mentioned herein may be amended, and the performance or observance by the Borrower of any terms of this Agreement or such other instrument or the continuance of any Default or Event of Default may be waived (either generally or in a particular instance and either retroactively or prospectively) with, but only with, the written consent of the Borrower and the Banks. To the extent permitted by law, no course of dealing or delay or omission on the part of any of the Banks or the Administrative Agent in exercising any right shall operate as a waiver thereof or otherwise be prejudicial thereto. No notice to or demand upon the Borrower shall entitle the Borrower to other or further notice or demand in similar or other circumstances. PARI PASSU TREATMENT. Notwithstanding anything to the contrary set forth herein, each payment or prepayment of principal and interest received after the occurrence of an Event of Default hereunder shall be distributed pari passu among the Banks, in accordance with the aggregate outstanding principal amount of the Obligations owing to each Bank divided by the aggregate outstanding principal amount of all Obligations. CONFIDENTIALITY. Each Bank and Agent agrees to hold any confidential information that it may receive from the Borrower pursuant to this Agreement or any other Loan Document in confidence, except for disclosure: (a) to any other Bank or Agent; (b) to legal counsel and accountants for the Borrower or any Bank or Agent; (c) to other professional advisors to the Borrower or any Bank or Agent, provided that the recipient has delivered to such Bank or Agent, as applicable, a written confidentiality agreement substantially similar to this 24; (d) to regulatory officials having jurisdiction over any Bank or Agent; (e) as required by law or legal process or in connection with any legal proceeding to which any Bank or Agent and the Borrower (or any Subsidiary of the Borrower) are adverse parties; and (f) to another financial institution in connection with a disposition or proposed disposition to that financial institution of all or part of any Bank's or Agent's interests hereunder or a participation interest in its Syndicated Note or Competitive Bid Note, provided that the recipient has delivered to such Bank or Agent, as applicable, a written confidentiality agreement substantially similar to this 24. Each Bank and Agent further agrees that it will not use any such confidential information in any activity or for any purpose other than the administration of the credit facilities extended to the Borrower under this Agreement. For purposes of the foregoing, "confidential information" shall mean any information respecting the Borrower or its Subsidiaries reasonably considered to be, is treated as, and is marked as, confidential by the Borrower, other than (i) information previously filed with any governmental agency and available to the public, (ii) information previously published in any public medium from a source other than, directly or indirectly, any Bank or Agent, (iii) information already known by any Bank or Agent or the other party in question other than as a result of a breach of this Agreement, and (iv) information previously disclosed by the Borrower or any Subsidiary to any Person not associated with the Borrower without a written confidentiality agreement substantially similar to this 24. Nothing in this Section shall be construed to create or give rise to any fiduciary duty on the part of any Bank or Agent to the Borrower or any Subsidiary. WAIVER OF JURY TRIAL. TO THE EXTENT PERMITTED BY APPLICABLE LAW, THE BORROWER HEREBY WAIVES ITS RIGHT TO A JURY TRIAL WITH RESPECT TO ANY ACTION OR CLAIM ARISING OUT OF ANY DISPUTE IN CONNECTION WITH THIS AGREEMENT, THE NOTES OR ANY OF THE OTHER LOAN DOCUMENTS, ANY RIGHTS OR OBLIGATIONS HEREUNDER OR THEREUNDER OR THE PERFORMANCE OF SUCH RIGHTS AND OBLIGATIONS. EXCEPT AS PROHIBITED BY LAW, THE BORROWER HEREBY WAIVES ANY RIGHT IT MAY HAVE TO CLAIM OR RECOVER IN ANY LITIGATION REFERRED TO IN THE PRECEDING SENTENCE ANY SPECIAL, EXEMPLARY, PUNITIVE OR CONSEQUENTIAL DAMAGES OR ANY DAMAGES OTHER THAN, OR IN ADDITION TO, ACTUAL DAMAGES. THE BORROWER (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY BANK OR THE AGENTS HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH BANK OR AGENT WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVERS AND (B) ACKNOWLEDGES THAT THE AGENTS AND THE BANKS HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS BECAUSE OF, AMONG OTHER THINGS, THE BORROWER'S WAIVERS AND CERTIFICATIONS CONTAINED HEREIN. GOVERNING LAW. THIS AGREEMENT AND EACH OF THE OTHER LOAN DOCUMENTS ARE CONTRACTS UNDER THE LAWS OF THE COMMONWEALTH OF MASSACHUSETTS AND SHALL FOR ALL PURPOSES BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF SAID COMMONWEALTH (EXCLUDING THE LAWS APPLICABLE TO CONFLICTS OR CHOICE OF LAW). THE BORROWER CONSENTS TO THE JURISDICTION OF ANY OF THE FEDERAL OR STATE COURTS LOCATED IN THE COMMONWEALTH OF MASSACHUSETTS IN CONNECTION WITH ANY SUIT TO ENFORCE THE RIGHTS OF THE BANKS OR THE AGENTS UNDER THIS AGREEMENT OR ANY OF THE OTHER LOAN DOCUMENTS. SEVERABILITY. The provisions of this Agreement are severable and if any one clause or provision hereof shall be held invalid or unenforceable in whole or in part in any jurisdiction, then such invalidity or unenforceability shall affect only such clause or provision, or part thereof, in such jurisdiction, and shall not in any manner affect such clause or provision in any other jurisdiction, or any other clause or provision of this Agreement in any jurisdiction. FINAL AGREEMENT. THIS WRITTEN AGREEMENT AND THE OTHER LOAN DOCUMENTS REPRESENT THE FINAL AGREEMENT BETWEEN THE PARTIES AND MAY NOT BE CONTRADICTED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS, OR SUBSEQUENT ORAL AGREEMENTS OF THE PARTIES. THERE ARE NO UNWRITTEN ORAL AGREEMENTS BETWEEN THE PARTIES. IN WITNESS WHEREOF, the undersigned have duly executed this Agreement under seal as of the date first set forth above. MILLIPORE CORPORATION By:_____________________________ ____ Name: Title: THE FIRST NATIONAL BANK OF BOSTON, Individually and as Administrative Agent By:_____________________________ ______ Name: Title: ABN AMRO BANK N.V., Individually and as Documentation Agent By:_____________________________ ______ Name: Title: By:_____________________________ ______ Name: Title: BOS-BUS:358151 FIRST AMENDMENT TO REVOLVING CREDIT AGREEMENT THIS FIRST AMENDMENT TO REVOLVING CREDIT AGREEMENT (this "First Amendment") is made and entered into as of February 11, 1997, by and among (a) MILLIPORE CORPORATION, a Massachusetts corporation having its principal place of business at 80 Ashby Road, Bedford, MA 01730 (the "Borrower"), (b) THE FIRST NATIONAL BANK OF BOSTON, a national banking association with its head office at 100 Federal Street, Boston, Massachusetts 02110 ("FNBB"), ABN AMRO BANK N.V., with its Boston branch at One Post Office Square, Boston, Massachusetts 02109 ("ABN"), and the other lending institutions party hereto (collectively with FNBB and ABN, the "Banks") and (c) THE FIRST NATIONAL BANK OF BOSTON, as administrative agent for the Banks (the "Administrative Agent") and ABN AMRO BANK N.V., as documentation agent for the Banks (the "Documentation Agent," and collectively with the Administrative Agent, the "Agents"). WHEREAS, the Borrower, FNBB, ABN, and the Agents entered into a Revolving Credit Agreement dated as of January 22, 1997 (the "Credit Agreement"), pursuant to which FNBB and ABN extended credit to the Borrower on the terms set forth therein; WHEREAS, FNBB and ABN (collectively, the "Assignor Banks") wish to assign interests in their Syndicated Loans, Letter of Credit Participations, Commitments, and other rights, interests and obligations under the Credit Agreement to the other financial institutions listed on Schedule 1 attached hereto (collectively, the "Assignee Banks"), and the Assignee Banks wish to assume such interests and become parties to the Credit Agreement, all as set forth in this First Amendment; and WHEREAS, the parties desire to amend the Credit Agreement to reflect such assignments and to amend certain terms of the Credit Agreement as set forth herein; NOW, THEREFORE, in consideration of the foregoing, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree to amend the Credit Agreement as follows: Definitions. Capitalized terms used herein without definition shall have the meanings assigned to such terms in the Credit Agreement. Amendment to 1.1. The following definitions in 1.1 of the Credit Agreement are hereby amended to read as follows: Drawdown Date. The date on which any Loan is made or is to be made, or any Loan is converted or continued in accordance with 2.7. Permitted Receivables Transaction. Any sale or sales (including on a revolving basis) of, and/or securitization of, any accounts receivable of the Borrower and/or any of its Subsidiaries not to exceed $100,000,000 in the aggregate at any one time outstanding. Amendment to 2.3(c). Section 2.3(c) is hereby amended to read as follows: (c) In the event that the Note Purchase Agreement is not amended on or before February 20, 1997, the Borrower may request that the Total Commitment be increased by $50,000,000 hereunder, which increase is subject to the approval of the Administrative Agent; provided, however, that in the event that such an increase is approved, (i) any Bank which is a party to this Agreement prior to such increase shall not be required to increase its Commitment hereunder, (ii) such Bank's Commitment Percentage shall be correspondingly decreased to reflect such increase in the Total Commitment, and (iii) any such increase and the $50,000,000 of Total Commitment reserved pursuant to 7.18 shall be used to repay the Borrower's obligations under the Note Purchase Agreement. Amendment to 3.2(a). Section 3.2(a) is amended by substituting the phrase, "date of any drawing under any Letter of Credit" for the phrase, "Drawdown Date" in subsection (ii) thereof. Amendment to 11.1. Section 11.1 is amended by substituting the phrase, "any Drawdown Date" for the phrase, "the making of such Loan." Amendment to 12.1(f). Section 12.1(f) is amended by inserting the phrase, "any obligation in respect of" immediately prior to the first occurrence of the words, "any Indebtedness." Amendment of 18. Section 18 is amended by deleting the word "Percentage" immediately following the word "Commitment" in the first sentence thereof. Waiver of the Requirements of 18. The parties hereto hereby agree that, to the extent that the actions taken in connection with the assignments contemplated hereunder do not comply with certain requirements set forth in 18, such requirements are hereby waived by all parties, and the assignments made pursuant to this First Amendment shall be fully effective to the same extent as if all such requirements had been fulfilled. Amendment to Schedule 1 to the Credit Agreement. Schedule 1 to the Credit Agreement is hereby amended by deleting such schedule in its entirety and substituting the Schedule 1 attached hereto in place thereof. The parties hereto hereby acknowledge and agree that each reference to Schedule 1 in the Credit Agreement or any other Loan Document shall henceforth be a reference to Schedule 1 attached hereto or as subsequently amended. Assignment. (a) Each Assignor Bank hereby sells and assigns to the Assignee Banks, and each Assignee Bank hereby purchases and assumes without recourse to the Assignor Banks, an interest in and to the rights, benefits, indemnities and obligations of the Assignor Banks under the Credit Agreement equal to such Assignee Bank's Commitment Percentage (as set forth on Schedule 1 hereto) in respect of the Total Commitment and the Letter of Credit Participations, each as in effect immediately prior to the Effective Date (as hereinafter defined). (b) Each of FNBB and ABN represents and warrants that, as of the date hereof, (i) ABN's Commitment is $100,000,000, its Commitment Percentage is 22.2222%, and the aggregate outstanding principal balance of its Syndicated Loans equals $60,000,000 and (ii) FNBB's Commitment is $350,000,000, its Commitment Percentage is 77.7778%, and the aggregate outstanding principal balance of its Syndicated Loans equals $210,000,000 (in each case, before giving effect to the assignments contemplated hereby or any contemplated assignments which have not yet become effective), (iii) there are no outstanding Letters of Credit, and (iv) there are no outstanding Competitive Bid Loans. (c) Each Assignor Bank (i) represents and warrants that it is legally authorized to enter into this First Amendment, but otherwise makes no representation or warranty, express or implied, and assumes no responsibility with respect to any statements, warranties or representations made in or in connection with the Credit Agreement or any of the other Loan Documents or the execution (other than on the part of the Assignor Banks), legality, validity, enforceability, genuineness, sufficiency or value of the Credit Agreement, the other Loan Documents or any other instrument or document furnished pursuant thereto, other than that it is the legal and beneficial owner of the interest being assigned by it hereunder free and clear of any claim or encumbrance; and (ii) makes no representation or warranty and assumes no responsibility with respect to the financial condition of the Borrower or any of its Subsidiaries, or the performance or observance by the Borrower or any of its Subsidiaries or any of their respective Subsidiaries in respect of any of the Obligations under the Credit Agreement or any of the other Loan Documents or any other instrument or document delivered or executed pursuant thereto. (d) Each of the Assignee Banks (i) represents and warrants that (A) it is duly and legally authorized to enter into this First Amendment, (B) the execution, delivery and performance of this First Amendment do not conflict with any provision of law or of the charter or bylaws of such Assignee Bank, or of any agreement binding on such Assignee Bank, and (C) all acts, conditions and things required to be done and performed and to have occurred prior to the execution, delivery and performance of this First Amendment, and to render the same the legal, valid and binding obligation of each of the Assignee Banks, enforceable against it in accordance with its terms, have been done and performed and have occurred in due and strict compliance with all applicable laws; (ii) confirms that it has received a copy of the Credit Agreement and each of the other Loan Documents, together with copies of the most recent financial statements delivered pursuant to 6.4 and 7.4 of the Credit Agreement and such other documents and information as it has deemed appropriate to make its own credit analysis and decision to enter into this First Amendment; (iii) agrees that it will, independently and without reliance upon any Assignor Bank, any Agent, or any Bank, and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Credit Agreement; (iv) appoints and authorizes the Administrative Agent to take such action as agent on its behalf and to exercise such powers under the Credit Agreement and the other Loan Documents as are delegated to the Administrative Agent by the terms thereof, together with such powers as are reasonably incidental thereto; (v) agrees that it will perform in accordance with their terms all of the obligations which by the terms of the Credit Agreement are required to be performed by it as a Bank; and (vi) agrees to treat in confidence any "confidential information" obtained by it concerning the Borrower and its Subsidiaries in accordance with the terms of 24 of the Credit Agreement. (e) From and after the Effective Date, each of the Assignee Banks shall be a party to the Credit Agreement, shall become a "Bank" for all purposes under the Credit Agreement and the Loan Documents, and shall have the rights and obligations of a Bank thereunder. Representations and Warranties. The Borrower represents and warrants as follows: (a) The execution and delivery of this First Amendment, the Replacement Notes (as hereinafter defined), the Competitive Bid Notes, and the Credit Agreement, as modified by this First Amendment, and the performance of the transactions contemplated hereby and thereby (i) are within the corporate authority of the Borrower, (ii) have been duly authorized by all necessary corporate proceedings on the part of the Borrower, (iii) do not conflict with or result in any material breach or contravention of any provision of law, statute, rule or regulation to which the Borrower is subject or any judgment, order, writ, injunction, license or permit applicable to the Borrower so as to materially adversely affect the assets, business or any activity of the Borrower, and (iv) do not conflict with any provision of the corporate charter or bylaws of the Borrower or any agreement or other instrument binding upon the Borrower. There have been no amendments to the charter documents or bylaws of the Borrower since January 22, 1997. (b) The execution and delivery of this First Amendment, the Replacement Notes, the Competitive Bid Notes, and the Credit Agreement, as modified by this First Amendment, and the performance of the transactions contemplated hereby and thereby will result in valid and legally binding obligations of the Borrower party thereto enforceable against the Borrower in accordance with the respective terms and provisions hereof and thereof, except as enforceability is limited by bankruptcy, insolvency, reorganization, moratorium or other laws relating to or affecting generally the enforcement of creditors rights and except to the extent that availability of the remedy of specific performance or injunctive relief is subject to the discretion of the court before which any proceeding therefor may be brought. (c) The execution and delivery by the Borrower of this First Amendment, the Replacement Notes, the Competitive Bid Notes, and the Credit Agreement, as modified by this First Amendment, and the consummation by the Borrower of the transactions contemplated hereby and thereby do not require any approval or consent of, or filing with, any governmental agency or authority other than those already obtained. (d) The representations and warranties contained in the Credit Agreement or in any document or instrument delivered pursuant to or in connection with the Credit Agreement, the Replacement Notes, the Competitive Bid Notes, or this First Amendment were true as of the date as of which they were made and are true at and as of the Effective Date with the same effect as if made at and as of that time (except to the extent of changes resulting from transactions contemplated or permitted by the Credit Agreement and changes occurring in the ordinary course of business which singly or in the aggregate are not materially adverse, and to the extent that such representations and warranties relate expressly and solely to an earlier date). (e) The Borrower has performed and complied with all terms and conditions in the Credit Agreement and this First Amendment required to be performed or complied with by it prior to or at the Effective Date, and no Default or Event of Default or condition which would result in a Default or Event of Default has occurred and is continuing. Ratification, etc. Except as expressly amended hereby, the Credit Agreement, the other Loan Documents and all documents, instruments and agreements related thereto are hereby ratified and confirmed in all respects and shall continue in full force and effect. This First Amendment and the Credit Agreement shall hereafter be read and construed together as a single document, and all references in the Credit Agreement, any other Loan Document or any agreement or instrument related to the Credit Agreement shall hereafter refer to the Credit Agreement as amended by this First Amendment. GOVERNING LAW. THIS FIRST AMENDMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE COMMONWEALTH OF MASSACHUSETTS (WITHOUT REFERENCE TO CONFLICT OF LAWS) AND SHALL TAKE EFFECT AS A SEALED INSTRUMENT IN ACCORDANCE WITH SUCH LAWS. Counterparts. This First Amendment may be executed in any number of counterparts and by different parties hereto on separate counterparts, each of which when so executed and delivered shall be an original, but all of which counterparts taken together shall be deemed to constitute one and the same instrument. Effectiveness. This First Amendment shall become effective upon the satisfaction of each of the following conditions (the "Effective Date"): (a) This First Amendment shall have been executed and delivered by the respective parties hereto; (b) The Borrower shall have executed and delivered (i) to each Assignor Bank a replacement Syndicated Note and (ii) to each Assignee Bank a Syndicated Note, in each case in substantially the form of Exhibit A to the Credit Agreement and in an amount equal to such Bank's Commitment Percentage (as reflected on Schedule 1 attached hereto) multiplied by the Total Commitment (collectively, the "Replacement Notes"), and (iii) to each Assignee Bank so requesting, a Competitive Bid Note in substantially the form of Exhibit B to the Credit Agreement; (c) All corporate action necessary for the valid execution and delivery by the Borrower of this First Amendment, the Credit Agreement, as amended by this First Amendment, the Replacement Notes, and the Competitive Bid Notes, and the performance of the transactions contemplated hereby and thereby shall have been taken, and satisfactory evidence thereof shall have been provided to the Administrative Agent; and (d) The Administrative Agent shall have received a favorable opinion addressed to the Administrative Agent dated the Effective Date, in form and substance satisfactory to the Administrative Agent, regarding the authority, the due and valid execution and delivery, and the enforceability of this First Amendment, the Replacement Notes, and the Competitive Bid Notes. Return of Old Notes. As soon as practicable after the Effective Date, each Assignor Bank shall return to the Borrower marked "Substituted" its Syndicated Note issued by the Borrower to such Assignor Bank on the Closing Date. IN WITNESS WHEREOF, each of the undersigned has duly executed this First Amendment under seal as of the date first set forth above. THE BORROWER: MILLIPORE CORPORATION By: Name: Title: THE BANKS AND AGENTS: THE FIRST NATIONAL BANK OF BOSTON, individually and as Agent By: Elizabeth C. Everett Director ABN AMRO BANK N.V. By: Name: Title: By: Name: Title: THE DAI-ICHI KANGYO BANK, LTD. By: Name: Title: By: Name: Title: THE SUMITOMO BANK, LIMITED By: Name: Title: By: Name: Title: THE SAKURA BANK, LIMITED NEW YORK BRANCH By: Name: Title: By: Name: Title: THE CHASE MANHATTAN BANK By: Name: Title: BANK OF TOKYO-MITSUBISHI TRUST COMPANY By: Name: Title: By: Name: Title: CREDIT LYONNAIS NEW YORK BRANCH By: Name: Title: By: Name: Title: THE BANK OF NOVA SCOTIA By: Name: Title: By: Name: Title: FLEET NATIONAL BANK By: Name: Title: By: Name: Title: MELLON BANK, N.A. By: Name: Title: By: Name: Title: STATE STREET BANK AND TRUST COMPANY By: Name: Title: By: Name: Title: CITIZENS BANK OF MASSACHUSETTS By: Name: Title: By: Name: Title: MORGAN GUARANTY TRUST COMPANY OF NEW YORK By: Name: Title: By: Name: Title: THE SANWA BANK, LIMITED By: Name: Title: By: Name: Title: YASUDA TRUST & BANKING CO. By: Name: Title: By: Name: Title: SCHEDULE 1 BANKS; COMMITMENT PERCENTAGES BANK COMMITMENT PERCENTAGE The First National Bank of Boston Domestic and Eurodollar 10.00000000% Lending Office: 100 Federal Street Boston, MA 02110 Attention: Elizabeth C. Everett, Director Fax Number: (617) 434-0819 ABN Amro Bank N.V. Domestic and Eurodollar Lending Office: 10.00000000% One Post Office Square, 39th Floor Boston, MA 02109 Attention: Charles Wahle Fax Number: (617) 988-7910 The Dai-Ichi Kangyo Bank, Ltd. Domestic and Eurodollar 4.44444444% Lending Office: One World Trade Center, Suite 4911 New York, NY 10048 Attention: Tom Fennessey Fax Number: (212) 524-0579 The Sumitomo Bank, Limited Domestic and Eurodollar Lending Office: 4.44444444% U.S. Corporate Department 277 Park Avenue New York, NY 10172 Attention: Angelo Balestrieri Fax Number: (212) 224-5188 The Sakura Bank, Limited New York Branch Domestic and Eurodollar 4.44444444% Lending Office: 277 Park Avenue, 45th floor New York, NY 10172 Attention: Shelly Yu Fax Number: (212) 888-7651 The Chase Manhattan Bank Domestic and Eurodollar Lending Office: 8.70370370% 999 Broad Street Bridgeport, CT 06604 Attention: David Nackley Fax Number: (203) 382-6314 Bank of Tokyo-Mitsubishi Trust Company Domestic and Eurodollar 8.70370370% Lending Office: 1251 Avenue of the Americas New York, NY 10020-1104 Attention: Frederick Leone, Esq. Fax Number: (212) 782-6420 Credit Lyonnais New York Branch Domestic and Eurodollar 6.11111111% Lending Office: 53 State Street Boston, MA 02110 Attention: David O'Connell Fax Number: (617) 723-4803 The Bank of Nova Scotia Domestic and Eurodollar Lending Office: 6.11111111% 101 Federal Street, 16th floor Boston, MA 02210 Attention: Mike Bradley Fax Number: (617) 951-2177 Fleet National Bank Domestic and Eurodollar Lending Office: 8.70370370% One Federal Street, MAOFO305 Boston, MA 02211 Attention: Amy Tsokanis Fax Number: (617) 346-0590 Mellon Bank, N.A. Domestic and Eurodollar Lending Office: 4.44444444% One Boston Place, Aim #024- 006A Boston, MA 02108 Attention: Rita Long Fax Number: (617) 722-7994 State Street Bank and Trust Company Domestic and Eurodollar 4.44444444% Lending Office: 225 Franklin Street, M2 Boston, MA 02110 Attention: Fran Rust Fax Number: (617) 664-3675 Citizens Bank of Massachusetts Domestic and Eurodollar 4.44444444% Lending Office: 55 Summer Street, 4th floor Boston, MA 02110 Attention: Bruce Bernier Fax Number: (617) 422-8354 Morgan Guaranty Trust Company of New York Domestic and Eurodollar 4.44444444% Lending Office: 60 Wall Street New York, NY 10260 Attention: Deborah Brodheim Fax Number: (212) 648-5018 The Sanwa Bank, Limited Domestic and Eurodollar Lending Office: 6.11111111% Park Avenue Plaza 55 East 52nd Street New York, NY 10055 Attention: Renko Hara Fax Number: (212) 754-2368 For credit matters, please copy correspondence to: One Financial Center, 2812 Boston, MA 02111 Attention: Dale Edmunds Fax Number: (617) 350-7212 Yasuda Trust & Banking Co. Domestic and Eurodollar Lending Office: 4.44444444% 666 5th Avenue New York, NY 10103 Attention: Ken Nasto Fax Number: (212) 373-5796 WAIVER TO REVOLVING CREDIT AGREEMENT WAIVER AGREEMENT (this "Waiver Agreement") TO THE REVOLVING CREDIT AGREEMENT dated as of January 22, 1997, as amended (the "Credit Agreement") made and entered into as of February 18, 1997, by and among (a) MILLIPORE CORPORATION, a Massachusetts corporation having its principal place of business at 80 Ashby Road, Bedford, MA 01730-2271 (the "Borrower"), (b) THE FIRST NATIONAL BANK OF BOSTON, a national banking association with its head office at 100 Federal Street, Boston, Massachusetts 02110 ("FNBB"), ABN AMRO BANK N.V., with its Boston branch at One Post Office Square, Boston, Massachusetts 02109 ("ABN"), and the other lending institutions party thereto (collectively with FNBB and ABN, the "Banks") and (c) THE FIRST NATIONAL BANK OF BOSTON, as administrative agent for the Banks (the "Administrative Agent") and ABN AMRO BANK N.V., as documentation agent for the Banks (the "Documentation Agent," and collectively with the Administrative Agent, the "Agents"). WHEREAS, the Agents and the Banks have agreed to waive certain provisions of the Credit Agreement on the conditions and for the period as hereinafter set forth; NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows: 1. Definitions. Capitalized terms used herein without definition shall have the meanings ascribed to them in the Credit Agreement. 2. Waiver of 7.18 of the Credit Agreement. (a) Any Event of Default which would otherwise occur under 7.18 as a result of the Borrower's failure to amend the Note Purchase Agreement on or before February 20, 1997 is hereby waived, provided that the Note Purchase Agreement shall be amended on or before March 21, 1997 and provided further that until such amendment is effective or the Note Purchase Agreement is terminated, the Borrower shall ensure that $50,000,000 of the Total Commitment remains available. (b) The Agents, the Banks, and the Borrower further agree that the Borrower may request an increase in the Total Commitment, subject to the conditions set forth in 2.3(c) of the Credit Agreement, as amended, in the event that the Note Purchase Agreement is not amended on or before March 21, 1997. 3. Ratification, etc. Except as expressly waived or amended hereby, the Credit Agreement, the other Loan Documents and all documents, instruments and agreements related thereto are hereby ratified and confirmed in all respects and shall continue in full force and effect. 4. Counterparts. This Waiver Agreement may be executed in any number of counterparts and by different parties hereto on separate counterparts, each of which when so executed and delivered shall be an original, but all of which counterparts taken together shall be deemed to constitute one and the same instrument. Complete sets of counterparts shall be lodged with the Banks. 5. Effectiveness. This Waiver Agreement shall become effective upon its execution and delivery by the respective parties hereto. IN WITNESS WHEREOF, each of the undersigned have duly executed this Waiver Agreement under seal as of the date first set forth above. THE BORROWER: MILLIPORE CORPORATION By: Jeffrey Rudin, Corporate Vice President THE BANKS AND AGENTS: THE FIRST NATIONAL BANK OF BOSTON, individually and as Agent By: Elizabeth C. Everett, Director ABN AMRO BANK N.V., individually and as Documentation Agent By: Carol A. Levine, Senior Vice President By: Charles J. Wahle, Vice President THE DAI-ICHI KANGYO BANK, LTD. By: Thomas M. Fennessey Assistant Vice President THE SUMITOMO BANK, LIMITED By: John C. Kissinger, Joint General Manager THE SAKURA BANK, LIMITED NEW YORK BRANCH By: Yasumasa Kikuchi, Senior Vice President THE CHASE MANHATTAN BANK By: David M. Nackley, Vice President BANK OF TOKYO-MITSUBISHI TRUST COMPANY By: Patrick D. Bonebrake, Assistant Vice President CREDIT LYONNAIS NEW YORK BRANCH By: Alain Papiasse, Executive Vice President THE BANK OF NOVA SCOTIA By: Terry M. Pitcher, Vice President By: Michael R. Bradley Senior Relationship Manager FLEET NATIONAL BANK By: Lisa S. Coney, Senior Vice President MELLON BANK, N.A. By: Rita C. Long, Vice President STATE STREET BANK AND TRUST COMPANY By: Monica M. Sheehan, Vice President CITIZENS BANK OF MASSACHUSETTS By: Bruce A. Bernier, Vice President MORGAN GUARANTY TRUST COMPANY OF NEW YORK By: Diana H. Imhof, Vice President THE SANWA BANK, LIMITED By: Yutaka Higashino, Senior Vice President YASUDA TRUST & BANKING CO. By: Rohn Laudenschlager, Senior Vice President CREDITO ITALIANO SPA By: Harmon P. Butler, First Vice President By: Saiyed A. Abbas, Assistant Vice President
-----END PRIVACY-ENHANCED MESSAGE-----